Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


FORM 10-K

 


 

x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2006

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission file number 1-11037

 


Praxair, Inc.

 


 

Praxair, Inc.   Tel. (203) 837-2000
39 Old Ridgebury Road   State of incorporation: Delaware
Danbury, Connecticut 06810-5113   IRS identification number: 06-124 9050

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:

  Registered on:
Common Stock ($0.01 par value)   New York Stock Exchange
Common Stock Purchase Rights   New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

 


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes   x     No ¨

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes    ¨     No    x

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes    x     No    ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K    x

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer   x     Accelerated Filer   ¨     Non- Accelerated Filer   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes   ¨     No   x

The aggregate market value of the voting and non-voting common stock held by non-affiliates, computed by reference to the price at which the stock was last sold on June 30, 2006, was approximately $17.4 billion.

At January 31, 2007, 320,370,106 shares of common stock of Praxair, Inc. were outstanding.

Documents incorporated by reference:

Portions of the 2006 Annual Report to Shareholders of the Registrant are incorporated in Parts I, II and IV of this report. Also, portions of the Proxy Statement of Praxair, Inc., anticipated to be filed on or about March 15, 2007, are incorporated in Part III of this report.

The Index to Exhibits is located on page 18 of this report.

 

 



Table of Contents

Forward-looking statements

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s reasonable expectations and assumptions as of the date the statements are made but involve risks and uncertainties. These risks and uncertainties include, without limitation: the performance of stock markets generally; developments in worldwide and national economies and other international events and circumstances; changes in foreign currencies and in interest rates; the cost and availability of electric power, natural gas and other raw materials; the ability to achieve price increases to offset cost increases; catastrophic events including natural disasters, epidemics and acts of war and terrorism; the ability to attract, hire, and retain qualified personnel; the impact of changes in financial accounting standards; the impact of tax, environmental, home healthcare and other legislation and government regulation in jurisdictions in which the company operates; the cost and outcomes of litigation and regulatory agency actions; continued timely development and market acceptance of new products and applications; the impact of competitive products and pricing; future financial and operating performance of major customers and industries served; and the effectiveness and speed of integrating new acquisitions into the business. These risks and uncertainties may cause actual future results or circumstances to differ materially from the projections or estimates contained in the forward-looking statements. The company assumes no obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The above listed risks and uncertainties are further described in Item 1A (Risk Factors) which should be reviewed carefully. Please consider the company’s forward-looking statements in light of those risks.


Table of Contents

INDEX

 

         PAGE
Part I   
Item 1:   Business    2
Item 1a:   Risk Factors    6
Item 1b:   Unresolved Staff Comments    9
Item 2:   Properties    10
Item 3:   Legal Proceedings    11
Item 4:   Submission of Matters to a Vote of Security Holders    11
Part II   
Item 5:   Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities    12
Item 6:   Selected Financial Data    12
Item 7:   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12
Item 7a:   Quantitative and Qualitative Disclosures About Market Risk    13
Item 8:   Financial Statements and Supplementary Data    13
Item 9:   Changes in and Disagreements with Accountants on Accounting and Financial Disclosure    13
Item 9a:   Controls and Procedures    13
Item 9b:   Other Information    13
Part III   
Item 10:   Directors, Executive Officers and Corporate Governance    14
Item 11:   Executive Compensation    14
Item 12:   Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters    15
Item 13:   Certain Relationships and Related Transactions and Director Independence    15
Item 14:   Principal Accounting Fees and Services    15
Part IV   
Item 15:   Exhibits and Financial Statement Schedules    16
Signatures    17
Index to Exhibits    18


Table of Contents

PART I

Praxair, Inc. and Subsidiaries


 

Item 1. B usiness

General

Praxair, Inc. (Praxair or Company) was founded in 1907 and became an independent publicly traded company in 1992. Praxair was the first company in the United States to produce oxygen from air using a cryogenic process and continues to be a major technological innovator in the industrial gases industry.

Praxair is the largest industrial gases supplier in North and South America, is rapidly growing in Asia, and has strong, well-established businesses in Europe. Praxair’s primary products for its industrial gases business are atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). The Company also designs, engineers, and builds equipment that produces industrial gases for internal use and external sale. The Company’s surface technologies segment, operated through Praxair Surface Technologies, Inc., supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders. Sales for Praxair were $8,324 million, $7,656 million, and $6,594 million for 2006, 2005 and 2004, respectively. Refer to Note 19 of the section captioned “Notes to Consolidated Financial Statements” in Praxair’s 2006 Annual Report to Shareholders for additional information related to Praxair’s reportable segments.

Praxair serves approximately 25 industries as diverse as healthcare and petroleum refining; computer-chip manufacturing and beverage carbonation; fiber-optics and steel making; and aerospace, chemicals and water treatment. In 2006, 94% of sales were generated in four regional segments (North America, Europe, South America, and Asia) primarily from the sale of industrial gases with the balance generated from the surface technologies segment. Praxair provides a competitive advantage to its customer base by continuously developing new products and applications, which allow them to improve their productivity, energy efficiency and environmental performance.

Industrial Gases Products and Manufacturing Processes

Atmospheric gases are the highest volume products produced by Praxair. Using air as its raw material, Praxair produces oxygen, nitrogen and argon through several air separation processes, of which, cryogenic air separation is the most prevalent. As a pioneer in the industrial gases industry, Praxair is a leader in developing a wide range of proprietary and patented applications and supply systems technology, including small cryogenic nitrogen plants. Praxair also led the development and commercialization of non-cryogenic air separation technologies for the production of industrial gases. These technologies open important new markets and optimize production capacity for the Company by lowering the cost of supplying industrial gases. These technologies include proprietary vacuum pressure swing adsorption (“VPSA”) and membrane separation to produce gaseous oxygen and nitrogen, respectively. Praxair also manufactures precious metal and ceramic sputtering targets used primarily in the production of semiconductors.

Process gases, including carbon dioxide, hydrogen, carbon monoxide, helium and acetylene are produced by methods other than air separation. Most carbon dioxide is purchased from by-product sources, including chemical plants, refineries, and industrial processes and is recovered from carbon dioxide wells. Carbon dioxide is processed in Praxair’s plants to produce commercial carbon dioxide. Hydrogen and carbon monoxide are produced by either steam methane reforming of natural gas or by purifying by-product sources obtained from the chemical and petrochemical industries. Most of the helium sold by Praxair is sourced from certain helium-rich natural gas streams in the United States, with additional supplies being acquired from outside the United States. Acetylene is typically produced from calcium carbide and water or purchased as a chemical by-product.

 

2


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Industrial Gases Distribution

There are three basic distribution methods for industrial gases: (i) on-site or tonnage; (ii) merchant liquid; and (iii) packaged or cylinder gases. These distribution methods are often integrated, with products from all three supply modes coming from the same plant. The method of supply is generally determined by the lowest cost means of meeting the customer’s needs, depending upon factors such as volume requirements, purity, pattern of usage, and the form in which the product is used (as a gas or as a cryogenic liquid).

On-site. Customers that require the largest volumes of product (typically oxygen, nitrogen and hydrogen) and that have a relatively constant demand pattern are supplied by cryogenic and process gas on-site plants. Praxair constructs plants on or adjacent to these customers’ sites and supplies the product directly to customers. Because these are usually dedicated plants, the product supply contracts generally are total requirement contracts with terms typically ranging from 10-20 years and containing minimum purchase requirements and price escalation provisions. Many of the cryogenic on-site plants also produce liquid products for the merchant market. New advanced air separation processes allow on-site delivery to customers with smaller volume requirements. Customers using these systems usually enter into requirement contracts with terms typically ranging from 5-15 years.

Merchant. The merchant business is generally associated with distributable liquid oxygen, nitrogen, argon, carbon dioxide, hydrogen and helium. The deliveries generally are made from Praxair’s plants by tanker trucks to storage containers owned or leased and maintained by Praxair or the customer at the customer’s site. Due to distribution cost, merchant oxygen and nitrogen generally have a relatively small distribution radius from the plants at which they are produced. Merchant argon, hydrogen and helium can be shipped much longer distances. The agreements used in the merchant business are usually three-to five-year requirement contracts, except for carbon dioxide, which typically has one-year requirement contracts in the United States.

Packaged Gases. Customers requiring small volumes are supplied products in metal containers called cylinders, under medium to high pressure. Packaged gases include atmospheric gases, carbon dioxide, hydrogen, helium and acetylene. Praxair also produces and distributes in cylinders a wide range of specialty gases and mixtures. Cylinders may be delivered to the customer’s site or picked up by the customer at a packaging facility or retail store. Packaged gases are generally sold by purchase orders.

A substantial amount of the cylinder gases sold in the United States is distributed by independent distributors that buy merchant gases in liquid form and repackage the products in their facilities. These businesses also distribute welding equipment purchased from independent manufacturers. Over time, Praxair has acquired several independent industrial gases and welding products distributors at various locations in the United States and continues to sell merchant gases to other independent distributors. Between its own distribution business, joint ventures and sales to independent distributors, Praxair is represented in 48 states, the District of Columbia and Puerto Rico.

Surface technologies

Praxair’s Surface technologies segment supplies wear-resistant and high-temperature corrosion-resistant metallic and ceramic coatings and powders to the aircraft, printing, textile, plastics, primary metals, petrochemical, and other industries. It also manufactures a complete line of electric arc, plasma, and high velocity oxygen fuel spray equipment as well as arc and flame wire equipment used for the application of wear resistant coatings. The coatings extend wear life and are applied at Praxair’s facilities using a variety of thermal spray coatings processes. The coated parts are finished to the customer’s precise specifications before shipment.

 

3


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Inventories —Praxair carries inventories of merchant and cylinder gases, hardgoods and coatings materials to supply products to its customers on a reasonable delivery schedule. On-site plants and pipeline complexes have limited inventory. Inventories, inventory obsolescence and backlogs are not material to Praxair’s business.

Customers —Praxair is not dependent upon a single customer or a few customers.

International —Praxair is a global enterprise with approximately 55% of its 2006 sales outside of the United States. It conducts industrial gases business through subsidiary and affiliated companies in Argentina, Belgium, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, France, Germany, India, Israel, Italy, Japan, South Korea, Malaysia, Mexico, the Netherlands, the People’s Republic of China, Paraguay, Peru, Portugal, Spain, Taiwan, Thailand, Uruguay and Venezuela. S.I.A.D. (Societa Italiana Acetilene & Derivati S.p.A.), an Italian company accounted for as an equity company, also has established positions in Austria, Bulgaria, Croatia, the Czech Republic, Hungary, Romania and Slovenia. Praxair’s surface technologies segment has operations in Brazil, France, Germany, Italy, Japan, Singapore, South Korea, Taiwan, Spain, Switzerland and the United Kingdom.

Praxair’s international business is subject to risks customarily encountered in foreign operations, including fluctuations in foreign currency exchange rates and controls, import and export controls, and other economic, political and regulatory policies of local governments. Also, see Note 1 of the section captioned “Notes to Consolidated Financial Statements,” and the section captioned “Management’s Discussion and Analysis—Market Risk and Sensitivity Analysis” in Praxair’s 2006 Annual Report to Shareholders.

Seasonality —Praxair’s business is generally not subject to seasonal fluctuations to any significant extent.

Research and Development —Praxair’s research and development is directed toward developing new and improved methods for the production and distribution of industrial gases and the development of new markets and applications for these gases. This results in the frequent introduction of new industrial gas applications, and the development of new advanced air separation process technologies. Research and development for industrial gases is principally conducted at Tonawanda, New York; Burr Ridge, Illinois; Rio de Janeiro, Brazil; and Shanghai, China.

Praxair conducts research and development for its surface technologies to improve the quality and durability of coatings and the use of specialty powders for new applications and industries. Surface technologies research is conducted at Indianapolis, Indiana.

Patents and Trademarks —Praxair owns or licenses a large number of United States and foreign patents that relate to a wide variety of products and processes. Praxair’s patents expire at various times over the next 20 years. While these patents and licenses are considered important, Praxair does not consider its business as a whole to be materially dependent upon any one particular patent or patent license. Praxair also owns a large number of trademarks.

Raw Materials and Energy Costs —Energy is the single largest cost item in the production and distribution of industrial gases. Most of Praxair’s energy requirements are in the form of electricity, natural gas and diesel fuel for distribution.

The supply of energy has not been a significant issue in the geographic areas where the company conducts business. However, the outcome of regional energy situations or new energy situations is unpredictable and may pose unforeseen future risks.

For carbon dioxide, carbon monoxide, helium, hydrogen, specialty gases and surface technologies, raw materials are largely purchased from outside sources. Praxair has contracts or commitments for, or readily available sources of, most of these raw materials; however, their long-term availability and prices are subject to market conditions.

Competition —Praxair operates within a highly competitive environment. Some of its competitors are larger in size and capital base than Praxair. Competition is based on price, product quality, delivery, reliability, technology and service to customers.

 

4


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Major competitors in the industrial gases industry both in the United States and worldwide include Air Products and Chemicals, Inc., Airgas Inc., L’Air Liquide S.A., and Linde AG. Principal domestic competitors for the surface technologies business are Chromalloy Gas Turbine Corporation, a subsidiary of Sequa Corporation, Sermatech International, Inc., a subsidiary of Teleflex, Inc., and Chemtronics, Inc., a subsidiary of GKN p.l.c. International competitors in surface technologies vary from country to country.

Employees and Labor Relations —As of December 31, 2006, Praxair had 27,042 employees worldwide. Of this number, 10,674 are employed in the United States. Praxair has collective bargaining agreements with unions at numerous locations throughout the world, which expire at various dates. Praxair considers relations with its employees to be good.

Environment —Information required by this item is incorporated herein by reference to the section captioned “Management’s Discussion and Analysis—Costs Relating to the Protection of the Environment” in Praxair’s 2006 Annual Report to Shareholders.

Website Access to Reports —Praxair’s company website is http://www.praxair.com. The Company makes its periodic and current reports available, free of charge, on its website as soon as practicable after such material is electronically filed with, or furnished to, the Securities and Exchange Commission (SEC). The SEC is located at 100 F Street NE, Washington, D.C. 20549 and its website address is http://www.sec.gov. In addition, investors may also access from the Company website other investor information such as press releases, business trends, presentations, etc. Information on the Company’s website is not incorporated by reference herein.

 

5


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Item 1a. Risk Factors

Due to the size and geographic reach of the Company’s operations, a wide range of factors, many of which are outside of the Company’s control, could materially affect the Company’s future operations and financial performance. Management believes the following risks may significantly impact the Company:

External factors

Significant external factors include:

 

   

General economic conditions;

 

   

Cost and availability of raw materials and energy;

 

   

International events and circumstances;

 

   

Macro-economic factors;

 

   

Competitor actions;

 

   

Governmental regulations; and

 

   

Catastrophic events.

General Economic Conditions

Although Praxair serves approximately 25 diverse industries across more than 30 countries, which generally leads to financial stability through various business cycles, demand for Praxair’s products would be adversely affected by a broad decline in general economic or business conditions in the industries served by its customers. In addition, many of the Company’s customers are in businesses that are cyclical in nature, such as the chemicals, metals and refining industries. Downturns in these industries may adversely impact Praxair’s financial position, results of operations and cash flows.

Cost and Availability of Raw Materials and Energy

Energy is the single largest cost item in the production and distribution of industrial gases. Most of Praxair’s energy requirements are in the form of electricity, natural gas and diesel fuel for distribution. Praxair attempts to minimize the financial impact of variability in these costs through the management of customer contracts, which typically have escalation and pass-through clauses for the Company’s larger contracts. Such attempts may not successfully mitigate the impact of cost variability which could negatively impact its financial condition or results of operations. The supply of energy has not been a significant issue in the geographic areas where it conducts business. However, regional energy conditions are unpredictable and may pose future risk.

For carbon dioxide, carbon monoxide, helium, hydrogen, specialty gases and surface technologies, raw materials are largely purchased from outside sources. Praxair has contracts or commitments for, or readily available sources of, most of these raw materials; however, their long-term availability and prices are subject to market conditions. A disruption in supply of such raw materials could impact the Company’s ability to meet contractual supply commitments.

International Events and Circumstances

Praxair has substantial international operations, which is subject to the risks of doing business abroad, including fluctuations in currency exchange rates, transportation delays and interruptions, political and economic instability and disruptions, restrictions on the transfer of funds, the imposition of duties and tariffs, import and export controls, changes in governmental policies, labor unrest, possible nationalization of assets, and current and changing regulatory environments. These events could have an adverse effect on the international operations in the future by reducing the demand for its products, decreasing the prices at which it can sell its products or otherwise having an adverse effect on its business, financial condition or results of operations.

 

6


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Macro-economic factors

Changes in U.S. and global financial and equity markets, including market disruptions and significant interest rate fluctuations, may make it more difficult for Praxair to obtain financing for its operations or increase the cost of obtaining financing. In addition, the Company’s borrowing costs can be affected by short and long-term debt ratings assigned by independent rating agencies which are based, in significant part, on the Company’s performance as measured by subjective credit criteria such as interest coverage and leverage ratios. A decrease in these ratings could increase the cost of borrowing or make it more difficult to obtain financing.

Competitor Actions

Praxair operates within a highly competitive environment worldwide. Competition is based on price, product quality, delivery, reliability, technology and service to customers. Competitors’ behavior related to these areas could potentially have significant impacts on the Company’s operations.

Governmental Regulations

Praxair’s operations are subject to a variety of United States and foreign government regulations. These regulations include those related to the following areas, among others:

 

   

Environmental protection and safety

 

   

Domestic and international tax laws and currency controls

 

   

Transportation

 

   

Safety

 

   

Securities laws (e.g., SEC and generally accepted accounting principles in the United States)

 

   

Patents

 

   

Trade restrictions

 

   

Antitrust matters

 

   

Home healthcare reimbursement regulations

Changes in these or other regulatory areas may impact the Company’s profitability, may require the Company to spend additional resources to comply with the regulations, or may restrict the Company’s ability to compete effectively in the marketplace.

Catastrophic events

The occurrence of catastrophic events ranging from natural disasters such as hurricanes, to epidemics such as health epidemics, to acts of war and terrorism, could disrupt or delay the Company’s ability to produce and distribute its products to customers and could potentially expose the Company to third-party liability claims. In addition, such events could impact the Company’s customers and suppliers resulting in temporary or long-term customer outages and/or the limitation of supply of energy and other raw materials used in normal business operations. These situations are outside the Company’s control and may have a significant adverse impact on the results of operations.

Internal Factors

Significant internal factors include:

 

   

Retaining qualified personnel;

 

   

Technological advances;

 

   

Litigation and governmental investigations;

 

   

Environmental laws and regulations;

 

   

Tax liabilities;

 

   

Operational risks; and

 

   

Acquisitions.

 

7


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Retaining qualified personnel

If Praxair fails to attract, hire and retain qualified personnel, the Company may not be able to develop, market or sell its products or successfully manage its business. Praxair is dependent upon its highly skilled, experienced and efficient workforce to be successful. Much of Praxair’s competitive advantage is based on the expertise and experience of its key personnel regarding its marketing, technology, manufacturing and distribution infrastructure, systems and products. The inability to attract and hire qualified individuals or the loss of key employees in very skilled areas could have a negative effect on the Company’s business, results of operations and financial condition.

Technological advances

If Praxair fails to keep pace with technological advances in the industry or if new technology initiatives do not become commercially accepted, customers may not continue to buy the Company’s products and results of operations could be adversely affected. Praxair’s research and development is directed toward developing new and improved methods for the production and distribution of industrial gases and the development of new markets and applications for the use of these gases. This results in the frequent introduction of new industrial gas applications, and the development of new advanced air separation process technologies. The Company also conducts research and development for its surface technologies to improve the quality and durability of coatings and the use of speciality powders for new applications and industries. The results of these research and development activities help Praxair to create a competitive advantage and provide a platform for the Company to grow its business at greater percentages than the rate of industrial production growth in the geographies where it operates. If Praxair’s research and development activities did not keep pace with competitors or if it did not create new applications that benefit customers, the Company’s future results of operations could be adversely affected.

Litigation and governmental investigations

Praxair is subject to various lawsuits and governmental investigations arising out of the normal course of business that may result in adverse outcomes. Praxair is subject to various lawsuits and government investigations from time to time. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Adverse outcomes in some or all of the claims pending may result in significant monetary damages or injunctive relief that could adversely affect its ability to conduct business. While management currently believes that resolving all of these matters, individually or in the aggregate, will not have a material adverse impact on the Company’s financial position or liquidity, the litigation and other claims Praxair faces are subject to inherent uncertainties and management’s view of these matters may change in the future. There exists the possibility of a material adverse impact on the Company’s results of operations for the period in which the effect of an unfavorable final outcome becomes probable and reasonably estimable.

Environmental laws and regulations

Praxair is subject to various environmental and occupational health and safety laws and regulations, including those governing the discharge of pollutants into the air or water, the storage, handling and disposal of chemicals, hazardous substances and wastes, and the remediation of contamination. Violations of these laws could result in substantial penalties, third party claims for property damage or personal injury, or sanctions. The Company may also be subject to liability for the investigation and remediation of environmental contamination at properties that it owns or operates and at other properties where Praxair or its predecessors have operated or arranged for the disposal of hazardous wastes. Although management does not believe that any such liabilities will have a material adverse impact on its financial position and results of operations, management cannot provide assurance that such costs will not increase in the future or will not become material.

Tax liabilities

Praxair is subject to income and other taxes in both the United States and numerous foreign jurisdictions. The determination of the Company’s worldwide provision for income taxes and other tax liabilities requires judgment and is based on diverse legislative and regulatory structures that exist in the various jurisdictions where the Company operates. Although management believes its estimates are reasonable, the ultimate tax outcome may differ from the amounts recorded in its financial statements and may materially affect the Company’s results of operations for the period when such determination is made.

 

8


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Operational risks

Praxair’s operating results are dependent on the continued operation of its production facilities and its ability to meet customer contract requirements and other needs. Insufficient or excess capacity threatens the Company’s ability to generate competitive profit margins and may expose the company to liabilities related to contract commitments. Operating results are also dependent on the Company’s ability to complete new construction projects on time, on budget and in accordance with performance requirements. Failure to do so may expose the business to loss of revenue, potential litigation and loss of business reputation.

Also inherent in the management of the Company’s production facilities and delivery systems, including storage, vehicle transportation and pipelines, are operational risks that require continuous training, oversight and control. Material operating failures at production, storage facilities or pipelines, including fire, toxic release and explosions, or the occurrence of vehicle transportation accidents could result in loss of life, damage to the environment, loss of production and/or extensive property damage, all of which may negatively impact the company’s results of operations, cash flows and reputation.

Acquisitions

Praxair has evaluated, and expects to continue to evaluate, a wide array of potential strategic transactions. Many of these transactions, if consummated, could be material to its financial condition and results of operations. In addition, the process of integrating an acquired company, business or group of assets may create unforeseen operating difficulties and expenditures. Although historically the Company has been successful with its acquisition strategy and execution, the areas where the Company may face risks include:

 

   

The need to implement or remediate controls, procedures and policies appropriate for a larger public company at companies that prior to the acquisition lacked these controls, procedures and policies;

 

   

Diversion of management time and focus from operating existing business to acquisition integration challenges;

 

   

Cultural challenges associated with integrating employees from the acquired company into the existing organization;

 

   

The need to integrate each company’s accounting, management information, human resource and other administrative systems to permit effective management;

 

   

Difficulty with the assimilation of acquired operations and products;

 

   

Failure to achieve targeted synergies; and

 

   

Inability to retain key employees and business relationships of acquired companies.

Foreign acquisitions involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries. Also, the anticipated benefit of the Company’s acquisitions may not materialize. Future acquisitions or dispositions could result in potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities or amortization expenses, or write-offs of goodwill, any of which could adversely impact the Company’s financial condition.

 

Ite m 1b. Unresolved Staff Comments

Praxair has received no written SEC staff comments regarding any of its Exchange Act reports which were issued 180 days or more preceding the end of its 2006 fiscal year and that remain unresolved.

 

9


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

Item 2. Pro perties

Praxair’s worldwide headquarters are located in leased office space in Danbury, Connecticut. Other principal administrative offices are owned in Tonawanda, New York, and Rio de Janeiro, Brazil and leased in Shanghai, China and Madrid, Spain.

Praxair designs, engineers, manufactures and operates facilities that produce and distribute industrial gases. These industrial gas production facilities and certain components are designed and/or manufactured at its facilities in Tonawanda, New York; Burr Ridge, Illinois and Rio de Janeiro, Brazil. Praxair’s Italian equity affiliate, Societa Italiana Acetilene & Derivati S.p.A. (S.I.A.D.), also has such capacity.

Due to the nature of Praxair’s industrial gas products, it is generally uneconomical to transport them distances of greater than 200 miles from the production facility. As a result, Praxair operates a significant number of production facilities spread throughout the geographic regions where the company has operations.

The following is a description of production facilities for Praxair by segment. No significant portion of these assets was leased at December 31, 2006. Generally, these facilities are fully utilized and are sufficient to meet our manufacturing needs.

North America

The North America segment operates production facilities in the U.S., Canada and Mexico; approximately 260 of which are cryogenic air separation plants, hydrogen plants and carbon dioxide plants. There are five major pipeline complexes in North America located in Northern Indiana, Houston, along the Gulf Coast of Texas, Detroit, and Louisiana. Also located throughout North America are packaged gas facilities, specialty gas plants, helium plants and other smaller plant facilities.

Europe

The Europe segment has production facilities primarily in Italy, Spain, Germany, the Benelux region and France which include more than 50 cryogenic air separation plants. There are three major pipeline complexes in Europe located in Northern Spain and the Rhine and Saar regions of Germany. These pipeline complexes are primarily supported by cryogenic air separation plants. Also located throughout Europe are specialty gas plants, packaged gas facilities and other smaller plant facilities.

South America

The South America segment operates more than 40 cryogenic air separation plants, primarily located in Brazil. Many of these plants support a major pipeline complex in Southern Brazil. Also located throughout South America are carbon dioxide plants, packaged gas facilities and other smaller plant facilities.

Asia

The Asia segment has production facilities located primarily in China, Korea and India which include more than 25 cryogenic air separation plants. Also located throughout Asia are specialty gas plants, packaged gas facilities and other smaller plant facilities.

Surface technologies

The Surface technologies segment provides coating services and manufactures coating equipment at approximately 40 sites. The majority of these sites are located in the United States and Europe, with smaller operations in Asia and Brazil.

 

10


Table of Contents

PART I (Continued)

Praxair, Inc. and Subsidiaries


 

I tem 3. Legal Proceedings

Information required by this item is incorporated herein by reference to the section captioned “Notes to Consolidated Financial Statements - Note 18 Commitments and Contingencies” in Praxair’s 2006 Annual Report to Shareholders.

 

Ite m 4. Submission of Matters to a Vote of Security Holders

Praxair did not submit any matters to a shareholder vote during the fourth quarter of 2006.

11


Table of Contents

PART II

Praxair, Inc. and Subsidiaries


 

Item 5. Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

Market, trading, shareholder and dividend information for Praxair’s common stock is incorporated herein by reference to the section captioned “Investor Information” in Praxair’s 2006 Annual Report to Shareholders.

On October 28, 2003, Praxair’s Board of Directors declared a two-for-one split of the Company’s common stock. The stock split was effected in the form of a stock dividend of one additional share for each share owned by stockholders of record on December 5, 2003, and each share held in treasury as of the record date.

Praxair’s annual dividend on its common stock for 2006 was $1.00 per share. On January 23, 2007, Praxair’s Board of Directors declared a dividend of $0.30 per share for the first quarter of 2007, or $1.20 per share annualized, which may be changed as Praxair’s earnings and business prospects warrant. The declaration of dividends is a business decision made by the Board of Directors based on Praxair’s earnings and financial condition and other factors the Board of Directors considers relevant.

Purchases of Equity Securities —Certain information regarding purchases made by or on behalf of the Company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Securities Exchange Act of 1934, as amended) of its common stock during the three months ended December 31, 2006 is provided below:

 

Period

  

Total
Number of
Shares

Purchased
(Thousands)

  

Average
Price

Paid

Per Share

  

Total Number of Shares
Purchased as Part of

Publicly Announced

Plans or Programs (1)

(Thousands)

   Maximum Number of
Shares that May Yet be
Purchased Under the
Program (2)

October

   1,332    $ 58.56    1,332    N/A

November

   772    $ 62.18    772    N/A

December

   1,636    $ 60.53    1,636    N/A
                     

Fourth Quarter 2006

   3,740    $ 60.17    3,740    N/A

(1) On January 20, 1997, the Company’s Board of Directors approved a share repurchase program, which authorized the Company to repurchase shares of its common stock from time to time, either directly or through agents, in the open market at prices and on terms satisfactory to the Company in order to offset some or all of such shares issued pursuant to the Company’s employee benefit plans and its Dividend Reinvestment and Stock Purchase Plan. The Company announced this program on January 21, 1997. The program has no expiration date.
(2) The Board-approved program does not contain any quantitative limit on the total number of shares, or dollar value, that may be purchased.

 

I tem 6. Selected Financial Data

Information required by this item is incorporated herein by reference to the sections captioned “Five-Year Financial Summary” and “Non-GAAP Financial Measures” in Praxair’s 2006 Annual Report to Shareholders. These items should be read in conjunction with the Consolidated Financial Statements and related Notes to Consolidated Financial Statements.

 

It em 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Information required by this item is incorporated herein by reference to the section captioned “Management’s Discussion and Analysis” in Praxair’s 2006 Annual Report to Shareholders.

 

12


Table of Contents

PART II (Continued)

Praxair, Inc. and Subsidiaries


 

Item 7a. Quantitative and Qualitative Disclosures About Market Risk

Information required by this item is incorporated herein by reference to the section captioned “Management’s Discussion and Analysis” in Praxair’s 2006 Annual Report to Shareholders.

 

Item 8. Financial Statements and Supplementary Data

Information required by this item is incorporated herein by reference to the sections captioned “Consolidated Statements of Income,” “Consolidated Balance Sheets,” “Consolidated Statements of Cash Flows,” “Consolidated Statements of Shareholders’ Equity” and “Notes to Consolidated Financial Statements” in Praxair’s 2006 Annual Report to Shareholders.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None noted.

 

Item 9a. Controls and Procedures

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

Based on an evaluation of the effectiveness of Praxair’s disclosure controls and procedures, which was made under the supervision and with the participation of management, including Praxair’s principal executive officer and principal financial officer, the principal executive officer and principal financial officer have each concluded that, as of the end of the annual period covered by this report, such disclosure controls and procedures are effective in ensuring that information required to be disclosed by Praxair in reports that it files under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission’s rules and forms.

Management’s Report on Internal Control Over Financial Reporting

Praxair’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the Company’s principal executive officer and principal financial officer, Praxair conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (often referred to as COSO ). Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective as of December 31, 2006.

Management’s assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2006 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report incorporated by reference in Item 15.

Changes in Internal Control over Financial Reporting

There were no changes in Praxair’s internal control over financial reporting that occurred during the fourth quarter of 2006 that have materially affected, or are reasonably likely to materially affect, Praxair’s internal control over financial reporting.

 

Item 9b. Other Information

None noted.

 

13


Table of Contents

PA RT III

Praxair, Inc. and Subsidiaries


 

Item 10. Directors, Executive Officers and Corporate Governance

Certain information required by this item is incorporated herein by reference to the sections captioned “The Board of Directors”, “Executive Officers” and “Corporate Governance And Board Practices-Section 16(a) Beneficial Ownership Reporting Compliance” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 24, 2007.

Identification of the Audit Committee

Praxair has a separately-designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934 as amended (the “Exchange Act”). The members of that Audit Committee are H. Mitchell Watson, Jr., Chairman, Ronald L. Kuehn, Jr., Raymond W. LeBoeuf and Robert L. Wood.

Audit Committee Financial Expert

The Praxair Board of Directors has determined that each of H. Mitchell Watson, Jr., Ronald L. Kuehn, Jr., Raymond W. LeBoeuf and Robert L. Wood is an “audit committee financial expert” as defined by Item 401(h) of Regulation S-K of the Exchange Act and is independent within the meaning of Item 7(d)(3)(iv) of Schedule 14A of the Exchange Act.

Code of Ethics

Praxair has adopted a code of ethics that applies to the Company’s directors and all employees, including its Chief Executive Officer, Chief Financial Officer, and Controller. This code of ethics has been approved by the Praxair Board of Directors and is named the “Compliance with Laws and Business Integrity and Ethics Policy”. To assist employees and directors in complying with this code of ethics, management, from time to time, develops specific standards implementing certain provisions of the code which standards are contained in Praxair’s “Standards of Business Integrity.” Both documents are posted on the Company’s public website, www.praxair.com.

 

Item 11. Executive Compensation

Information required by this item is incorporated herein by reference to the sections captioned “Executive Compensation” and “Director Compensation” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 24, 2007.

 

14


Table of Contents

PART III (Continued)

Praxair, Inc. and Subsidiaries


 

It em 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Equity Compensation Plans Information – The table below provides information as of December 31, 2006 about Company stock that may be issued upon the exercise of options, warrants and rights granted to employees or members of Praxair’s Board of Directors under present and former equity compensation plans, including plans approved by shareholders and one plan which has not been approved by shareholders, the 1996 Praxair, Inc. Performance Incentive Plan (the 1996 Plan). The equity compensation plan not approved by shareholders was terminated in March 2001 and directors and officers of the Company were not eligible to participate in that plan. Shareholder approval of that plan was not required under applicable NYSE rules. The 1996 plan provided for granting nonqualified or incentive stock options, stock grants, performance awards, and other stock related incentives for key employees. The exercise price under the 1996 Plan was equal to the closing price of Praxair’s common stock on the date of grant. Options that were granted under this plan became exercisable after one or more years after the date of grant and the option term was no more than ten years.

 

EQUITY COMPENSATION PLANS TABLE

     (a)    (b)    (c)

Plan Category

   Number of securities to be
issued upon exercise of
outstanding options,
warrants and rights
   Weighted-average exercise
price of outstanding
options, warrants and
rights
   Number of securities
remaining available for
future issuance under
equity compensation plans
(excluding securities
reflected in column (a))

Equity compensation plans approved by shareholders

   18,019,015    $ 38.08    14,066,092

Equity compensation plans not approved by shareholders

   3,752,067    $ 21.81    —  
                

Total

   21,771,082    $ 35.28    14,066,092

 

Certain information required by this item is incorporated herein by reference to the section captioned “Share Ownership” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 24, 2007.

 

Item 13. Certain Relationships and Related Transactions and Director Independence

Information required by this item is incorporated herein by reference to the sections captioned “Corporate Governance And Board Practices-Director Independence,” and “Corporate Governance And Board Practices-Certain Relationships and Transactions” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 24, 2007.

 

Item 14. Principal Accounting Fees and Services

Information required by this item is incorporated herein by reference to the section captioned “The Independent Auditor” in Praxair’s Proxy Statement for the Annual Meeting of Shareholders to be held on April 24, 2007.

 

15


Table of Contents

PART IV

Praxair, Inc. and Subsidiaries


 

Item 15. Exhibits and Financial Statement Schedules

 

(a) Documents filed as part of this report

 

(1) Financial Statements

 

    

Page No. in Praxair’s 2006

Annual Report (AR)*

    

Consolidated Statements of Income for the Years Ended December 31, 2006, 2005, and 2004

   AR-26

Consolidated Balance Sheets at December 31, 2006 and 2005

   AR-27

Consolidated Statements of Cash Flows for the Years Ended December 31, 2006, 2005, and 2004

   AR-28

Consolidated Statements of Shareholders’ Equity for the Years Ended December 31, 2006, 2005, and 2004

   AR-29

Notes to Consolidated Financial Statements

   AR-45 to AR-65

Report of Independent Registered Public Accounting Firm

   AR-67

* Incorporated by reference to the indicated pages of the 2006 Annual Report to Shareholders. With the exception of this information and the information incorporated in Items 3, 5, 6, 7, 7A, and 8, the 2006 Annual Report to Shareholders is not to be deemed filed as part of this Annual Report on Form 10-K.

 

(2) Financial Statement Schedules

All financial statement schedules have been omitted because they are not applicable or the required information is shown in the financial statements or notes thereto.

 

(3) Exhibits

Exhibits filed as a part of this annual report on Form 10-K are listed in the Index to Exhibits located on page 18 of this Report.

 

16


Table of Contents

SIGNATURES

Praxair, Inc. and Subsidiaries


 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    PRAXAIR, INC.
  (Registrant)
Date: February 27, 2007   By:  

/s/ Patrick M. Clark

    Patrick M. Clark
    Vice President and Controller
    ( On behalf of the Registrant and
    as Chief Accounting Officer)

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities indicated on February 27, 2007.

 

/s/ Dennis H. Reilley

   

/s/ Stephen F. Angel

   

/s/ James S. Sawyer

Dennis H. Reilley     Stephen F. Angel     James S. Sawyer
Chairman and Director     President and Chief Executive     Executive Vice President and
    Officer and Director     Chief Financial Officer

/s/ Claire W. Gargalli

   

/s/ Ira D. Hall

   

/s/ Ronald L. Kuehn, Jr.

Claire W. Gargalli     Ira D. Hall     Ronald L. Kuehn, Jr.
Director     Director     Director

/s/ Raymond W. LeBoeuf

   

/s/ José Paulo de Oliveira Alves

   

/s/ Wayne T. Smith

Raymond W. LeBoeuf     José Paulo de Oliveira Alves    

Wayne T. Smith

Director     Director     Director

/s/ H. Mitchell Watson, Jr.

   

/s/ Robert L. Wood

   

H. Mitchell Watson, Jr.

   

Robert L. Wood

   

Director

   

Director

   

 

17


Table of Contents

IN DEX TO EXHIBITS

Praxair, Inc. and Subsidiaries


 

Exhibit No.  

Description

    3.01   Restated Certificate of Incorporation of Praxair, Inc. as filed with the Secretary of State of the State of Delaware on May 8, 2006 (Filed as Exhibit 3.01 to the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2006, Filing No. 1-11037, and incorporated herein by reference).
    3.02   Amended By-Laws of Praxair, Inc. (Filed as Exhibit 3.02 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
    3.03   Certificate of Designations for the 7.48% Cumulative Preferred Stock, Series A (Filed on February 7, 1997 as Exhibit 3.3 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141).
    3.04   Certificate of Designations for the 6.75% Cumulative Preferred Stock, Series B (Filed on February 7, 1997 as Exhibit 3.4 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141).
    4.01   Common Stock Certificate (Filed as Exhibit 4.01 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
    4.02   Stockholder Protection Rights Agreement, dated as of May 3, 2004, between the registrant and Registrar and Transfer Company as Rights Agent (Filed on April 29, 2004 as Exhibit (1) to the Company’s Registration Statement on Form 8-A, Filing No. 1-11037, and incorporated herein by reference).
    4.03   Indenture, dated as of July 15, 1992, between Praxair, Inc. and State Street Bank and Trust Company, successor trustee to Fleet Bank of Connecticut and the ultimate successor trustee to Bank of America Illinois (formerly Continental Bank, National Association) (Filed as Exhibit 4 to the Company’s Form 10-Q for the quarter ended June 30, 1992, Filing No. 1-11037, and incorporated herein by reference).
    4.04   Copies of the agreements relating to long-term debt which are not required to be filed as exhibits to this Annual Report on Form 10-K will be furnished to the Securities and Exchange Commission upon request.
    4.05   Series A Preferred Stock Certificate (Filed on February 7, 1997 as Exhibit 4.3 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141).
    4.06   Series B Preferred Stock Certificate (Filed on February 7, 1997 as Exhibit 4.4 to Amendment #1 to the Company’s Registration Statement on Form S-3, Registration No. 333-18141).
*10.01   Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan (Filed as Exhibit 10.01 to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.01a   First amendment, dated as of October 24, 2006, to the Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan
*10.01b   Second amendment, dated as of January 23, 2007, to the Amended and Restated 2002 Praxair, Inc. Long Term Incentive Plan.
*10.01c
  Form of Standard Option Award under the 2002 Praxair, Inc. Long Term Incentive Plan.
*10.01d
  Form of Transferable Option Award under the 2002 Praxair, Inc. Long Term Incentive Plan.

 

18


Table of Contents

INDEX TO EXHIBITS (Continued)

Praxair, Inc. and Subsidiaries


 

Exhibit No.  

Description

*10.01e
  Form of Performance Share Award under the 2002 Praxair, Inc. Long Term Incentive Plan.
*10.02   Form of Executive Severance Compensation Agreement (Filed as Exhibit 10.02 to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.03   2002 Praxair, Inc. Variable Compensation Plan (Filed as Exhibit 10.03 to the Company’s 2001 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.03a   First Amendment, dated as of December 12, 2005, to the 2002 Praxair, Inc. Variable Compensation Plan. (Filed as Exhibit 10.03a to the Company’s 2005 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.04   Amended and Restated 1995 Stock Option Plan for Non-Employee Directors (Filed as Exhibit 10.04 to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.04a
  First Amendment, dated as of October 24, 2006, to the Amended and Restated 1995 Stock Option Plan for Non-Employee Directors.
*10.04b   2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc. (Filed as Exhibit 10.04 to the Company’s Current Report on Form 8-K dated April 29, 2005, Filing No. 1-11037, and incorporated herein by reference).
*10.04c
  First Amendment, dated as of October 24, 2006, to the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc.
*10.04d   Form of Option Award under the 2005 Equity Compensation Plan for Non-employee Directors of Praxair, Inc (Filed as Exhibit 10.04a to the Company’s Form 10-Q for the quarter ended June 30, 2005, Filing No. 1-11037, and incorporated herein by reference).
*10.05   Special Severance Protection Program (Filed as Exhibit 10.05 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
*10.06   Amended and Restated Praxair, Inc. Directors’ Fees Deferral Plan (Filed as Exhibit 10.06 to the Company’s Current Report on Form 8-K dated January 25, 2005, Filing No. 1-11037, and incorporated herein by reference).
*10.06a   Fourth Amendment to the Praxair Inc. Directors’ Fees Deferral Plan (Filed as Exhibit 10.06a to the Company’s Current Report on Form 8-K dated April 29, 2005, Filing 1-11037, and incorporated herein by reference).
*10.07   Amended and Restated 1993 Praxair Compensation Deferral Program (Filed as Exhibit 10.07 to the Company’s 1996 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.07a   First Amendment, dated as of April 1, 2001, to the Amended and Restated 1993 Praxair Compensation Deferral Program (Filed as Exhibit 10.07a to the Company’s 2001 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
*10.07b   Second Amendment, dated as of October 28, 2003, to the Amended and Restated 1993 Praxair Compensation Deferral Program (Filed as Exhibit 10.07b to the Company’s 2003 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).

 

19


Table of Contents

INDEX TO EXHIBITS (Continued)

Praxair, Inc. and Subsidiaries


 

Exhibit No.  

Description

10.08   Transfer Agreement dated January 1, 1989, between Union Carbide Corporation and the registrant (Filed as Exhibit 10.06 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.08a   Amendment No. 1 dated as of December 31, 1989, to the Transfer Agreement (Filed as Exhibit 10.07 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.08b   Amendment No. 2 dated as of July 2, 1990, to the Transfer Agreement (Filed as Exhibit 10.08 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.08c   Amendment No. 3 dated as of January 2, 1991, to the Transfer Agreement (Filed as Exhibit 10.09 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.09   Transfer Agreement dated January 1, 1989, between Union Carbide Corporation and Union Carbide Coatings Service Corporation (Filed as Exhibit 10.14 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.09a   Amendment No. 1 dated as of December 31, 1989, to the Transfer Agreement (Filed as Exhibit 10.15 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.09b   Amendment No. 2 dated as of July 2, 1990, to the Transfer Agreement (Filed as Exhibit 10.16 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.10   Additional Provisions Agreement dated as of June 4, 1992 (Filed as Exhibit 10.21 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.11   Amended and Restated Realignment Indemnification Agreement dated as of June 4, 1992 (Filed as Exhibit 10.23 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.12   Environmental Management, Services and Liabilities Allocation Agreement dated as of January 1, 1990 (Filed as Exhibit 10.13 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.12a   Amendment No. 1 to the Environmental Management, Services and Liabilities Allocation Agreement dated as of June 4, 1992 (Filed as Exhibit 10.22 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.13   Danbury Lease-Related Services Agreement dated as of June 4, 1992 (Filed as Exhibit 10.24 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
10.13a   First Amendment to Danbury Lease-Related Services Agreement (Filed as Exhibit 10.13a to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).

 

20


Table of Contents

INDEX TO EXHIBITS (Continued)

Praxair, Inc. and Subsidiaries


 

Exhibit No.  

Description

  10.14   Danbury Lease Agreements, as amended (Filed as Exhibit 10.26 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
  10.14a   Second Amendment to Linde Data Center Lease (Danbury) (Filed as Exhibit 10.14a to the Company’s 1993 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.14b   Fourth Amendment to Carbide Center Lease (Filed as Exhibit 10.14b to the Company’s 1993 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.14c   Third Amendment to Linde Data Center Lease (Filed as Exhibit 10.14c to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.14d   Fifth Amendment to Carbide Center Lease (Filed as Exhibit 10.14d to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.14e   Sixth Amendment to Carbide Center Lease (Filed as Exhibit 10.14e to the Company’s 2004 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.15   Employee Benefits Agreement dated as of June 4, 1992 (Filed as Exhibit 10.25 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
  10.15a   First Amendatory Agreement to the Employee Benefits Agreement (Filed as Exhibit 10.15a to the Company’s 1994 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.16   Tax Disaffiliation Agreement dated as of June 4, 1992 (Filed as Exhibit 10.20 to the Company’s Registration Statement on Form 10, Filing No. 1-11037, and incorporated herein by reference).
  10.17   Credit Agreement dated as of December 23, 2004 among Praxair, Inc., The Eligible Subsidiaries Referred to Therein, The Lenders Listed Therein, JP Morgan Chase Bank, N. A., as Administrative Agent, Bank of America, N. A., as Syndication Agent, and Citibank, N. A. and Credit Suisse First Boston as Co-Documentation Agents (Filed as Exhibit 10.17 to the Company’s 2004 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.17a   Amendment No. 1, dated February 15, 2006, to Credit Agreement, dated as of December 23, 2004 (referenced as Exhibit 10.17) (Filed as Exhibit 10.17a to the Company’s 2005 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.17b
  Extension Agreement, dated October 18, 2006, to Credit Agreement, dated as of December 23, 2004 (referenced as Exhibit 10.17)
  10.18   Facility Agreement dated as of November 29, 2004 among Praxair Euroholding, S. L., an indirect wholly-owned subsidiary of the Company, as Borrower, Praxair, Inc., as Guarantor, The Lenders Party Thereto, Citigroup Global Markets, Inc., as Syndication Agent and ABN AMRO Bank N. V., as Administrative Agent and Documentation Agent (Filed as Exhibit 10.18 to the Company’s 2004 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).
  10.18a   Amendment No. 1 to Facility Agreement (Filed as Exhibit 10.18a to the Company’s Current Report on Form 8-K dated March 1, 2005, Filing No. 1-11037, and incorporated herein by reference).
*10.19   Praxair, Inc. Plan for Determining Performance-Based Awards Under Section 162(M) (Filed as Exhibit 10.19 to the Company’s 2001 Annual Report on Form 10-K, Filing No. 1-11037, and incorporated herein by reference).

 

21


Table of Contents

INDEX TO EXHIBITS (Continued)

Praxair, Inc. and Subsidiaries


 

Exhibit No.  

Description

12.01   Computation of Ratio of Earnings to Fixed Charges.
13.01
  Financial Section (pages 26 to 69 and page 71) of Praxair’s 2006 Annual Report to Shareholders (such information, except for those portions which are expressly referred to in this Form 10-K, is furnished for the information of the Commission and is not deemed “filed” as part of this Form 10-K).
21.01
  Subsidiaries of Praxair, Inc.
23.01   Consent of Independent Registered Public Accounting Firm.
31.01
  Rule 13a-14(a) Certification
31.02
  Rule 13a-14(a) Certification
32.01
  §1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act).
32.02   §1350 Certification (such certifications are furnished for the information of the Commission and shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act).

Copies of exhibits incorporated by reference can be obtained from the SEC and are located in SEC File No. 1-11037.


* Indicates a management contract or compensatory plan or arrangement.

 

22

Exhibit 10.01a

AMENDMENT TO THE

RESTATED 2002 PRAXAIR, INC. LONG TERM INCENTIVE PLAN

Section 5.3 of the Restated 2002 Praxair, Inc. Long Term Incentive Plan, is hereby amended in its entirety as follows, effective as of October 24, 2006:

“5.3 Adjustment in the Event of Recapitalization, etc. In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make equitable adjustments in the number of shares and prices per share applicable to Stock Option Awards then outstanding and in the number of shares which are available thereafter for Stock Option Awards or other awards, both under the Plan as a whole and with respect to individuals and award type. Such adjustments shall be made in a manner that the Committee determines is necessary and appropriate, and shall be conclusive and binding for all purposes of the Plan.”

 

October 24, 2006
PRAXAIR, INC.

Exhibit 10.01b

AMENDMENT TO THE

RESTATED 2002 PRAXAIR, INC. LONG TERM INCENTIVE PLAN

The Restated 2002 Praxair, Inc. Long Term Incentive Plan (the “Plan”) is hereby amended as follows, effective as of January 23, 2007:

1. Section 6.7 of the Plan is hereby amended in its entirety as follows:

“6.7 Initial Vesting. A Stock Option Award by its terms shall be exercisable only after the earliest of:

(i) such period of time as the Committee shall determine and specify in the grant, but in no event less than three years following the date of grant of such award provided that options granted may partially vest after no less than one year so long as the entire grant does not fully vest until at least three years have elapsed from the date of grant;

(ii) the Participant’s death; or

(iii) a Change in Control of the Company.

In the event of the Participant’s Disability or Retirement or termination by the Company of the Participant’s employment other than for cause, a Stock Option Award shall not be exercisable at the time of such event but shall become exercisable at the time specified in clauses (i), (ii) or (iii) above. Notwithstanding the foregoing: (a) in the event of a Participant’s Retirement prior to the first anniversary date after the date of a Stock Option Award, such Stock Option Award shall not vest but shall be immediately forfeited; and (b) except as otherwise determined by the Company’s Chief Executive Officer or his designee, in the event of the termination by the Company of the Participant’s employment other than for cause prior to the first anniversary date after the date of a Stock Option Award, such Stock Option Award shall not vest but shall be immediately forfeited.”

2. Section 6.8(iii) is of the Plan is hereby amended in its entirety as follows:

“(iii) in the case of termination by the Company of the Participant’s employment other than for cause, the Stock Option Award, to the extent not forfeited in accordance with Section 6.7 above, shall remain exercisable during a three (3) year period commencing on the effective date of such termination;”

 

January 23, 2007
PRAXAIR, INC.

Exhibit 10.01c

Form of Standard OPTION AWARD

UNDER THE

2002 PRAXAIR, INC.

LONG TERM INCENTIVE PLAN

This Award , made as of the          day of                          (the “Grant Date”) by PRAXAIR, INC., a Delaware corporation, having an office at 39 Old Ridgebury Road, Danbury, Connecticut 06810-5113 (hereinafter called the “Corporation”).

W I T N E S S E T H:

The Corporation hereby grants to                          (hereinafter called the “Participant”), as of the Grant Date, a non-qualified stock option to purchase                      shares of the common stock of the Corporation (par value of $.01 per share) at $              per share upon the following terms and conditions:

1. Vesting . Except as otherwise provided in this Award and subject to the provisions of paragraph 3, this option may be exercised only on or after                  , [in no event less than three years following the date of grant, provided that the option may partially vest after no less than one year so long as the entire grant does not vest fully until at least three years have elapsed from the date of grant]. The option may be exercised only in a whole number of shares. In the event that the option is not evenly divisible by three, the remaining amount shall be added to the last vesting period. Notwithstanding the foregoing, the entire option shall become immediately vested and exercisable upon the occurrence of either the Participant’s death or a Change in Control.

2. Expiration . Except as otherwise provided herein, this option shall expire on the tenth anniversary of the Grant Date.

3. Exercisability .

(a) This option shall be exercisable by the Participant only while the Participant is in active employment with the Corporation or a Subsidiary or Affiliate of the Corporation and shall be immediately forfeited upon the effective date of the Participant’s termination of employment with the Corporation or a Subsidiary or Affiliate of the Corporation, except that this option shall continue to be exercisable:

(i) at any time prior to its expiration date in the case of the Participant’s Disability or Retirement; provided, however, that following the Participant’s Disability or Retirement, this option shall only become vested and exercisable in accordance with paragraph 1; and provided further, that in the event of the Participant’s Retirement prior to [one year from the date of grant], this option shall never become vested and exercisable and shall be immediately forfeited upon the effective date of the Participant’s Retirement;

 

Page 1


(ii) during a three-year period commencing on the date of the Participant’s termination of employment by the Corporation or a Subsidiary or Affiliate of the Corporation other than for cause provided, however, that following such termination of the Participant’s employment other than for cause, this option shall only become vested and exercisable in accordance with paragraph 1 above; and provided further, that, except as otherwise determined by the Corporation’s Chief Executive Officer or his designee, in the event of the Participant’s termination of employment by the Corporation or a Subsidiary or Affiliate of the Corporation other than for cause prior to [one year from the date of grant], this option shall never become vested and exercisable and shall be immediately forfeited upon the effective date of such termination of the Participant’s employment;

(iii) during a three-year period commencing on the date of the Participant’s death;

(iv) during a three-year period commencing on the date of termination of the Participant’s employment, by the Participant or by the Corporation or a Subsidiary or Affiliate of the Corporation, other than for cause, within two years after a Change in Control, or

(v) otherwise as the Committee may determine, if the Committee decides that it is in the best interests of the Corporation to permit individual exceptions.

(b) In no event may this option be exercised on or after its expiration date.

(c) An individual who is employed by a Subsidiary or Affiliate of the Corporation shall be deemed to have terminated employment for purposes of this Award at such time as the Corporation and its Subsidiaries own, either directly or indirectly, less than 50% of the employing Subsidiary’s or Affiliate’s total financial interests or combined voting power.

4. Transferability . This option is not transferable other than (a) in the event of the Participant’s death, in which case this option shall be transferred pursuant to the beneficiary designation then on file with the Corporation, or, in the absence of such a beneficiary designation, by will or the laws of descent and distribution, or (b) in the event of a beneficiary’s or distributee’s death, this option shall be transferred to his/her estate and may be exercised only by the executor or administrator of such estate. In either of the foregoing events, this option may be exercised by the executor or administrator of the Participant’s estate, by the Participant’s beneficiary or distributee(s), or by the executor or administrator of the beneficiary’s or distributee’s estate, as applicable, within the time limitations provided in paragraphs 1, 2 and 3 hereof.

5. Exercise of Option .

(a) Notice of Exercise. This option may be exercised at the office of the Corporation in Danbury, Connecticut (or at such other location as determined by the Corporation) with respect to a part or all of the shares covered by the option and then exercisable by giving notice to the Corporation (or its designee as communicated from time to time) of the exercise of the option.

(b) Exercise Price Payment. The option price for the shares for which this option is exercised shall be paid by the exerciser not later than ten business days after the date of exercise, (i) in cash, (ii) in whole shares of common stock of the Corporation owned by the exerciser prior to exercising the option, (iii) by having the Corporation withhold shares that would otherwise be delivered to the exerciser pursuant to the exercise of the option, or (iv) in a combination of cash and delivery of whole shares, or cash and the withholding of shares. The value of any share of common stock delivered or withheld in payment of the option price shall be its Market Price on the date the option is exercised. Notwithstanding the foregoing, the Corporation may refuse to allow payment by any method other than cash if the Corporation determines that allowing such payment would result in the imposition of variable accounting on the Corporation.

 

Page 2


(c) Taxes. To enable the Corporation to meet any applicable federal, state or local withholding tax requirements arising as a result of the exercise of the option, the exerciser shall pay the Corporation the amount of tax to be withheld, if any, (i) in cash, (ii) in whole shares of common stock of the Corporation owned by the exerciser prior to exercising the option, (iii) for exercises by the Participant only, by having the Corporation withhold shares that would otherwise be delivered to the Participant pursuant to the exercise of the option (but only to cover the minimum legally required tax withholding), or (iv) in a combination of cash and a delivery of whole shares. The value of any share of common stock so delivered or withheld shall be the Market Price on the date used to determine the amount of tax to be withheld. The Corporation reserves the right to (i) disapprove a Participant’s election to utilize any of the alternatives under this paragraph (c), and (ii) to delay the completion of any exercise of this option until the applicable withholding tax has been paid.

(d) Delivery of Shares. Upon the exercise of an option with respect to a part or all of the shares in the manner and within the time herein provided, the Corporation shall issue and deliver to the exerciser, or to the exerciser’s dividend reinvestment account, the number of shares of its common stock with respect to which the option was exercised. However, if an option is exercised after the death of the Participant, beneficiary or distributee, then the Corporation shall have the right, in lieu of issuing and delivering shares of stock, of returning the option payment to the exerciser and paying to such person the amount by which the Market Price on the date of exercise exceeds the option price with respect to the number of shares for which the option was exercised.

6. Terms and Conditions . This option is awarded pursuant to the Plan and is subject to all of the terms and conditions of the Plan which terms and conditions shall control in the event of any conflict with this Award.

7. Applicable Law . This Award shall be interpreted and construed in accordance with the laws of the State of Connecticut.

8. Definitions .

(a) “Change in Control” means a change in control of the Corporation as defined in the Plan.

(b) “Committee” means the Compensation and Management Development Committee of the Board of Directors of the Corporation or any other Committee which such Board of Directors appoints to administer the Plan.

(c) “Corporation” means Praxair, Inc.

(d) “Disability” means a Participant’s inability to engage in any substantial gainful activity because of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of six (6) months or longer.

(e) “Market Price” means the mean of the high and low prices of the common stock of the Corporation as reported in the New York Stock Exchange Composite Transactions on the specified date (or on the next preceding day such stock was traded on a stock exchange included in the New York Stock Exchange—Composite Transactions if it was not traded on any such exchange on the specified date).

(f) “Plan” means the 2002 Praxair, Inc. Long Term Incentive Plan, as amended and restated as of February 24, 2004, and as further amended from time to time.

(g) “Retirement” means termination of employment with the Corporation or a Subsidiary

 

Page 3


or Affiliate, other than for cause, with the right under the Corporation’s Retirement Program to receive a non-actuarially reduced pension immediately upon separation from service. Provided, however, that if the Participant is employed by a foreign Affiliate of the Corporation and/or is not eligible to participate in the Corporation’s Retirement Program, Retirement means termination of employment with the Corporation or a Subsidiary or Affiliate, other than for cause, after (i) attaining age 65, (ii) attaining age 62 and completing at least 10 years of employment with the Corporation, or (iii) having accumulated 85 points, where each year of the Participant’s age and each year of employment with the Corporation count for one point.

9. Notwithstanding any other provision of this Award, the Committee may, in its sole discretion, cancel, rescind, suspend, withhold, or otherwise limit or restrict this Award, and/or recover any gains realized by the Participant in connection with this Award, in the event of any actions by the Participant determined by the Committee to (a) constitute a conflict of interest with the Corporation, (b) be prejudicial to the Corporation’s interests, or (c) violate any non-compete agreement or obligation of the Participant to the Corporation, any confidentiality agreement or obligation of the Participant to the Corporation, the Corporation’s applicable policies, or the Participant’s terms and conditions of employment.

IN WITNESS WHEREOF, the Corporation has caused this instrument to be executed by its proper officer hereunto duly authorized, as of the day and year first hereinabove written.

 

P RAXAIR , I NC .

By:

 
 

 

 

Page 4

Exhibit 10.01d

Form of Transferable OPTION AWARD

UNDER THE

2002 PRAXAIR, INC.

LONG TERM INCENTIVE PLAN

This Award , made as of the          day of                          (the “Grant Date”) by PRAXAIR, INC., a Delaware corporation, having an office at 39 Old Ridgebury Road, Danbury, Connecticut 06810-5113 (hereinafter called the “Corporation”).

W I T N E S S E T H:

The Corporation hereby grants to                          (hereinafter called the “Participant”), as of the Grant Date, a non-qualified stock option to purchase                      shares of the common stock of the Corporation (par value of $.01 per share) at $              per share upon the following terms and conditions:

1. Vesting . Except as otherwise provided in this Award and subject to the provisions of paragraph 3, this option may be exercised only on or after                  , [in no event less than three years following the date of grant, provided that the option may partially vest after no less than one year so long as the entire grant does not vest fully until at least three years have elapsed from the date of grant]. The option may be exercised only in a whole number of shares. In the event that the option is not evenly divisible by three, the remaining amount shall be added to the last vesting period. Notwithstanding the foregoing, the entire option shall become immediately vested and exercisable upon the occurrence of either the Participant’s death or a Change in Control.

2. Expiration . Except as otherwise provided herein, this option shall expire on the tenth anniversary of the Grant Date.

3. Exercisability .

(a) This option shall be exercisable by the Participant only while the Participant is in active employment with the Corporation or a Subsidiary or Affiliate of the Corporation and shall be immediately forfeited upon the effective date of the Participant’s termination of employment with the Corporation or a Subsidiary or Affiliate of the Corporation, except that this option shall continue to be exercisable:

(i) at any time prior to its expiration date in the case of the Participant’s Disability or Retirement; provided, however, that following the Participant’s Disability or Retirement, this option shall only become vested and exercisable in accordance with paragraph 1; and provided further, that in the event of the Participant’s Retirement prior to [one year from the date of grant], this option shall never become vested and exercisable and shall be immediately forfeited upon the effective date of the Participant’s Retirement;

(ii) during a three-year period commencing on the date of the Participant’s termination of employment by the Corporation or a Subsidiary or Affiliate of the Corporation other than for cause provided, however, that following such termination of the Participant’s employment other than for cause, this option shall only become vested and exercisable in accordance with paragraph 1 above; and provided further, that, except as otherwise determined by the Corporation’s Chief Executive Officer or his designee, in the event of the Participant’s termination of employment by the Corporation or a

 

Page 1


Subsidiary or Affiliate of the Corporation other than for cause prior to [one year from the date of grant], this option shall never become vested and exercisable and shall be immediately forfeited upon the effective date of such termination of the Participant’s employment;

(iii) during a three-year period commencing on the date of the Participant’s death;

(iv) during a three-year period commencing on the date of termination of the Participant’s employment, by the Participant or by the Corporation or a Subsidiary or Affiliate of the Corporation, other than for cause, within two years after a Change in Control, or

(v) otherwise as the Committee may determine, if the Committee decides that it is in the best interests of the Corporation to permit individual exceptions.

(b) In no event may this option be exercised on or after its expiration date.

(c) An individual who is employed by a Subsidiary or Affiliate of the Corporation shall be deemed to have terminated employment for purposes of this Award at such time as the Corporation and its Subsidiaries own, either directly or indirectly, less than 50% of the employing Subsidiary’s or Affiliate’s total financial interests or combined voting power.

4. Transferability . This option is not transferable other than;

(a) in the case of the Participant’s death, pursuant to the beneficiary designation then on file with the Corporation, or, in the absence of such a beneficiary designation, by will or the laws of descent and distribution (in such event, this option may be exercised by the executor or administrator of the Participant’s estate or by the Participant’s distributee(s) within the time limitations provided in paragraphs 1, 2 and 3 hereof); or

(b) if the Participant has met the Corporation’s stock ownership guidelines applicable to him/her at the time of such proposed transfer, by the Participant in whole or in parts to;

(i) the Participant’s spouse, children (including by adoption), stepchildren or grandchildren (“immediate family members”),

(ii) a partnership in which such immediate family members are the only partners, or

(iii) a trust for the exclusive benefit of such immediate family members; or

(c) in the case of a transferee’s, beneficiary’s or distributee’s death, to his/her estate, in which case this option may be exercised only by the executor or administrator of such estate and shall not be subject to further transfer.

5 . Transfer of Option.

(a) Any transfer of this option, in whole or in part, is subject to acceptance by the Corporation in its sole discretion and shall be effected according to such procedures as the Vice President, Human Resources may establish.

(b) The provisions of this Award, including without limitation, paragraphs 3 and 6(c) relating to the Participant, shall apply to this option notwithstanding any transfer to a third party.

6. Exercise of Option .

(a) Notice of Exercise. This option may be exercised at the office of the Corporation in Danbury,

 

Page 2


Connecticut (or at such other location as determined by the Corporation) with respect to a part or all of the shares covered by the option and then exercisable by giving notice to the Corporation (or its designee as communicated from time to time) of the exercise of the option.

(b) Exercise Price Payment. The option price for the shares for which this option is exercised shall be paid by the exerciser not later than ten business days after the date of exercise, (i) in cash, (ii) in whole shares of common stock of the Corporation owned by the exerciser prior to exercising the option, (iii) by having the Corporation withhold shares that would otherwise be delivered to the exerciser pursuant to the exercise of the option, or (iv) in a combination of cash and delivery of whole shares, or cash and the withholding of shares. The value of any share of common stock delivered or withheld in payment of the option price shall be its Market Price on the date the option is exercised. Notwithstanding the foregoing, the Corporation may refuse to allow payment by any method other than cash if the Corporation determines that allowing such payment would result in the imposition of variable accounting on the Corporation.

(c) Taxes. To enable the Corporation to meet any applicable federal, state or local withholding tax requirements arising as a result of the exercise of the option, the exerciser shall pay the Corporation the amount of tax to be withheld, if any, (i) in cash, (ii) in whole shares of common stock of the Corporation owned by the exerciser prior to exercising the option, (iii) for exercises by the Participant only, by having the Corporation withhold shares that would otherwise be delivered to the Participant pursuant to the exercise of the option (but only to cover the minimum legally required tax withholding), or (iv) in a combination of cash and a delivery of whole shares. The value of any share of common stock so delivered or withheld shall be the Market Price on the date used to determine the amount of tax to be withheld. The Corporation reserves the right to (i) disapprove a Participant’s election to utilize any of the alternatives under this paragraph (c), and (ii) to delay the completion of any exercise of this option until the applicable withholding tax has been paid.

(d) Delivery of Shares. Upon the exercise of an option with respect to a part or all of the shares in the manner and within the time herein provided, the Corporation shall issue and deliver to the exerciser, or to the exerciser’s dividend reinvestment account, the number of shares of its common stock with respect to which the option was exercised. However, if an option is exercised after the death of the Participant, beneficiary or distributee, then the Corporation shall have the right, in lieu of issuing and delivering shares of stock, of returning the option payment to the exerciser and paying to such person the amount by which the Market Price on the date of exercise exceeds the option price with respect to the number of shares for which the option was exercised.

7. Terms and Conditions . This option is awarded pursuant to the Plan and is subject to all of the terms and conditions of the Plan which terms and conditions shall control in the event of any conflict with this Award.

8. Applicable Law . This Award shall be interpreted and construed in accordance with the laws of the State of Connecticut.

9. Definitions .

(a) “Change in Control” means a change in control of the Corporation as defined in the Plan.

(b) “Committee” means the Compensation and Management Development Committee of the Board of Directors of the Corporation or any other Committee which such Board of Directors appoints to administer the Plan.

(c) “Corporation” means Praxair, Inc.

(d) “Disability” means a Participant’s inability to engage in any substantial gainful activity

 

Page 3


because of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted, or can be expected to last, for a continuous period of six (6) months or longer.

(e) “Market Price” means the mean of the high and low prices of the common stock of the Corporation as reported in the New York Stock Exchange Composite Transactions on the specified date (or on the next preceding day such stock was traded on a stock exchange included in the New York Stock Exchange—Composite Transactions if it was not traded on any such exchange on the specified date).

(f) “Plan” means the 2002 Praxair, Inc. Long Term Incentive Plan, as amended and restated as of February 24, 2004, and as further amended from time to time.

(g) “Retirement” means termination of employment with the Corporation or a Subsidiary or Affiliate, other than for cause, with the right under the Corporation’s Retirement Program to receive a non-actuarially reduced pension immediately upon separation from service. Provided, however, that if the Participant is employed by a foreign Affiliate of the Corporation and/or is not eligible to participate in the Corporation’s Retirement Program, Retirement means termination of employment with the Corporation or a Subsidiary or Affiliate, other than for cause, after (i) attaining age 65, (ii) attaining age 62 and completing at least 10 years of employment with the Corporation, or (iii) having accumulated 85 points, where each year of the Participant’s age and each year of employment with the Corporation count for one point.

10. The Corporation’s grant of this option to the Participant pursuant to this Award, and the Participant’s eligibility for any right, payment, issue or award with respect to this option, are contingent on the Participant’s execution and filing with the Corporation, or the employing Subsidiary, as applicable, of a non-compete agreement in a form, and within a timeframe, acceptable to the Corporation or the employing Subsidiary.

11. Notwithstanding any other provision of this Award, the Committee may, in its sole discretion, cancel, rescind, suspend, withhold, or otherwise limit or restrict this Award, and/or recover any gains realized by the Participant in connection with this Award, in the event of any actions by the Participant determined by the Committee to (a) constitute a conflict of interest with the Corporation, (b) be prejudicial to the Corporation’s interests, or (c) violate any non-compete agreement or obligation of the Participant to the Corporation, any confidentiality agreement or obligation of the Participant to the Corporation, the Corporation’s applicable policies, or the Participant’s terms and conditions of employment.

IN WITNESS WHEREOF, the Corporation has caused this instrument to be executed by its proper officer hereunto duly authorized, as of the day and year first hereinabove written.

 

P RAXAIR , I NC .
By:  
 

 

 

Page 4

Exhibit 10.01e

FORM OF

PERFORMANCE SHARE AWARD

UNDER THE

2002 PRAXAIR, INC.

LONG TERM INCENTIVE PLAN

Effective as of                                          (the “Date of Grant”), Praxair, Inc. (the “Company”), a Delaware corporation, hereby grants to                          (the “Participant”) the following Performance Award under the 2002 Praxair, Inc. Long Term Incentive Plan (the “Plan”), subject to the terms and conditions of the Plan, which are incorporated herein by reference, and those set forth below. Capitalized terms used herein and not defined shall have the meanings set forth in the Plan, as the same may be amended from time to time. In the event of any conflict between this award and the Plan, the Plan shall control.

1. Award of Performance Shares . The Participant is hereby granted a Performance Award of              Performance Shares (the “Award”). The value of a single Performance Share is equal to the value of a single share of Stock of the Company. For purposes of this Award,     [same number]              Performance Shares is considered the Participant’s “Target Amount.”

2. Vesting of Award; Treatment upon Termination of Service .

(a) Vesting Generally . Subject to the following provisions of this Section 2 and the other terms and conditions of this Award, this Award shall become vested on the              anniversary of the Date of Grant, provided that the Participant has remained continuously employed by the Company or its Affiliate or Subsidiary from the Date of Grant through the              anniversary of the Date of Grant.

(b) Death, Disability, Change in Control . Notwithstanding any provision of this Section 2 to the contrary, this Award shall become immediately vested in full and payment shall be made pursuant to Section 3(b)(i) upon the earlier of (i) the Participant’s death or Disability, or (ii) a Change in Control of the Company, each occurring prior to the              anniversary of the Date of Grant and while the Participant remains employed by the Company or its Affiliate or Subsidiary.

(c) Retirement; Termination by Action of Company Other than for Cause . Notwithstanding any provision of this Section 2 to the contrary, in the event of the Participant’s Retirement after the              anniversary of the Date of Grant, or the termination by the Company of the Participant’s employment other than for cause after the              anniversary of the Date of Grant, this Award shall become vested on the              anniversary of the Date of Grant and payment shall be made pursuant to Section 3(b)(ii).


(d) Any other termination of the Participant’s employment with the Company or its Affiliates or Subsidiaries before the              anniversary of the Date of Grant and before the occurrence of an event described in Section 2(b) or (c) above, shall result in an immediate and total forfeiture of this Award.

3. Payment of Award .

(a) Determination of Amount of Payment . Except as otherwise described in Section 3(b), the amount of the payment due with respect to a vested Award shall be determined based on the Company’s performance during calendar year(s)              (the “Performance Period”). Specifically, the Participant’s Target Amount will be multiplied by the average of the annual corporate consolidated financial performance factors determined and used as a factor under the 2002 Praxair, Inc. Variable Compensation Plan (as may be amended from time to time) for each year of the Performance Period. This annual corporate consolidated financial performance factor for each year of the Performance Period shall be determined by the Committee in its sole discretion and can range from zero to 200%. The payment with respect to the Participant’s vested Award, if any, will be made in the form of shares of Stock of the Company, as soon as practicable after the second anniversary of the Date of Grant, but in no event later than              . Solely by way of example, if the Committee determines that the annual corporate consolidated financial performance factor for 2007 is 100% and for 2008 is 200%, the Participant’s Target Amount will be multiplied by 150% and the resulting number will be the number of shares of Stock paid with respect to the Participant’s vested Award .

(b) Termination, Change in Control, etc . Upon the occurrence of an event which satisfies the requirements of Sections 2(b) or 2(c) prior to the              anniversary of the Date of Grant, the following shall apply:

(i) In the event the Participant becomes vested in this Award as the result of the occurrence of an event described in Section 2(b), this Award shall be settled by payment of a number of shares of Stock equal to the Participant’s Target Amount as soon as practicable after the occurrence of such event, but in no event later than              , and no further payment will be made with respect to this Award.

(ii) In the event the Participant becomes vested in this Award as the result of the occurrence of any event described in Section 2(c), payment of this Award will be made in an amount (if any) and at such time, as described in Section 3(a).

4. Other Terms and Conditions . It is understood and agreed that the Award of Performance Shares evidenced hereby is subject to the following terms and conditions:

(a) Rights of Participant . The Participant shall have no right to transfer, pledge, hypothecate or otherwise encumber the Award. Prior to the payment of shares

 

2


of Stock in satisfaction of this Award, the Participant shall have none of the rights of a stockholder of the Company with respect to the Award, including, but not limited to, voting rights and the right to receive or accrue dividends.

(b) No Right to Continued Employment . This Award shall not confer upon the Participant any right with respect to continuance of employment by the Company or its Subsidiaries and Affiliates nor shall this Award interfere with the right of the Company to terminate the Participant’s employment at any time.

5. Tax Withholding . No later than the date of payment of the Award, the Participant shall pay to the Company an amount sufficient to allow the Company to satisfy its tax withholding obligations. To this end, the Participant shall either:

(a) pay the Company the amount of tax to be withheld (including through payroll withholding),

(b) deliver to the Company other shares of Stock of the Company owned by the Participant prior to such date having a fair market value, as determined by the Committee, not less than the amount of the withholding tax due, which either have been owned by the Participant for more than six (6) months or were not acquired, directly or indirectly, from the Company,

(c) make a payment to the Company consisting of a combination of cash and such shares of Stock, or

(d) request that the Company cause to be withheld a number of shares of Stock otherwise due the Participant hereunder having a then fair market value sufficient to discharge minimum required federal, state and local tax withholding (but no greater than such amount).

6. References . References herein to rights and obligations of the Participant shall apply, where appropriate, to the Participant’s legal representative or estate without regard to whether specific reference to such legal representative or estate is contained in a particular provision of this Award.

7. Governing Law . This Award shall be governed by and construed in accordance with the laws of Connecticut, without giving effect to principles of conflict of laws.

             IN WITNESS WHEREOF, the Company has caused this instrument to be executed by its proper officer hereunto duly authorized, as of the day and year first hereinabove written.

 

P RAXAIR , I NC .
By:  
 

 

 

3

Exhibit 10.04a

AMENDMENT TO THE

PRAXAIR, INC. 1995 STOCK OPTION PLAN

FOR NON-EMPLOYEE DIRECTORS

Section 9 of the Praxair, Inc. 1995 Stock Option Plan for Non-Employee Directors is hereby amended in its entirety as follows, effective as of October 24, 2006:

“9. Dilution and Other Adjustment.

In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make equitable adjustments in the number of shares and prices per share applicable to options then outstanding and in the number of shares which are available thereafter for option grants, both under the Plan as a whole and with respect to individuals. Such adjustments shall be made in a manner that the Committee determines is necessary and appropriate, and shall be conclusive and binding for all purposes of the Plan.”

 

October 24, 2006
PRAXAIR, INC.

Exhibit 10.04c

FIRST AMENDMENT TO THE

2005 EQUITY COMPENSATION PLAN

FOR NON-EMPLOYEE DIRECTORS OF PRAXAIR, INC.

Section 5.10 of the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc., is hereby amended in its entirety as follows, effective as of October 24, 2006:

“5.10 Adjustment in the Event of Recapitalization, etc.

In the event of any change in the outstanding shares of the Company by reason of any stock split, stock dividend, recapitalization, merger, consolidation, combination or exchange of shares or other similar corporate change or in the event of any special distribution to the stockholders, the Committee shall make equitable adjustments in the number of shares and prices per share applicable to Stock Option grants then outstanding and in the number of shares which are available thereafter for Stock Option grants or other awards, both under the Plan as a whole and with respect to individuals and award type. Such adjustments shall be made in a manner that the Committee determines is necessary and appropriate, and shall be conclusive and binding for all purposes of the Plan.”

 

October 24, 2006
PRAXAIR, INC.

Exhibit 10.17b

EXTENSION AGREEMENT

JPMorgan Chase Bank, N.A.,

as Administrative Agent

under the Credit Agreement

referred to below

270 Park Avenue

New York, NY 10017

Gentlemen:

The undersigned hereby agrees to extend, effective October 18, 2006, the Termination Date under the Credit Agreement dated as of December 23, 2004 (as amended from time to time, the “ Credit Agreement ”) among Praxair, Inc., a Delaware corporation (the “ Company ”), the Subsidiaries referred to therein, the Lenders party thereto, JPMorgan Chase Bank, N.A., as Administrative Agent (the “ Administrative Agent ”), Bank of America, N.A., as Syndication Agent and Citibank, N.A. and Credit Suisse First Boston, as Co-Documentation Agents, for one year to December 23, 2011. Terms defined in the Credit Agreement are used herein with the same meaning.

This Extension Agreement shall be construed in accordance with and governed by the law of the State of New York.

 

[LENDERS]
By:  

 

Name:  
Title:  

Agreed and accepted:

 

PRAXAIR, INC.
By:  

/s/ Micheal J. Allan

Name:   Micheal J. Allan
Title:   Vice President and Treasurer

 

JPMORGAN CHASE BANK, N.A., as

Administrative Agent

By:  

/s/ Stacey Haimes

Name:   Stacey Haimes
Title:   Vice President

RATIO OF EARNINGS TO FIXED CHARGES

Praxair, Inc. and Subsidiaries


Exhibit 12.01

 

(Dollar amounts in millions, except ratios)    Year Ended December 31,  
     2006     2005     2004     2003     2002  

Pre-tax income from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees

   $ 1,364     $ 1,130     $ 948     $ 771     $ 717  

Capitalized interest

     (21 )     (11 )     (7 )     (9 )     (9 )

Depreciation of capitalized interest

     14       14       13       12       12  

Dividends from less than 50%-owned companies carried at equity

     9       17       11       19       9  
                                        

Adjusted pre-tax income from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees

   $ 1,366     $ 1,150     $ 965     $ 793     $ 729  
                                        

Fixed charges

          

Interest on long-term and short-term debt

   $ 155     $ 163     $ 155     $ 151     $ 206  

Capitalized interest

     21       11       7       9       9  

Rental expenses representative of an interest factor

     32       32       29       31       32  

Preferred stock dividend requirements of consolidated subsidiaries

     —         —         1       —         1  
                                        

Total fixed charges

     208       206       192       191       248  

Less: preferred stock dividend requirements of consolidated subsidiaries

     —         —         (1 )     —         (1 )
                                        

Total fixed charges less preferred stock dividends

   $ 208     $ 206     $ 191     $ 191     $ 247  
                                        

Pre-tax income from continuing operations before adjustment for minority interests in consolidated subsidiaries or income or loss from equity investees plus fixed charges and preferred stock dividend requirements of consolidated subsidiaries

   $ 1,574     $ 1,356     $ 1,157     $ 984     $ 977  

Less: preferred stock dividend requirements of consolidated subsidiaries

     —         —         (1 )     —         (1 )
                                        

Total earnings less preferred stock dividends

   $ 1,574     $ 1,356     $ 1,156     $ 984     $ 976  
                                        

RATIO OF EARNINGS TO FIXED CHARGES AND PREFERRED STOCK DIVIDENDS

     7.6       6.6       6.0       5.2       3.9  
          

RATIO OF EARNINGS TO FIXED CHARGES

     7.6       6.6       6.1       5.2       3.9  
Table of Contents

Exhibit 13.01

FINANCIAL TABLE OF CONTENTS

 

AUDITED CONSOLIDATED FINANCIAL STATEMENTS

   26

Consolidated Statements of Income

   26

Consolidated Balance Sheets

   27

Consolidated Statements of Cash Flows

   28

Consolidated Statements of Shareholders’ Equity

   29

MANAGEMENT’S DISCUSSION AND ANALYSIS

   30

Business Overview

   30

Executive Summary – Financial Results & Outlook

   30

Consolidated Results

   31

Segment Discussion

   34

Liquidity, Capital Resources and Financial Data

   38

Critical Accounting Policies

   41

New Accounting Standards

   43

Market Risks and Sensitivity Analyses

   43

Forward-Looking Statements

   44

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

   45

Note 1. Summary of Significant Accounting Policies

   45

Note 2. Change in Accounting Principle

   48

Note 3. Acquisitions

   48

Note 4. Leases

   49

Note 5. Supplementary Income Statement Information

   50

Note 6. Income Taxes

   50

Note 7. Earnings per Share

   52

Note 8. Supplementary Balance Sheet Information

   52

Note 9. Property, Plant and Equipment – Net

   53

Note 10. Goodwill

   53

Note 11. Other Intangible Assets

   54

Note 12. Debt

   54

Note 13. Financial Instruments

   55

Note 14. Shareholders’ Equity

   56

Note 15. Preferred Stock

   56

Note 16. Stock-Based Compensation

   57

Note 17. Retirement Programs

   58

Note 18. Commitments and Contingencies

   62

Note 19. Segment Information

   63

Note 20. Quarterly Data

   65

MANAGEMENT’S STATEMENT OF RESPONSIBILITY FOR FINANCIAL STATEMENTS

   66

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

   66

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

   67

FIVE-YEAR FINANCIAL SUMMARY

   68

NON-GAAP FINANCIAL MEASURES

   69

INVESTOR INFORMATION

   71

 

25


Table of Contents
CONSOLIDATED STATEMENTS OF INCOME   PRAXAIR, INC. AND SUBSIDIARIES

 

(Dollar amounts in millions, except per share data)

                  

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

SALES

   $ 8,324     $ 7,656     $ 6,594  

Cost of sales, exclusive of depreciation and amortization

     4,968       4,641       3,987  

Selling, general and administrative

     1,086       987       869  

Depreciation and amortization

     696       665       578  

Research and development

     87       80       77  

Other income (expenses) – net

     32       10       20  
                        

OPERATING PROFIT

     1,519       1,293       1,103  

Interest expense – net

     155       163       155  
                        

INCOME BEFORE TAXES

     1,364       1,130       948  

Income taxes

     355       376       232  
                        
     1,009       754       716  

Minority interests

     (31 )     (37 )     (30 )

Income from equity investments

     10       15       11  
                        

INCOME BEFORE CUMULATIVE EFFECT OF CHANGE IN ACCOUNTING PRINCIPLE

     988       732       697  

Cumulative effect of change in accounting principle (Note 2)

     —         (6 )     —    
                        

NET INCOME

   $ 988     $ 726     $ 697  
                        

PER SHARE DATA

      

Basic earnings per share

      

Income before cumulative effect of change in accounting principle

   $ 3.05     $ 2.26     $ 2.14  

Cumulative effect of change in accounting principle

     —         (0.02 )     —    
                        

Net income

   $ 3.05     $ 2.24     $ 2.14  
                        

Diluted earnings per share

      

Income before cumulative effect of change in accounting principle

   $ 3.00     $ 2.22     $ 2.10  

Cumulative effect of change in accounting principle

     —         (0.02 )     —    
                        

Net income

   $ 3.00     $ 2.20     $ 2.10  
                        

WEIGHTED AVERAGE SHARES OUTSTANDING (000’S)

      

Basic shares outstanding

     323,495       323,765       325,891  

Diluted shares outstanding

     329,293       329,685       331,403  

The accompanying Notes on pages 45 to 65 are an integral part of these financial statements.

 

26


Table of Contents
CONSOLIDATED BALANCE SHEETS   PRAXAIR, INC. AND SUBSIDIARIES

 

(Dollar amounts in millions, except per share data)

            

DECEMBER 31,

   2006     2005  

ASSETS

    

Cash and cash equivalents

   $ 36     $ 173  

Accounts receivable

     1,456       1,386  

Inventories

     381       373  

Prepaid and other current assets

     186       201  
                

TOTAL CURRENT ASSETS

     2,059       2,133  

Property, plant and equipment – net

     6,694       6,108  

Equity investments

     218       218  

Goodwill

     1,613       1,545  

Other intangible assets – net

     71       81  

Other long-term assets

     447       406  
                

TOTAL ASSETS

   $ 11,102     $ 10,491  
                

LIABILITIES AND EQUITY

    

Accounts payable

   $ 682     $ 639  

Short-term debt

     130       231  

Current portion of long-term debt

     56       290  

Accrued taxes

     295       199  

Other current liabilities

     595       642  
                

TOTAL CURRENT LIABILITIES

     1,758       2,001  

Long-term debt

     2,981       2,926  

Other long-term liabilities

     931       833  

Deferred credits

     656       627  
                

TOTAL LIABILITIES

     6,326       6,387  
                

Commitments and contingencies (Note 18)

    

Minority interests

     222       202  

Shareholders’ equity

    

Common stock $0.01 par value, authorized – 800,000,000 shares, issued 2006 – 367,644,882 shares and 2005 – 363,712,929 shares

     4       4  

Additional paid-in capital

     2,729       2,489  

Retained earnings

     4,687       4,022  

Accumulated other comprehensive income (loss)

     (1,127 )     (1,257 )

Less: Treasury stock, at cost (2006 – 46,784,036 shares and

    

2005 – 41,374,130 shares)

     (1,739 )     (1,356 )
                

TOTAL SHAREHOLDERS’ EQUITY

     4,554       3,902  
                

TOTAL LIABILITIES AND EQUITY

   $ 11,102     $ 10,491  
                

The accompanying Notes on pages 45 to 65 are an integral part of these financial statements.

 

27


Table of Contents
CONSOLIDATED STATEMENTS OF CASH FLOWS   PRAXAIR, INC. AND SUBSIDIARIES

 

(Millions of dollars)

                  

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

      

OPERATIONS

      

Net income

   $ 988     $ 726     $ 697  

Adjustments to reconcile net income to net cash provided by operating activities:

      

Change in accounting principle (Note 2)

     —         6       —    

Depreciation and amortization

     696       665       578  

Deferred income taxes

     90       200       89  

Stock option expense

     42       —         —    

Non-cash charges and other

     (6 )     1       11  

Working capital

      

Accounts receivable

     (90 )     (165 )     (203 )

Inventories

     (15 )     (41 )     (24 )

Prepaid and other current assets

     1       (23 )     6  

Payables and accruals

     207       332       272  

Pension contributions

     (126 )     (140 )     (119 )

Long-term assets, liabilities and other

     (35 )     (86 )     (64 )
                        

NET CASH PROVIDED BY OPERATING ACTIVITIES

     1,752       1,475       1,243  
                        

INVESTING

      

Capital expenditures

     (1,100 )     (877 )     (668 )

Acquisitions (Note 3)

     (14 )     (44 )     (929 )

Divestitures and asset sales

     126       34       45  
                        

NET CASH USED FOR INVESTING ACTIVITIES

     (988 )     (887 )     (1,552 )
                        

FINANCING

      

Short-term debt repayments – net

     (338 )     (232 )     (113 )

Long-term debt borrowings

     490       453       924  

Long-term debt repayments

     (530 )     (224 )     (145 )

Issuances of common stock

     267       242       212  

Purchases of common stock

     (487 )     (396 )     (394 )

Cash dividends

     (323 )     (233 )     (195 )

Minority interest transactions and other

     (13 )     (48 )     (8 )

Excess tax benefit on stock option exercises

     29       —         —    
                        

NET CASH PROVIDED BY (USED FOR) FINANCING ACTIVITIES

     (905 )     (438 )     281  
                        

Effect of exchange rate changes on cash and cash equivalents

     4       (2 )     3  
                        

Change in cash and cash equivalents

     (137 )     148       (25 )

Cash and cash equivalents, beginning-of-year

     173       25       50  
                        

Cash and cash equivalents, end-of-year

   $ 36     $ 173     $ 25  
                        

SUPPLEMENTAL DATA

      

Taxes paid

   $ 190     $ 127     $ 154  

Interest paid

   $ 168     $ 175     $ 156  

The accompanying Notes on pages 45 to 65 are an integral part of these financial statements.

 

28


Table of Contents
CONSOLIDATED STATEMENTS OF SHA REHOLDERS’ EQUITY   PRAXAIR, INC. AND SUBSIDIARIES

 

(Dollar amounts in millions, except per share data, shares in thousands)

                                             

ACTIVITY

  

COMMON

STOCK

   ADDITIONAL
PAID-IN
CAPITAL
  

TREASURY

STOCK

    RETAINED
EARNINGS
   

ACCUMULATED

OTHER

COMPREHENSIVE

INCOME (LOSS)

(NOTE 8)

   

TOTAL

 
   SHARES    AMOUNTS       SHARES     AMOUNTS        

Balance, December 31, 2003

   354,951    $ 4    $ 2,148    28,865     $ (739 )   $ 3,027     $ (1,352 )   $ 3,088  
                                                         

Net income

                  697         697  

Translation adjustments

                    230       230  

Minimum pension liability, net of $31 million taxes

                    (58 )     (58 )
                         

Comprehensive income

                      869  

Dividends on common stock ($0.60 per share)

                  (195 )       (195 )

Issuances of common stock

                   

For the dividend reinvestment and stock purchase plan

   106         4              4  

For employee savings and incentive plans

   4,734         134    (2,758 )     75           209  

Purchases of common stock

            10,063       (395 )         (395 )

Tax benefit from stock options

           28              28  
                                                         

Balance, December 31, 2004

   359,791    $ 4    $ 2,314    36,170     $ (1,059 )   $ 3,529     $ (1,180 )   $ 3,608  
                                                         

Net income

                  726         726  

Translation adjustments

                    (28 )     (28 )

Minimum pension liability, net of $25 million taxes

                    (49 )     (49 )
                         

Comprehensive income

                      649  

Dividends on common stock ($0.72 per share)

                  (233 )       (233 )

Issuances of common stock

                   

For the dividend reinvestment and stock purchase plan

   88         4              4  

For employee savings and incentive plans

   3,834         143    (3,216 )     101           244  

Purchases of common stock

            8,420       (398 )         (398 )

Tax benefit from stock options

           28              28  
                                                         

Balance, December 31, 2005

   363,713    $ 4    $ 2,489    41,374     $ (1,356 )   $ 4,022     $ (1,257 )   $ 3,902  
                                                         

Net income

                  988         988  

Translation adjustments

                    175       175  

Minimum pension liability, net of $89 million taxes

                    139       139  
                         

Comprehensive income

                      1,302  

Dividends on common stock ($1.00 per share)

                  (323 )       (323 )

Issuances of common stock

                   

For the dividend reinvestment and stock purchase plan

   91         5              5  

For employee savings and incentive plans

   3,841         155    (3,113 )     107           262  

Purchases of common stock

            8,523       (490 )         (490 )

Tax benefit from stock options

           38              38  

Stock option expense

           42              42  

Initial funded status – SFAS No. 158, net of $111 million taxes (Note 17)

                    (184 )     (184 )
                                                         

Balance, December 31, 2006

   367,645    $ 4    $ 2,729    46,784     $ (1,739 )   $ 4,687     $ (1,127 )   $ 4,554  
                                                         

The accompanying Notes on pages 45 to 65 are an integral part of these financial statements.

 

29


Table of Contents

MANAGEMENT’S DISCUSSION AND ANALYSIS

BUSINESS OVERVIEW

Praxair is the largest industrial gases supplier in North and South America, is rapidly growing in Asia, and has strong, well-established businesses in Europe. The company’s primary products are oxygen, hydrogen, nitrogen, argon, carbon dioxide, helium, electronic gases and a wide range of specialty gases. Praxair Surface Technologies supplies high-performance coatings that protect metal parts from wear, corrosion and high heat. In 2006, 94% of sales were generated in four regional segments (North America, Europe, South America, and Asia) primarily from the sale of industrial gases. The Surface technologies segment generated the remaining 6% of sales.

Praxair serves approximately 25 industries as diverse as healthcare and petroleum refining; computer-chip manufacturing and beverage carbonation; fiber-optics and steel making; and aerospace, chemicals and water treatment. The diversity of end markets creates financial stability for Praxair in varied business cycles.

Praxair focuses its operational and growth strategies on the following 11 core geographies where the company has its strongest market positions and where distribution and production operations allow the company to deliver the highest level of service to its customers at the lowest cost.

 

NORTH AMERICA    SOUTH AMERICA    EUROPE    ASIA
United States    Brazil    Spain    China
Canada       Italy    India
Mexico       Germany/Benelux    Thailand
         Korea

Praxair manufactures and distributes its products through a network of hundreds of production plants, pipeline complexes, distribution centers and delivery vehicles. Major pipeline complexes are located in the United States, Brazil, Spain and Germany. This network is a competitive advantage, providing the foundation of reliable product supply to the company’s customer base. The majority of Praxair’s business is conducted through long-term contracts which provide stability in cash flow and the ability to pass through changes in energy costs to its customers. The company has significant growth opportunities including: hydrogen for refining; oxygen for healthcare; nitrogen and carbon dioxide for oil and gas production; and high purity gases for the semiconductor manufacturing industry.

EXECUTIVE SUMMARY – FINANCIAL RESULTS & OUTLOOK

Praxair delivered strong financial results in 2006, reporting record sales and earnings. Sales growth was driven by volume growth and higher pricing in all geographic regions. Strong sales growth to the global electronics, manufacturing, energy and metals markets came from the start-up of new supply systems and new applications technologies, many of which help Praxair’s customers improve their energy efficiency, reduce environmental emissions, or improve productivity. Operating profit and net income grew at a faster pace than sales primarily as a result of the company’s focus on pricing, fixed-cost management, and productivity programs.

2006 YEAR IN REVIEW

 

 

Sales up 9% to $8,324 million versus $7,656 million in 2005, reflecting strong new business growth and increased pricing levels, partially offset by lower natural gas costs passed through in hydrogen prices.

 

 

Operating profit of $1,519 million, a 17% increase over $1,293 million in 2005, reflecting volume growth, higher pricing and productivity savings which more than offset higher energy costs, general cost inflation and the introduction of stock option expense in 2006.

 

 

Net income of $988 million and diluted earnings per share of $3.00.

 

 

Cash flow from operations of $1,752 million, a 19% increase over $1,475 million in 2005.

2007 OUTLOOK

 

 

Sales growth of 8% – 10% versus 2006.

 

 

Diluted earnings per share in the range of $3.30 to $3.45.

 

 

Effective tax rate in the range of 26% to 27%.

 

 

Capital expenditures in the range of $1.1 billion to $1.2 billion.

The above guidance should be read in conjunction with the section entitled “Forward-Looking Statements” on page 44.

        Praxair provides quarterly updates on operating results, material trends that may affect financial performance, and financial earnings guidance via earnings releases and investor teleconferences. These materials are available on the company’s website, www.praxair.com, but are not incorporated herein.

 

30


Table of Contents

CONSOLIDATED RESULTS

The following table provides summary data for 2006, 2005, and 2004:

 

(Millions of dollars)

                     VARIANCE  

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2006 VS. 2005     2005 VS. 2004  

Sales

   $ 8,324     $ 7,656     $ 6,594     9 %   16 %

Gross margin (a)

   $ 3,356     $ 3,015     $ 2,607     11 %   16 %

As a percent of sales

     40.3 %     39.4 %     39.5 %    

Selling, general and administrative

   $ 1,086     $ 987     $ 869     10 %   14 %

As a percent of sales

     13.0 %     12.9 %     13.2 %    

Depreciation and amortization

   $ 696     $ 665     $ 578     5 %   15 %

Other income (expenses) – net

   $ 32     $ 10     $ 20      

Operating profit

   $ 1,519     $ 1,293     $ 1,103     17 %   17 %

Interest expense – net

   $ 155     $ 163     $ 155     (5 %)   5 %

Effective tax rate

     26.0 %     33.3 %     24.5 %    

Income (b)

   $ 988     $ 732     $ 697     35 %   5 %

Number of employees

     27,042       27,306       27,020     (1 %)   1 %

(a) Gross margin excludes depreciation and amortization expense.
(b) 2005 income is before the cumulative effect of change in accounting principle. It includes a $92 million, or $0.28 per diluted share, income tax charge for the repatriation of foreign earnings pursuant to the American Jobs Creation Act of 2004 and other tax adjustments.

2006 COMPARED WITH 2005

Sales in 2006 increased $668 million, or 9%, versus 2005. Underlying sales growth was 10% excluding the impact of lower natural gas costs passed through in hydrogen prices which decreased sales by $87 million, or 1%, with a minimal impact on operating profit. Sales grew year over year from volume growth in all geographic regions and higher overall pricing. Volume growth of 4% was driven by new business activity in Asia, North America and South America in the manufacturing, electronics, and metals end-markets. Price increases of 4% were predominantly realized in North America and South America due to pricing actions and the pass-through of higher power costs and surcharges. The impacts of currency, primarily in South America, Canada and Asia, favorably impacted sales growth by 2%.

Gross margin in 2006 improved $341 million, or 11%, versus 2005. The 90 basis point increase in the gross margin percentage, to 40.3%, was primarily due to a larger proportion of growth in atmospheric gases sales which have higher average gross margins versus hydrogen sales, realized price increases and cost reduction programs which continued to outpace underlying inflationary cost pressures.

Selling, general and administrative expenses in 2006 were $1,086 million, or 13.0% of sales, versus $987 million, or 12.9% of sales, for 2005. 2006 included stock option expense of $39 million versus 2005 which did not include stock option expense. Including pro forma stock option expense of $37 million in 2005, selling, general and administrative expenses were 13.4% of sales. The underlying decrease in selling, general and administrative expense as a percentage of sales was due to realized benefits from the company’s focus on fixed-cost management and productivity initiatives.

Depreciation and amortization expense in 2006 increased $31 million, or 5%, versus 2005. The increase was principally due to higher capital spending and currency effects.

Other income (expenses) – net in 2006 was a $32-million benefit compared to a $10-million benefit in 2005. See Note 5 to the consolidated financial statements for a summary of the major components of Other income (expense) – net.

Operating profit in 2006 increased $226 million, or 17%, versus 2005. Stock option expense reduced operating profit by $42 million in 2006. Including pro forma stock option expense of $40 million in 2005, underlying operating profit increased $266 million, or 21%. Increased sales volumes, pricing and the continued impact of productivity programs were the primary drivers of growth.

 

31


Table of Contents

Interest expense – net in 2006 decreased $8 million, or 5%, versus 2005 due to the capitalization of interest related to higher capital expenditures on the company’s backlog of projects which are expected to come on-stream over the next three years.

The effective income tax rate for 2006 was 26.0% versus 33.3% in 2005. 2005 income taxes included an income tax charge of $92 million for the repatriation of foreign earnings and other tax adjustments, and a net $9 million income tax benefit in Europe principally related to a tax legislation change (see Note 6 to the consolidated financial statements). Excluding these items, the underlying effective tax rate was approximately 26% in 2005.

At December 31, 2006, minority interests consisted principally of minority shareholders’ investments in Asia (primarily in China and India), Europe (primarily in Italy), and North America (primarily within Praxair Distribution). The decrease in minority interests of $6 million in 2006 was primarily in Italy.

Praxair’s significant equity investments are in Italy, the United States and China. The company’s share of net income from corporate equity investments decreased $5 million in 2006 primarily due to a decrease in Italy and the divestiture of a Turkish joint venture in July 2006.

Income in 2006 increased $256 million, or 35%, from 2005. Stock option expense reduced income by $28 million in 2006. Income in 2005 included the impact of the $92 million income tax charge. Excluding the impact of the income tax charge in 2005 and including pro forma stock option expense of $26 million for 2005, income increased $190 million, or 24%. Operating profit growth was the primary driver of the income improvement.

The number of employees at December 31, 2006 was 27,042 reflecting a decrease of 264 employees from December 31, 2005, primarily due to the divestiture of the aviation services business.

2005 COMPARED WITH 2004

Sales in 2005 increased $1,062 million, or 16%, versus 2004. Favorable currency movements, principally in South America, Canada and Asia, generated 4% of sales growth. Acquisitions contributed 5% to sales growth due to the acquisition of industrial gas assets in Germany and Home Care Supply (HCS) in 2004. Underlying sales growth of 6% was driven by realized price increases in North and South America and volume growth mainly in the worldwide energy, chemicals, metals and manufacturing markets. The underlying volume growth of 2% understates the strong demand throughout the year in most of the company’s end markets and regions. Volume growth was mitigated by reduced on-site volumes in North America due to temporary customer outages and business interruptions in the second half of the year partly resulting from Hurricanes Katrina and Rita. The increase in raw material costs resulting from higher natural gas prices, which Praxair is contractually entitled to pass through to on-site hydrogen customers, increased sales by $72 million, or 1%, with an insignificant impact on operating profit.

Gross margin in 2005 improved $408 million, or 16%, versus 2004, in line with the sales increase. Significant energy-cost increases, averaging 16% in 2005, and general inflation were offset by pricing increases and productivity initiatives.

Selling, general and administrative expenses in 2005 were $987 million, or 12.9% of sales, versus $869 million, or 13.2% of sales, for 2004. The $118 million increase was primarily due to the year-over-year impact of acquisitions in 2004 and currency effects. General inflationary pressures continued to be offset by worldwide cost efficiency programs.

Depreciation and amortization expense in 2005 increased $87 million, or 15%, versus 2004. The increase was primarily due to an increase in the 2005 capital base resulting from plant start-ups and increased capital spending due to the strong project backlog. Acquisitions and currency effects also contributed to the growth.

Other income (expenses) – net in 2005 was a $10-million benefit compared to a $20-million benefit in 2004. See Note 5 to the consolidated financial statements for a summary of the major components of Other income (expenses) – net.

 

32


Table of Contents

Operating profit in 2005 increased $190 million, or 17%, versus 2004. Strong volumes and pricing, the continued impact of productivity and cost reduction initiatives, and the contribution from acquisitions were primarily responsible for the operating profit growth. Favorable currency effects contributed 4% to operating profit growth.

Interest expense – net in 2005 increased $8 million, or 5%, versus 2004 as a result of the increase in average full-year debt levels compared to the prior year, which was due to the financing of acquisitions made in 2004.

The effective income tax rate for 2005 was 33.3% versus 24.5% in 2004. In 2005, income taxes included a charge of $92 million for the repatriation of foreign earnings and other tax adjustments offset by a net $9 million income tax benefit in Europe principally related to a tax legislation change. 2004 income taxes included a $3 million income tax benefit resulting from the resolution of various tax matters. Excluding these tax items, the underlying effective tax rates were approximately 26% in 2005 and 25% in 2004. This increase was due primarily to higher earnings contributions in countries with higher marginal tax rates.

At December 31, 2005, minority interests consisted principally of minority shareholders’ investments in Europe (primarily in Italy), Asia (primarily in China and India) and North America (primarily within Praxair Distribution). The increase in minority interests of $7 million in 2005 was due to improved profitability of the entities located in Italy and China.

Praxair’s significant equity investments are in Italy, the United States and Spain. The company’s share of net income from corporate equity investments increased $4 million in 2005 primarily due to an asset impairment charge of $3 million recorded in 2004 for an unconsolidated joint venture.

Income in 2005 increased $35 million, or 5%, versus 2004. Income excluding the impact of the third-quarter income tax charge of $92 million increased 18%. Operating-profit growth was the primary driver of the net-income improvement.

The number of employees at December 31, 2005 was 27,306, reflecting a small increase of 286 employees from December 31, 2004.

CHANGE IN ACCOUNTING PRINCIPLE

In 2005, Praxair completed its assessment of conditional asset retirement obligations required for the adoption of FASB Interpretation No. (FIN) 47, “Accounting for Conditional Asset Retirement Obligations.” The assessment resulted in the recognition of a liability related to asset retirement obligations for assets currently in use. As a result, a $6 million non-cash transition charge to earnings was recorded as a cumulative effect of change in accounting principle. See Note 2 to the consolidated financial statements.

RELATED PARTY TRANSACTIONS

The company’s related parties are primarily unconsolidated equity affiliates. The company did not engage in any material transactions involving related parties that included terms or other aspects that differ from those which would be negotiated with independent parties.

COSTS RELATING TO THE PROTECTION OF THE ENVIRONMENT

Praxair’s principal operations relate to the production and distribution of atmospheric and other industrial gases, which historically have not had a significant impact on the environment. However, worldwide costs relating to environmental protection may continue to grow due to increasingly stringent laws and regulations, and Praxair’s ongoing commitment to rigorous internal standards. Environmental protection costs in 2006 included approximately $14 million in capital expenditures and $22 million of expenses. Environmental protection expenditures were approximately $5 million higher in 2006 versus 2005 primarily due to increases in capital projects and increased compliance costs. Praxair anticipates that future environmental protection expenditures will be similar to 2006, subject to any significant changes in existing laws and regulations. Based on historical results and current estimates, management does not believe that environmental expenditures will have a material adverse effect on the consolidated financial position or on the consolidated results of operations or cash flows in any given year.

LEGAL PROCEEDINGS

See Note 18 to the consolidated financial statements for information concerning legal proceedings.

 

33


Table of Contents

SEGMENT DISCUSSION

The following summary of sales and operating profit by segment provides a basis for the discussion that follows (for additional information concerning Praxair’s segments, see Note 19 to the consolidated financial statements):

 

(Millions of dollars)

                  VARIANCE  

YEAR ENDED DECEMBER 31,

   2006    2005    2004    2006 VS. 2005     2005 VS. 2004  

SALES (a)

             

North America

   $ 4,696    $ 4,429    $ 3,959    6 %   12 %

Europe

     1,163      1,088      836    7 %   30 %

South America

     1,348      1,123      866    20 %   30 %

Asia

     636      543      487    17 %   11 %

Surface technologies

     481      473      446    2 %   6 %
                                 
   $ 8,324    $ 7,656    $ 6,594    9 %   16 %
                                 

OPERATING PROFIT

             

North America

   $ 822    $ 685    $ 623    20 %   10 %

Europe

     266      263      214    1 %   23 %

South America

     252      202      152    25 %   33 %

Asia

     111      95      80    17 %   19 %

Surface technologies

     68      48      34    42 %   41 %
                                 
   $ 1,519    $ 1,293    $ 1,103    17 %   17 %
                                 

(a) 2005 and 2004 sales have been reclassified to conform to the 2006 presentation. See Note 19 to the consolidated financial statements.

NORTH AMERICA

The North America segment includes Praxair’s industrial and packaged gases operations in the U.S., Canada and Mexico.

Sales for 2006 increased $267 million, or 6%, versus 2005. Underlying sales growth was 8% excluding the impact of lower natural gas costs passed through in hydrogen prices which decreased sales by $87 million, or 2%, with a minimal impact on operating profit. Pricing increased sales by 5% due to the contractual pass-through of higher power costs to on-site customers, surcharges for higher power and transportation fuel costs for merchant and packaged gases, and the impact of general pricing actions. Volume contributed 2% to growth reflecting strong sales to the metals, manufacturing and electronics end-markets which was offset by lower energy market on-site volumes due to a customer outage on the U.S. Gulf Coast. Currency contributed 1% to sales growth.

Operating profit in 2006 increased $137 million, or 20%, versus 2005. 2006 included $24 million of stock option expense. Including pro forma stock option expense of $23 million in 2005, underlying operating profit increased $160 million, or 24%. Increased sales volumes to the metals, electronics and manufacturing markets and productivity programs were the primary drivers to the significant operating profit growth.

Sales for 2005 increased $470 million, or 12%, versus 2004. Acquisitions contributed 2% to sales growth due to the mid-year 2004 acquisition of HCS. Underlying sales growth of 7% was due to higher pricing and volumes, as compared to 2004. Pricing increased sales by 5% and was the result of the contractual pass-through of higher power costs to on-site customers, surcharges for higher power and transportation fuel costs for merchant and packaged gases, and the impact of pricing actions. Volume growth of 2% reflects strong merchant liquid and packaged gases volumes offset by lower on-site volumes, which was primarily a result of customer outages on the U.S. Gulf Coast in the second half of 2005, resulting in reduced volumes to the chemicals and refining industries. Volumes to general manufacturing markets were strong throughout the year. Merchant-liquid demand was strong in most end markets, particularly energy and oil well services. Strong results in Canada and Mexico also contributed to sales growth. The increase in raw material costs resulting from higher natural gas prices, which Praxair is contractually entitled to pass through to on-site hydrogen customers, increased sales by $72 million, or 2%, with an insignificant impact on operating profit.

 

34


Table of Contents

Operating profit in 2005 increased $62 million, or 10%, versus 2004. Acquisitions and currency favorably impacted operating profit growth by 3%. Underlying growth was 7%, in line with sales growth, from the combined impact of pricing actions and cost reduction activities, which more than offset the significantly higher energy costs and underlying general cost inflation.

On June 14, 2004, Praxair acquired 100% of the outstanding common shares of HCS for a purchase price of $245 million. HCS was the largest privately-held home-respiratory and medical-equipment provider in the United States with 59 locations in 13 states. See Note 3 to the consolidated financial statements for additional information related to the acquisition.

EUROPE

Praxair’s European industrial gases business is primarily in Italy, Spain, Germany, the Benelux region and France.

Sales for 2006 increased $75 million, or 7%, versus 2005 due to sales volume growth of 4% and 3% higher pricing. Volume growth was due to strong on-site and merchant demand in Germany, Spain, Italy and Western Europe in the manufacturing and metals markets as well as in Spain’s homecare business.

Operating profit for 2006 increased $3 million, or 1%, versus 2005. 2006 included $5 million of stock option expense. Including pro forma stock option expense of $4 million in 2005, underlying operating profit increased $7 million, or 3%. The underlying increase was due to productivity and cost reduction initiatives and pricing which outpaced inflationary pressures.

Sales for 2005 increased $252 million, or 30%, versus 2004. The full-year impact of the German acquisition accounted for 28% of the sales growth. The favorable impact of the stronger euro increased sales by 1%. Excluding the acquisition and the impact of currency, sales increased 1% due to higher volumes from new business and applications. Organic business activity remained stable, with modest volume growth in Spain and Germany offsetting weaker volumes in Italy and Western Europe due to a slowing economic environment.

Operating profit for 2005 increased $49 million, or 23%, versus 2004. The contribution of the German acquisition accounted for most of the operating-profit growth. Inflationary pressures continued to be largely offset by productivity programs.

On December 2, 2004, Praxair acquired industrial gas assets and related businesses in Germany for a purchase price of $667 million. The acquired assets and businesses consist of industrial gas plants and pipeline assets in the Rhine/Ruhr and Saar areas, bulk distribution and packaged-gas businesses. The businesses serve large customers in the refining, chemical and steel industries along the pipeline systems, in addition to 40,000 smaller customers in bulk, medical, specialty and packaged gases. See Note 3 to the consolidated financial statements for additional information related to the acquisition.

SOUTH AMERICA

Praxair’s South American industrial gases operations are conducted by its subsidiary, White Martins Gases Industriais Ltda. (White Martins), the largest industrial gases company in Brazil. White Martins also manages Praxair’s operations in Argentina, Bolivia, Chile, Colombia, Paraguay, Peru, Uruguay and Venezuela.

Sales for 2006 increased $225 million, or 20%, versus 2005. The favorable impact of currency increased sales by 9%. Excluding the impact of currency, sales grew 11%, primarily due to higher volumes due to new plant start-ups and increased sales to the metals, manufacturing and healthcare markets. An equipment sale to a Venezuela customer contributed 2% to sales growth.

Operating profit for 2006 increased $50 million, or 25%, versus 2005. 2006 included $6 million of stock option expense. Including pro forma stock option expense of $5 million in 2005, underlying operating profit increased $55 million, or 28%. Increased volumes and cost-reduction programs outpaced inflationary pressures contributing 8% and 17% to operating profit growth, respectively. Currency also contributed to operating profit growth in 2006.

Sales for 2005 increased $257 million, or 30%, versus 2004. The favorable impact of currency increased sales by 17%. Excluding the impact of currency, sales increased 13%, driven by higher pricing and volumes primarily to the manufacturing and healthcare markets.

Operating profit increased $50 million, or 33%, versus 2004. Higher pricing and cost-reduction programs outpaced underlying inflation pressures, favorably impacting operating profit. The favorable impact of currency contributed 15% to operating profit growth in 2005.

 

35


Table of Contents

ASIA

The Asia segment includes Praxair’s industrial gases operations in China, India, Korea and Thailand, with smaller operations in Japan, Malaysia and Taiwan.

Sales for 2006 increased $93 million, or 17%, versus 2005. Sales growth was principally due to new plant start-ups and strong volumes of gases and materials to electronics customers as demand from the semiconductor and LCD markets was strong. Higher sales to the metals markets in China and India also contributed to volume growth. Pricing was neutral as favorable pricing trends in atmospheric gases were offset by lower pricing for electronics specialty gases and materials. Favorable currency movements improved sales by 2%.

Operating profit for 2006 increased $16 million, or 17%, versus 2005. 2006 included $4 million of stock option expense. Including pro forma stock option expense of $4 million in 2005, underlying operating profit increased $20 million, or 22%. Increased sales volumes and productivity initiatives were the primary drivers of operating profit growth.

Sales for 2005 increased $56 million, or 11%, versus 2004. Strong volume growth, primarily to the electronics and metals markets, contributed 9% to the increase. The increase in sales to electronics, the segment’s largest end-market, was due to sales of sputtering targets and strong demand for specialty gases for the semiconductor and LCD markets. Growth in the on-site and liquid product lines, primarily in China, Korea and Thailand, also contributed to volume increases. Pricing declined by 2%. Favorable pricing trends in Thailand and India were offset by pricing declines in electronics specialty gases. Favorable currency movements improved sales by 4%.

Operating profit for 2005 increased $15 million, or 19%, versus 2004. The increase in operating profit was a result primarily of volume growth and cost-efficiency improvements in the supply system.

SURFACE TECHNOLOGIES

Surface technologies provides high-performance coatings and thermal-spray powders in the U.S. and Europe, with smaller operations in Asia and Brazil.

On July 3, 2006, Praxair completed the sale of its aviation services business, which contributed full year 2005 sales of approximately $67 million to the Surface technologies segment.

Sales for 2006 increased $8 million, or 2%, versus 2005. Excluding the impact of the aviation services divestiture in the third quarter, underlying sales increased 9% for the year. Volume growth of 4% was driven by higher coatings volumes for OEM aircraft engine parts, industrial power turbines in the U.S. and Europe and oil field service components. Realized price increases contributed 5% to sales growth.

Operating profit for 2006 increased $20 million, or 42%, versus 2005. 2006 included a gain of approximately $7 million from the aviation services divestiture, and $3 million of stock option expense. Excluding the gain on the sale of a business in 2006 and including pro forma stock option expense of $4 million in 2005, underlying operating profit increased $17 million, or 39%. The increase was principally driven by higher pricing and volume growth as well as the favorable benefits of ongoing cost reduction actions.

Sales for 2005 increased $27 million, or 6%, versus 2004. Higher volumes of coatings for OEM aircraft engine parts primarily drove the overall volume increase of 3%. Industrial coatings for power turbines and oil field service components also were higher compared to the prior year. Realized price increases were 2%.

Operating profit for 2005 increased $14 million, or 41%, versus 2004. The increase was principally driven by the higher sales volumes. Pricing actions and cost reduction activities offset increasing raw material costs.

 

36


Table of Contents

CURRENCY

The results of Praxair’s non-U.S. operations are translated to the company’s reporting currency, the U.S. dollar, from the functional currencies used in the countries in which the company operates. For most foreign operations, Praxair uses the local currency as its functional currency. There is inherent variability and unpredictability in the relationship of these functional currencies to the U.S. dollar and such currency movements may materially impact Praxair’s results of operations in any given period.

To help understand the reported results, the following is a summary of the significant currencies underlying Praxair’s consolidated results and the exchange rates used to translate the financial statements (rates of exchange expressed in units of local currency per U.S. dollar):

 

CURRENCY

  

PERCENT OF
2006
CONSOLIDATED

SALES (a)

    INCOME STATEMENT    BALANCE SHEET
     AVERAGE YEAR ENDED DECEMBER 31,    DECEMBER 31,
     2006    2005    2004    2006    2005

Brazilian real

   14 %   2.17    2.43    2.92    2.14    2.34

European euro

   13 %   0.80    0.80    0.81    0.76    0.85

Canadian dollar

   9 %   1.14    1.21    1.31    1.16    1.17

Mexican peso

   5 %   10.91    10.96    11.30    10.88    10.68

Chinese RMB

   2 %   7.98    8.20    8.28    7.81    8.07

Indian rupee

   2 %   45.38    44.02    45.41    44.38    45.20

Korean won

   2 %   959    1,027    1,151    930    1,013

Argentinean peso

   1 %   3.08    2.92    2.94    3.06    3.03

Venezuelan Bolivar

   <1 %   2,150    2,107    1,883    2,150    2,150

(a) Certain Surface technologies segment sales are included in European and Brazilian sales.

 

37


Table of Contents

LIQUIDITY, CAPITAL RESOURCE S AND FINANCIAL DATA

 

(Millions of dollars)

                  

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

NET CASH PROVIDED BY (USED FOR)

      

OPERATING ACTIVITIES

      

Net income plus depreciation and amortization and change in accounting principle

   $ 1,684     $ 1,397     $ 1,275  

Working capital

     (23 )     (37 )     (68 )

Other – net

     91       115       36  
                        

Total provided by operating activities

   $ 1,752     $ 1,475     $ 1,243  
                        

INVESTING ACTIVITIES

      

Capital expenditures

   $ (1,100 )   $ (877 )   $ (668 )

Acquisitions

     (14 )     (44 )     (929 )

Divestitures and asset sales

     126       34       45  
                        

Total used for investing

   $ (988 )   $ (887 )   $ (1,552 )
                        

FINANCING ACTIVITIES

      

Debt increases (reductions) – net

   $ (378 )   $ (3 )   $ 666  

Issuances (purchases) of stock – net

     (220 )     (154 )     (182 )

Cash dividends

     (323 )     (233 )     (195 )

Minority transactions and other

     (13 )     (48 )     (8 )

Excess tax benefit on stock option exercises

     29       —         —    
                        

Total provided by (used for) financing

   $ (905 )   $ (438 )   $ 281  
                        

OTHER FINANCIAL DATA (a)

      

Debt-to-capital ratio

     39.9 %     45.6 %     47.9 %

After-tax return on capital

     14.6 %     12.8 %     12.1 %

(a) Non-GAAP measures. See the Non-GAAP Financial Measures on page 69 for definitions and reconciliations to reported amounts.

CASH FLOW FROM OPERATIONS

2006 COMPARED WITH 2005

Cash flow from operations increased $277 million to $1,752 million in 2006 from $1,475 million in 2005. The growth is a result of the strong cash flow generated from the improved operating profits on higher sales and continued focus on the management of working capital which grew at a slower pace than sales. Pension contributions were $126 million in 2006.

2005 COMPARED WITH 2004

Cash flow from operations increased $232 million to $1,475 million in 2005 from $1,243 million in 2004. The growth is a result of the strong cash flow generated from the improved operating profits on higher sales and continued focus on the management of working capital which grew at a slower pace than sales. Pension contributions were $140 million in 2005.

Cash Flow From Operations

(Millions of dollars)

LOGO

INVESTING

2006 COMPARED WITH 2005

Net cash used for investing activities of $988 million in 2006 increased $101 million versus 2005. The increase was largely due to $223 million higher capital expenditures in 2006 partially offset by increased proceeds from divestitures and asset sales in 2006.

Capital expenditures in 2006 were $1,100, an increase of $223 million from 2005. This increase reflects investments in new projects primarily in North America and Asia which will come on-stream over the next three years.

Acquisition expenditures in 2006 were $14 million, a decrease of $30 million from 2005 levels.

Capital Expenditures

(Millions of dollars)

LOGO


(a) $983 million includes the purchase of previously leased assets for $339 million ($644 million excluding leased asset purchases)

 

38


Table of Contents

Divestitures and asset sales in 2006 totaled $126 million, an increase of $92 million from 2005, primarily due to cash received from the divestiture of the aviation services business and a Turkish joint venture in 2006.

On a worldwide basis, capital expenditures for 2007 are expected to be in the range of $1,100 million to $1,200 million. By region, over half of forecasted capital expenditures will be for projects in North America, the largest of which are energy-related. The second largest region for investment is Asia with a concentration of projects in China and India primarily to fund supply systems for customers in the electronics, metals and chemicals markets.

2005 COMPARED WITH 2004

Net cash used for investing activities of $887 million in 2005 decreased $665 million versus 2004. Cash used for acquisitions decreased by $885 million as 2004 included the German and HCS acquisitions. This decrease was partially offset by higher capital expenditures in 2005, which increased $209 million to $877 million, reflecting a strong backlog of projects that will begin production in 2006 and 2007.

Acquisition expenditures in 2005 were $44 million, related primarily to the purchase of a North American packaged gas distributor in December.

Divestitures and asset sales in 2005 totaled $34 million, a decrease of $11 million from 2004. An increase in underlying asset sales in 2005 was offset by a $20-million sale of assets in Europe related to a customer contract termination in 2004.

FINANCING

Praxair’s financing strategy is to secure long-term committed funding at attractive interest rates by issuing U.S. public notes and debentures and commercial paper backed by a standby long-term bank credit agreement. Its international operations are funded through a combination of local borrowing and inter-company funding to minimize the total cost of funds and to manage and centralize currency exchange exposures. As deemed necessary, Praxair manages its exposure to interest-rate changes through the use of financial derivatives (see Note 13 to the consolidated financial statements and the section entitled “Market Risks and Sensitivity Analyses” on page 43).

Debt-to-Capital Ratio

LOGO

At December 31, 2006, Praxair’s total debt outstanding was $3,167 million, $280 million lower than $3,447 million at December 31, 2005. The December 31, 2006 debt balance includes $2,321 million in public notes and $846 million representing primarily worldwide bank borrowings. At December 31, 2006, Praxair was in compliance with its borrowing covenants and its global effective borrowing rate was approximately 6%. See Note 12 to the consolidated financial statements for additional information on the company’s indebtedness.

Cash used for financing activities was $905 million in 2006 compared to $438 million in 2005. This increase was primarily due to net debt repayments of $378 million during 2006. Dividend payments increased $90 million to $1.00 per share compared to $0.72 per share in 2005, an increase of 39%. Cash used for minority transactions and other decreased $35 million to $13 million in 2006 due primarily to dividend payments to a minority shareholder in Italy in 2005.

OTHER FINANCIAL DATA

The following discussion includes non-GAAP measures that may not be comparable to similar definitions used by other companies. Praxair believes that its debt-to-capital ratio is appropriate for measuring its financial leverage. The company believes that its after-tax return on capital ratio is an appropriate measure for judging performance as it reflects the approximate after-tax profit earned as a percentage of investments by all parties in the business (debt, minority interests and shareholders’ equity). See Non-GAAP Financial Measures on page 69 for definitions and reconciliation of these two non-GAAP measures to reported amounts.

Praxair’s debt-to-capital ratio decreased to 39.9% at December 31, 2006 versus 2005. The improvement is attributed to lower debt levels and an increase in shareholders’ equity due to 2006 net income slightly offset by an increase in 2006 dividends declared and paid.

After-tax return on capital increased to 14.6% at December 31, 2006 versus 2005 due primarily to the productivity increases achieved by growing operating profit at a faster rate than required capital investments.

 

39


Table of Contents

OFF-BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

The following table sets forth Praxair’s material contractual obligations and other commercial commitments as of December 31, 2006:

 

(Millions of dollars)

  CONTRACTUAL OBLIGATIONS   OTHER COMMERCIAL COMMITMENTS

DUE OR
EXPIRING BY
DECEMBER 31,

  DEBT AND
CAPITALIZED
LEASE
MATURITIES
  CONTRACTUAL
INTEREST
ON DEBT
  OBLIGATIONS
UNDER
OPERATING
LEASES
  UNCONDITIONAL
PURCHASE
OBLIGATIONS
  TOTAL   CONSTRUCTION
COMMITMENTS
  GUARANTEES
AND OTHER
  TOTAL

2007

  $ 186   $ 148   $ 82   $ 220   $ 636   $ 671   $ 77   $ 748

2008

    572     127     59     175     933     296     —       296

2009

    608     117     47     150     922     3     1     4

2010

    13     96     34     118     261     —       —       —  

2011

    509     87     22     115     733     —       —       —  

Thereafter

    1,279     132     71     413     1,895     —       11     11
                                               
  $ 3,167   $ 707   $ 315   $ 1,191   $ 5,380   $ 970   $ 89   $ 1,059
                                               

Debt and capitalized lease maturities of $3,167 million are more fully described in Note 12 to the consolidated financial statements and are included on the company’s balance sheet as long- and short-term liabilities. Maturities of short-term borrowings under the €450-million, five-year borrowing facility of $590 million are included in 2009 due to the company’s ability and intent to refinance amounts outstanding against this facility through the final maturity date under the terms of this agreement. In addition, $500 million of notes due in 2007 are reflected in 2011 maturities due to the company’s intent and ability to refinance this debt on a long-term basis.

Contractual interest on debt of $707 million represents interest the company is contracted to pay on outstanding long-term debt and capital lease obligations, calculated on a basis consistent with planned debt maturities. At December 31, 2006, Praxair had fixed-rate debt of $2,378 million and floating-rate debt of $789 million. The rate assumed for floating-rate debt was the rate in effect at December 31, 2006.

Obligations under operating leases of $315 million represent non-cancelable contractual obligations primarily for manufacturing and distribution equipment and office space. See Note 4 to the consolidated financial statements for further details.

Unconditional purchase obligations of $1,191 million represent contractual commitments under various long- and short-term take-or-pay arrangements with suppliers. These obligations are primarily minimum-purchase commitments for helium, electricity, natural gas and feedstock used to produce atmospheric gases, carbon dioxide and hydrogen. During 2006, payments under these contracts totaled $717 million, including $302 million for electricity and $278 million for natural gas. A significant portion of these obligations is passed on to customers through similar take-or-pay contractual arrangements. Purchase obligations that are not passed along to customers do not represent a significant risk to Praxair.

Construction commitments of $970 million represent outstanding commitments to customers or suppliers to complete authorized construction projects as of December 31, 2006. A significant portion of Praxair’s capital spending is related to the construction of new production facilities to satisfy customer commitments which may take a year or more to complete. Significant commitments include a large hydrogen plant in northern California to supply Chevron’s Richmond Refinery and a project with Jiangsu SOPO (Group) Co., Ltd in China to build an air separation unit to support their coal gasification project.

Guarantees and other of $89 million include $22 million related to required minimum pension contributions and $67 million related to Praxair’s contingent obligations under guarantees of certain debt of unconsolidated affiliates. Unconsolidated equity investees had total debt of approximately $285 million at December 31, 2006, which was non-recourse to Praxair with the exception of the guaranteed portions described above. Praxair has no financing arrangements with closely-held related parties.

See Note 18 to the consolidated financial statements for more information concerning commitments and contingencies. In addition, see Note 8 to the consolidated financial statements for a summary of long-term liabilities which consist primarily of pension and other post-retirement benefit liabilities (OPEB).

 

40


Table of Contents

RETIREMENT BENEFITS

The non-cash SFAS No. 158 pension/OPEB funded status liability increased $67 million to $382 million at December 31, 2006 ($251 million after-tax) from the $315 million SFAS No. 87 minimum pension liability at December 31, 2005 ($206 million after-tax). The increase was due to the adoption of SFAS No. 158 which more than offset the strong pension asset return in 2006 (see Note 17 to the consolidated financial statements). The increase did not affect net income as the offsetting, after-tax charge was made to Accumulated Other Comprehensive Income within Shareholders’ Equity pursuant to U.S. GAAP.

Pension contributions were $126 million in 2006 and $140 million in 2005. Estimates of 2007 contributions are in the area of $25 million to $50 million.

Praxair assumes an expected return on plan assets for 2007 in the U.S. of 8.25%. In 2007, consolidated pension expense is expected to be approximately $51 million versus $56 million in 2006 and $44 million in 2005.

INSURANCE

Praxair purchases insurance to limit a variety of risks, including those related to workers’ compensation, third-party liability and property. Currently, the company self-retains the first $5 million per occurrence for workers’ compensation and general liability and retains $1 million to $5 million per occurrence for its various properties worldwide. To mitigate its aggregate loss potential above varying retentions, the company purchases insurance coverage from highly rated insurance companies at what it believes are reasonable coverage levels.

At December 31, 2006 and 2005, the company had recorded a total of $47 million and $42 million, respectively, representing an estimate of the retained liability for the ultimate cost of claims incurred and unpaid as of the balance sheet dates. The estimated liability is established using statistical analyses and is based upon historical experience, actuarial assumptions and professional judgment. These estimates are subject to the effects of trends in loss severity and frequency and are subject to a significant degree of inherent variability. If actual claims differ from the company’s estimates, financial results could be impacted.

Praxair recognizes estimated insurance proceeds relating to damages at the time of loss only to the extent of incurred losses. Any insurance recoveries for business interruption and for property damages in excess of the net book value of the property are recognized only when realized.

CRITICAL ACCOUNTING POLICIES

The policies discussed below are considered by management to be critical to understanding Praxair’s financial statements and accompanying Notes prepared in accordance with accounting principles generally accepted in the United States (U.S. GAAP). Their application places significant importance on management’s judgment as a result of the need to make estimates of matters that are inherently uncertain. Praxair’s financial position, results of operations and cash flows could be materially affected if actual results differ from estimates made. These policies are determined by management and have been reviewed by Praxair’s Audit Committee.

DEPRECIABLE LIVES OF PROPERTY, PLANT AND EQUIPMENT

Praxair’s net property, plant and equipment at December 31, 2006 was $6,694 million, representing 60% of the company’s consolidated total assets. Depreciation expense for the year ended December 31, 2006 was $681 million, or 10% of total operating costs. Management judgment is required in the determination of the estimated depreciable lives that are used to calculate the annual depreciation expense and accumulated depreciation.

Property, plant and equipment are recorded at cost and depreciated over the assets’ estimated useful lives on a straight-line basis for financial-reporting purposes. The estimated useful life represents the projected period of time that the asset will be productively employed by the company and is determined by management based on many factors, including historical experience with similar assets, technological life cycles, geographic locations and contractual supply relationships with on-site customers. Circumstances and events relating to these assets, such as on-site contract modifications, are monitored to ensure that changes in asset lives or impairments (see “Asset Impairment” below) are identified and prospective depreciation expense or impairment expense is adjusted accordingly. Praxair’s largest asset values relate to cryogenic air-separation production plants with average depreciable lives of 15 years.

Based upon the assets as of December 31, 2006, if depreciable lives of machinery and equipment, on average, were increased or decreased by one year, annual depreciation expense would be decreased by approximately $33 million or increased by approximately $37 million, respectively.

 

41


Table of Contents

PENSION BENEFITS

Pension benefits represent financial obligations that will be ultimately settled in the future with employees who meet eligibility requirements. Because of the uncertainties involved in estimating the timing and amount of future payments, significant estimates are required to calculate pension expense and liabilities related to the company’s plans. The company utilizes the services of several independent actuaries, whose models are used to facilitate these calculations.

Several key assumptions are used in actuarial models to calculate pension expense and liability amounts recorded in the financial statements. Management believes the three most significant variables in the models are the expected long-term rate of return on plan assets, the discount rate, and the expected rate of compensation increase. The actuarial models also use assumptions for various other factors, including employee turnover, retirement age, and mortality. Praxair management believes the assumptions used in the actuarial calculations are reasonable, reflect the company’s experience and expectations for the future and are within accepted practices in each of the respective geographic locations in which it operates. Actual results in any given year will often differ from actuarial assumptions because of economic and other factors.

The weighted-average expected long-term rates of return on pension plan assets were 8.25% for U.S. plans and 8.30% for international plans at December 31, 2006 (8.50% and 7.75%, respectively, at December 31, 2005). These rates are determined annually by management based on a weighted average of current and historical market trends, historical and expected portfolio performance and the current and expected portfolio mix of investments. A 0.50% change in these expected long-term rates of return, with all other variables held constant, would change Praxair’s pension expense by approximately $7 million.

The weighted-average discount rates for pension plan liabilities were 5.88% for U.S. plans and 6.0% for international plans at December 31, 2006 (5.62% and 5.45%, respectively, at December 31, 2005). These rates are used to calculate the present value of plan liabilities and are determined annually by management. The discount rate for the U.S. plan is established utilizing a bond matching model provided by the company’s independent actuaries. The portfolio of bonds includes only Moody’s Aa-graded corporate bonds and matches the U.S. plan’s projected cash flows to the spot rates and calculates the single equivalent discount rate which produces the same present value. The discount rates for the international plans are based on market yields for high-quality fixed income investments representing the approximate duration of the pension liabilities on the measurement date. A 0.50% change in discount rates, with all other variables held constant, would change Praxair’s pension expense by approximately $10 million and would impact the projected benefit obligation (PBO) by approximately $115 million.

The weighted-average expected rate of compensation increase was 3.50% for U.S. plans and 3.0% for international plans at December 31, 2006 (3.25% and 3.0%, respectively, at December 31, 2005). The estimated annual compensation increase is determined by management every year and is based on historical trends and market indices. A 0.50% change in the expected rate of compensation increase, with all other variables held constant, would change Praxair’s pension expense by approximately $4 million and would impact the PBO by approximately $21 million. A change in this assumption usually coincides with a change in the discount rate assumption, and the earnings impacts generally offset one another.

ASSET IMPAIRMENT

GOODWILL

At December 31, 2006, the company had goodwill of $1,613 million, which represents the aggregate of the excess purchase price for acquired businesses over the fair value of the net assets acquired.

The company performs a goodwill impairment test annually in the second quarter or more frequently if events or circumstances indicate that an impairment loss may have been incurred. The impairment test requires that the company estimate and compare the fair value of its reporting units to their carrying value. Fair value is determined through the use of projected future cash flows, multiples of earnings and sales and other factors.

Such analysis requires the use of certain future market assumptions and discount factors, which are subjective in nature. Estimated values can be affected by many factors beyond the company’s control such as business and economic trends, government regulation, and technological changes. Management believes that the assumptions used to determine fair value are appropriate and reasonable. However, changes in circumstances or conditions affecting these assumptions could have a significant impact on the fair value determination, which could then result in a material impairment charge to the company’s results of operations.

See Note 10 to the consolidated financial statements for disclosures concerning the carrying value of goodwill.

 

42


Table of Contents

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment is tested for impairment whenever events or changes in circumstances indicate that the carrying amount of an individual asset or asset group may not be recoverable. To test recoverability, the company compares management’s best estimate of the future cash flows expected to be generated from the asset or asset group to compare against the carrying amount of the asset or asset group. Should these undiscounted future cash flows be less than the carrying amount of the asset or asset group, an impairment charge reducing the carrying amount to fair value is required. Fair value is determined based on the most appropriate valuation technique, including discounted cash flows. This analysis requires management to make various subjective estimates and assumptions, including the amount of projected future cash flows related to the potentially impaired asset or asset group, the useful life over which cash flows will occur and the asset’s residual value, if any.

INCOME TAXES

At December 31, 2006, Praxair had deferred tax assets of $462 million (net of valuation allowances of $ 234 million), and deferred tax liabilities of $973 million. Income tax expense was $355 million for the year ended December 31, 2006.

In the preparation of consolidated financial statements, Praxair estimates income taxes based on diverse legislative and regulatory structures that exist in various jurisdictions where the company conducts business. Deferred income tax assets and liabilities represent tax benefits or obligations that arise from temporary differences due to differing treatment of certain items for accounting and income tax purposes. Praxair evaluates deferred tax assets each period to ensure that estimated future taxable income will be sufficient in character (e.g. capital gain versus ordinary income treatment), amount and timing to result in their recovery. A valuation allowance is established when management determines that it is more likely than not that a deferred tax asset will not be realized to reduce the assets to their realizable value. Considerable judgments are required in establishing deferred tax valuation allowances and in assessing probable exposures related to tax matters. Praxair’s tax returns are subject to audit and local taxing authorities could challenge the company’s tax positions. The company’s practice is to review tax-filing positions by jurisdiction and to record provisions for probable tax assessments, including interest and penalties when assessed, if applicable. Praxair believes it records and/or discloses such potential tax liabilities as appropriate and has reasonably estimated its income tax liabilities and recoverable tax assets.

NEW ACCOUNTING STANDARDS

See Notes 1 and 2 to the consolidated financial statements for information concerning new accounting standards and the impact of the implementation of these standards on the company’s financial statements.

MARKET RISKS AND SENSITIVITY ANALYSES

Praxair is exposed to market risks relating to fluctuations in interest rates and currency exchange rates. The objective of financial risk management at Praxair is to minimize the negative impact of interest rate and foreign exchange rate fluctuations on the company’s earnings, cash flows and equity.

To manage these risks, Praxair uses various derivative financial instruments, including interest-rate swaps, currency swaps, forward contracts and commodity contracts. Praxair only uses commonly traded and non-leveraged instruments. These contracts are entered into primarily with major banking institutions thereby minimizing the risk of credit loss. Also, see Notes 1 and 13 to the consolidated financial statements for a more complete description of Praxair’s accounting policies and use of such instruments.

The following discussion presents the sensitivity of the market value, earnings and cash flows of Praxair’s financial instruments to hypothetical changes in interest and exchange rates assuming these changes occurred at December 31, 2006. The range of changes chosen for these discussions reflect Praxair’s view of changes which are reasonably possible over a one-year period. Market values represent the present values of projected future cash flows based on interest rate and exchange rate assumptions.

INTEREST RATE AND DEBT SENSITIVITY ANALYSIS

At December 31, 2006, Praxair had debt totaling $3,167 million ($3,447 million at December 31, 2005). There were no interest-rate swap agreements outstanding at December 31, 2006 and 2005, respectively. As considered necessary, interest-rate swaps are entered into as hedges of underlying financial instruments to effectively change the characteristics of the interest rate without actually changing the underlying financial instrument. For fixed-rate instruments, interest-rate changes affect the fair market value but do not impact earnings or cash flows. Conversely, for floating-rate instruments, interest-rate changes generally do not affect the fair market value but impact future earnings and cash flows, assuming other factors are held constant.

 

43


Table of Contents

At December 31, 2006, Praxair had fixed-rate debt of $2,378 million and floating-rate debt of $789 million, representing 75% and 25%, respectively, of total debt. At December 31, 2005, Praxair had fixed-rate debt of $2,241 million and floating-rate debt of $1,206 million, representing 65% and 35%, respectively, of total debt. Holding other variables constant (such as foreign exchange rates, swaps and debt levels), a one-percentage-point decrease in interest rates would increase the unrealized fair market value of the fixed-rate debt by approximately $84 million ($71 million in 2005). At December 31, 2006 and 2005, the after-tax earnings and cash flows impact for the subsequent year resulting from a one-percentage-point increase in interest rates would be approximately $5 million and $8 million, respectively, holding other variables constant.

EXCHANGE RATE SENSITIVITY ANALYSIS

Praxair’s exchange-rate exposures result primarily from its investments and ongoing operations in South America (primarily Brazil, Argentina and Venezuela), Europe (primarily Italy, Spain, and Germany), Canada, Mexico, Asia (primarily China, India, Korea and Thailand) and other business transactions such as the procurement of equipment from foreign sources. Among other techniques, Praxair utilizes foreign exchange forward contracts to hedge these exposures. At December 31, 2006, Praxair had $758 million notional amount ($768 million at December 31, 2005) of foreign exchange contracts of which all ($756 million in 2005) were to hedge recorded balance-sheet exposures or forecasted transactions. At December 31, 2006, there were no foreign exchange contracts to hedge anticipated net income ($12 million at December 31, 2005).

Holding other variables constant, if there were a 10% adverse change in foreign-currency exchange rates for the portfolio, the fair market value of foreign-currency contracts outstanding at December 31, 2006 and 2005 would decrease by approximately $40 million and $5 million, respectively, which would be offset by an equal but offsetting gain or loss on the foreign-currency fluctuation of the underlying exposure being hedged.

FORWARD-LOOKING STATEMENTS

This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s reasonable expectations and assumptions as of the date the statements are made but involve risks and uncertainties. These risks and uncertainties include, without limitation: the performance of stock markets generally; developments in worldwide and national economies and other international events and circumstances; changes in foreign currencies and in interest rates; the cost and availability of electric power, natural gas and other raw materials; the ability to achieve price increases to offset cost increases; catastrophic events including natural disasters, epidemics and acts of war and terrorism; the ability to attract, hire, and retain qualified personnel; the impact of changes in financial accounting standards; the impact of tax, environmental, home healthcare and other legislation and government regulation in jurisdictions in which the company operates; the cost and outcomes of litigation and regulatory agency actions; continued timely development and market acceptance of new products and applications; the impact of competitive products and pricing; future financial and operating performance of major customers and industries served; and the effectiveness and speed of integrating new acquisitions into the business. These risks and uncertainties may cause actual future results or circumstances to differ materially from the projections or estimates contained in the forward-looking statements. The company assumes no obligation to update or provide revisions to any forward-looking statement in response to changing circumstances. The above listed risks and uncertainties are further described in Item 1A (Risk Factors) in the company’s latest Annual Report on Form 10-K filed with the SEC which should be reviewed carefully. Please consider the company’s forward-looking statements in light of those risks.

 

44


Table of Contents

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Operations – Praxair, Inc. (Praxair or company) is one of the largest industrial gases companies worldwide, the largest in North and South America. Praxair produces, sells and distributes atmospheric, process and specialty gases, and high-performance surface coatings to a diverse group of industries including aerospace, chemicals, electronics, energy, food and beverage, healthcare, manufacturing and metals.

Principles of Consolidation – The consolidated financial statements include the accounts of all significant subsidiaries where control exists and, in limited situations, variable-interest entities where the company is the primary beneficiary. Equity investments generally consist of 20% to 50% owned operations where the company exercises significant influence. Operations less than 20% owned, where the company does not exercise significant influence, are generally carried at cost. Pre-tax income from equity investments that are partnerships or limited-liability corporations (LLC) is included in Other income (expenses) – net with related taxes included in Income taxes and remaining equity earnings are reported as Income from equity investments, net of income taxes. Partnership and LLC net assets are reported as Equity investments in the balance sheet. Significant inter-company transactions are eliminated and any significant related-party transactions have been disclosed.

Use of Estimates – The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. While actual results could differ, management believes such estimates to be reasonable.

Revenue Recognition – Revenue is recognized when: a firm sales agreement exists; product is shipped or services are provided to customers; and collectibility of the fixed or determinable sales price is reasonably assured. A small portion of the company’s revenues relate to long-term construction contracts and are generally recognized using the percentage-of-completion method. Under this method, revenues from sales of major equipment, such as large air-separation facilities, are recognized based primarily on cost incurred to date compared with total estimated cost. Changes to total estimated cost and anticipated losses, if any, are recognized in the period determined. For contracts that contain multiple products and/or services, amounts assigned to each component are based on its objectively determined fair value, such as the sales price for the component when it is sold separately or competitor prices for similar components. Certain of the company’s customer contracts qualify for lease accounting treatment under EITF Issue 01-8, “Determining Whether an Arrangement Contains a Lease.” The associated revenue streams are classified as rental revenue and are not significant. Sales returns and allowances are not a normal practice in the industry and are de minimis.

Amounts billed for shipping and handling fees are recorded as sales, generally on FOB destination terms, and costs incurred for shipping and handling are recorded as cost of sales.

Amounts billed for sales and use taxes, value-added taxes, and certain excise and other specific transactional taxes imposed on revenue producing transactions are presented on a net basis and are not included in sales in the consolidated statement of income.

Cash Equivalents – Cash equivalents are considered to be highly liquid securities with original maturities of three months or less.

Inventories – Inventories are stated at the lower of cost or market. Cost is determined using the last-in, first-out (LIFO) method for certain U.S. operations and the average-cost method for most other operations.

Property, Plant and Equipment – Net – Property, plant and equipment are carried at cost, net of accumulated depreciation. The company capitalizes interest as part of the cost of constructing major facilities (see Note 5). Depreciation is calculated on the straight-line method based on the estimated useful lives of the assets, which range from 3 years to 40 years (see Note 9). Praxair uses accelerated depreciation methods for tax purposes where appropriate. Maintenance of property, plant and equipment is generally expensed as incurred.

The company performs a test for impairment whenever events or changes in circumstances indicate that the carrying amount of an individual asset or asset group may not be recoverable. Should projected undiscounted future cash flows be less than the carrying amount of the asset or asset group, an impairment charge reducing the carrying amount to fair value is required. Fair value is determined based on the most appropriate valuation technique, including discounted cash flows.

Asset-Retirement Obligations – An asset-retirement obligation is recognized in the period in which sufficient information exists to determine the fair value of the liability with a corresponding increase to the carrying amount of the related property, plant and equipment which is then depreciated over its useful life. The liability is initially measured at discounted fair value and then accretion expense is recorded in each subsequent period. The company’s asset-retirement obligations are primarily associated with its on-site long-term supply arrangements where the company has built a facility on land leased from the customer and is obligated to remove the facility at the end of the contract term. The company’s asset-retirement obligations are not material to its financial statements.

 

45


Table of Contents

 

Foreign Currency Translation – For most foreign operations, the local currency is the functional currency and translation gains and losses are reported as part of the Accumulated other comprehensive income (loss) component of Shareholders’ equity as a cumulative translation adjustment (see Note 8). For other foreign operations, the U.S. dollar is the functional currency and translation gains and losses are included in income.

Financial Instruments – Praxair enters into various derivative financial instruments to manage its exposure to fluctuating interest and currency exchange rates and energy costs. Such instruments primarily include interest-rate swap agreements; currency swap; forward contracts; and commodity-swap agreements. These instruments are not entered into for trading purposes. Praxair only uses commonly traded and non-leveraged instruments. There are two types of derivatives the company enters into: hedges of fair-value exposures and hedges of cash-flow exposures. Fair-value exposures relate to recognized assets or liabilities, and firm commitments; while cash-flow exposures relate to the variability of future cash flows associated with recognized assets or liabilities, or forecasted transactions.

When a derivative is executed and hedge accounting is appropriate, it is designated as either a fair-value hedge or a cash-flow hedge. Currently, Praxair designates all interest-rate and commodity-swap agreements as hedges; however, currency contracts are generally not designated as hedges for accounting purposes. All derivatives are linked to an appropriate underlying exposure. On an ongoing basis, the company assesses the hedge effectiveness of all derivatives designated as hedges to determine if they continue to be highly effective in offsetting changes in fair values or cash flows of the underlying hedged items. If it is determined that the hedge is not highly effective, then hedge accounting will be discontinued prospectively.

Changes in the fair value of derivatives designated as fair-value hedges are recognized in earnings as an offset to the change in the fair values of the underlying exposures being hedged. The changes in fair value of derivatives that are designated as cash-flow hedges are deferred in Accumulated other comprehensive income (loss) and are recognized in earnings as the underlying hedged transaction occurs. Any ineffectiveness is recognized in earnings immediately. Derivatives that are entered into for risk-management purposes and are not designated as hedges (primarily related to anticipated net income and currency derivatives other than for firm commitments) are recorded at their fair market values and recognized in current earnings.

The company recognizes the changes in the fair value associated with currency contracts as follows: hedges of debt instruments are recorded in interest expense and generally offset the underlying hedged items. Hedges of other balance-sheet exposures, commodity contracts, forecasted transactions, lease obligations, firm commitments and anticipated future net income are recognized in Other income (expenses) – net and generally offset the underlying hedged items. Hedges of net investments in foreign subsidiaries are recognized in the cumulative translation adjustment component of Accumulated other comprehensive income (loss) on the consolidated balance sheet to offset translation gains and losses associated with the hedged net investment.

Praxair uses the following methods and assumptions to estimate the fair value of each class of financial instrument. The fair value of interest-rate swaps and currency-exchange contracts is estimated based on market prices obtained from independent dealer or market quotes. The fair value of long-term debt is estimated based on the quoted market prices for the same or similar issues. Due to their nature, the carrying value of cash, short-term investments and short-term debt, receivables and payables approximates fair value.

Goodwill – Acquisitions are accounted for using the purchase method which requires allocation of the purchase price to assets acquired and liabilities assumed based on estimated fair values. Any excess of the purchase price over the fair value of the assets and liabilities acquired is recorded as goodwill (see Note 10). Allocations of the purchase price are based on preliminary estimates and assumptions at the date of acquisition. Allocations are subject to revision based on final information received, including appraisals and other analyses which support underlying estimates.

Goodwill is reviewed annually in the second quarter or more frequently if events or circumstances indicate that an impairment may have occurred. The impairment test requires that the company estimate and compare the fair value of its reporting units to their carrying value. Fair value is determined through the use of projected future cash flows, multiples of earnings and sales and other factors.

Other Intangible Assets – Patents are recorded at historical cost and are amortized over their remaining useful lives. Customer and license/use agreements, non-compete agreements and patents and other intangibles are amortized over the estimated period of benefit. The determination of the estimated period of benefit will be dependent upon the use and underlying characteristics of the intangible asset. Praxair evaluates the recoverability of its intangible assets subject to amortization when facts and circumstances indicate that the carrying value of the asset may not be recoverable. If the carrying value is not recoverable, impairment is measured as the amount by which the carrying value exceeds its estimated fair value. Fair value is generally estimated based on either appraised value or other valuation techniques.

 

46


Table of Contents

Income Taxes – Deferred income taxes are recorded for the temporary differences between the financial statement and tax bases of assets and liabilities using currently enacted tax rates. Valuation allowances are established against deferred tax assets whenever circumstances indicate that it is more likely than not that such assets will not be realized in future periods. The provision for income taxes includes probable exposures for tax matters and related interest and penalties when assessed, if applicable. Interest and penalties are classified as income tax expense in the financial statements.

Pension and Other Retirement Programs – Most Praxair employees worldwide are covered by various pension plans. The cost of pension benefits under these plans is determined using the projected-unit-credit actuarial cost method. Funding of pension plans varies and is in accordance with local laws and practices.

Praxair accrues the cost of retiree life and health insurance benefits during the employees’ service period when such benefits are earned.

Post-employment Benefits – Praxair recognizes the estimated cost of future benefits provided to former and inactive employees after employment but before retirement on the accrual basis.

Stock-based Compensation – In 2006, the company adopted Statement of Financial Accounting Standard (SFAS) No. 123 (revised 2004), “Share-Based Payment” and related interpretations (SFAS No. 123R) which require the measurement and recognition of compensation expense for all share-based payments to employees and directors based on their fair value. Stock option expense is recognized on a straight-line basis over the stated vesting period. For stock option awards granted to full-retirement-eligible employees, expense is recognized over the period from the grant date to the date retirement eligibility is achieved.

The company has elected the modified prospective transition method as permitted by SFAS No. 123R. Prior periods have not been restated to reflect the impact of stock option expense. Stock option expense is recorded for all new and unvested stock options that are expected to vest over the service period beginning on January 1, 2006.

Prior to 2006, the company accounted for stock options using the intrinsic value method under Accounting Principles Board Opinion No. 25 (APB 25), “Accounting for Stock Issued to Employees.” Accordingly, prior to 2006, stock option expense was not recognized in net income as the exercise price of options granted was equal to the market value of the stock at the date of grant. Pro forma net income and earnings per share amounts as if stock option expense had been recognized based on fair value for 2005 and 2004 are provided in Note 16.

Prior to the adoption of SFAS No. 123R, the company presented tax benefits resulting from the exercise of stock options as operating cash flows in the Consolidated Statements of Cash Flows. SFAS No. 123R requires that cash flows resulting from tax deductions in excess of that which would have been recognized had SFAS No. 123 been applied in previous periods be classified as financing cash flows.

See Note 16 for further disclosures relating to stock-based compensation.

RECENTLY ISSUED ACCOUNTING STANDARDS

ACCOUNTING STANDARDS IMPLEMENTED IN 2006

Effective January 1, 2006, the company adopted SFAS No. 123R which requires the measurement and recognition of compensation expense for all share-based payments to employees and directors based on their fair value effective January 1, 2006. See Note 16 for information relating to the implementation of this standard and other required stock-based compensation disclosures.

In May 2005, the FASB issued SFAS No. 154, “Accounting Changes and Error Corrections-a replacement of APB Opinion No. 20 and FASB Statement No. 3.” Effective January 1, 2006, SFAS No. 154 requires retrospective application for changes in accounting principle whenever practicable, rather than including the cumulative effect of an accounting change in net income in the period of change. SFAS No. 154 applies to voluntary changes in accounting principle and also changes required by new accounting pronouncements if specific transition provisions are not provided. The adoption of this statement did not have a material impact on the company’s consolidated financial statements.

In September 2005, the Emerging Issues Task Force (“EITF”) ratified EITF 04-13, “Accounting for Purchases and Sales of Inventory with the Same Counterparty.” This issue addresses the circumstances under which two or more inventory purchase and sales transactions with the same counterparty should be viewed as a single exchange transaction and whether there are circumstances under which such nonmonetary exchanges should be accounted for at fair value. The adoption of this interpretation is effective for new or modified agreements for fiscal periods beginning after March 15, 2006. The adoption of this statement did not have a material impact on the company’s consolidated financial statements.

              In September 2006, the SEC issued Staff Accounting Bulletin (SAB) No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements,” to address diversity in practice in quantifying financial statement misstatements. SAB 108 requires the quantification of misstatements based on their impact to both the balance sheet and the income statement to determine materiality. The guidance provides for a onetime cumulative-effect adjustment to correct for misstatements for errors that were not deemed material under a company’s prior approach but are material under the SAB 108 approach. SAB 108 is effective for the fiscal year ended December 31, 2006 for Praxair and did not impact the consolidated financial statements.

 

47


Table of Contents

 

In September 2006, the FASB issued SFAS No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans, an amendment of FASB Statements No. 87, 88, 106, 132(R)” (SFAS No. 158), effective December 31, 2006 for Praxair. Under the new standard, companies are required to recognize the funded status of their pension and other postretirement plans on their balance sheet beginning in the fourth quarter 2006 using the projected benefit obligation and accumulated postretirement benefit obligation. See Note17 for information related to the adoption of SFAS No. 158.

ACCOUNTING STANDARDS TO BE IMPLEMENTED

In July 2006, the FASB issued FASB Interpretation No. (FIN) 48, “Accounting for Uncertainty in Income Taxes, an interpretation of FASB Statement 109” which clarifies the accounting for uncertainty in income taxes recognized in accordance with FASB Statement No. 109, “Accounting for Income Taxes.” FIN 48 is a comprehensive model for how a company should recognize, measure, and disclose in its financial statements uncertain tax positions that the company has taken or expects to take on a tax return. Under FIN 48, a company will recognize the benefit of an income tax position only if it is more likely than not (greater than 50%) that the tax position will be sustained upon tax examination, based solely on the technical merits of the tax position. Otherwise, no benefit can be recognized. Additionally, companies will be required to accrue interest and related penalties, if applicable, on all tax exposures for which reserves have been established consistent with jurisdictional tax laws. This interpretation is effective on January 1, 2007 for Praxair and any initial impact is required to be recorded as an adjustment directly to the beginning balance of consolidated retained earnings as a change in accounting principle in the first quarter of 2007. The company is currently in the process of finalizing its assessment of the initial impact of this interpretation on the consolidated financial statements; however, based on current estimates, the required reduction to consolidated retained earnings could range up to approximately $170 million with no cash flow impact.

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements,” which provides a single definition of fair value, and requires additional disclosure about the use of fair value to measure assets and liabilities. The standard emphasizes that fair value is a market-based measurement and should be determined based on the assumptions that market participants would use in valuing assets or liabilities. This standard is effective on January 1, 2008 for Praxair and the company is currently in the process of evaluating the impact of this interpretation on the consolidated financial statements.

Reclassifications – Certain prior years’ amounts have been reclassified to conform to the current year’s presentation.

NOTE 2. CHANGE IN ACCOUNTING PRINCIPLE

Effective December 31, 2005, Praxair adopted FIN 47, “Accounting for Conditional Asset Retirement Obligations,” which provides guidance on when a company has sufficient information to reasonably estimate an asset-retirement obligation’s fair value as required under SFAS 143, “Accounting for Asset Retirement Obligations.” Under FIN 47, uncertainty as to the timing and/or method of settlement of a conditional asset-retirement obligation should be factored into the measurement of the liability when sufficient information exists. At December 31, 2005, the company recognized transition amounts for existing asset-retirement obligation liabilities, associated capitalizable costs and accumulated depreciation to date. An after-tax transition charge of $6 million was recorded as the cumulative effect of a change in accounting principle for the year ended December 31, 2005.

NOTE 3. ACQUISITIONS

The results of operations of the following acquired businesses have been included in Praxair’s consolidated statements of income since their respective dates of acquisition.

CONSTAR LLC

On December 31, 2005, Praxair acquired the packaged gas business and facilities of Constar LLC for a purchase price of $31 million. The acquisition resulted in approximately $14 million of goodwill, adjusted for the final purchase price allocation. The business includes 10 facilities in Georgia, Tennessee and South Carolina which fill and distribute high-pressure industrial, medical and specialty-gas cylinders and other gas containers. Constar also operates several retail stores for the sale of welding and related equipment, supplies and services. The acquisition facilitated Praxair’s expansion into a new geography and strengthened the company’s ability to serve customers throughout North America.

 

48


Table of Contents

GERMAN ACQUISITION

On December 2, 2004, Praxair acquired certain industrial gas assets and related businesses in Germany for a purchase price of €497 million plus acquisition and other costs of €7 million (or $667 million as of the date of acquisition). The acquisition resulted in approximately $258 million of goodwill. Intangible assets acquired of approximately $28 million consist of covenants not to compete, land rights and other intangible assets which are being amortized over a weighted-average life of 10 years. The purchase was funded largely by a €450 million, five-year revolving-credit arrangement which Praxair entered into with a syndicate of international banks in November 2004 (see Note 12). The assets and businesses acquired consist of industrial gas plants and pipeline assets in the Rhine/Ruhr and Saar areas, and bulk distribution and packaged gas businesses. The businesses serve large customers in the refining, chemical and steel industries along the pipeline systems, plus smaller customers in bulk, medical, specialty and packaged gases. The acquisition significantly strengthened Praxair’s operations in the Germany/Benelux region.

HOME CARE SUPPLY (HCS)

On June 15, 2004, Praxair acquired 100% of the outstanding common shares of Home Care Supply, Inc. (HCS) for a purchase price of $245 million. The acquisition resulted in approximately $172 million of goodwill. Intangible assets acquired of approximately $12 million consist of customer relationships and covenants not to compete which are being amortized over a weighted-average life of 3 years. Headquartered in Beaumont, Texas, HCS was a privately held home-respiratory and medical-equipment provider in the United States. The acquisition expanded Praxair’s home-healthcare presence from the mid-Atlantic to Texas, provides an excellent platform for sustained growth and will further accelerate Praxair’s hospital-to-home strategy.

Other acquisitions in 2006, 2005, and 2004 were not significant.

NOTE 4. LEASES

In the normal course of its business, Praxair enters into various leases primarily involving manufacturing and distribution equipment and office space. Non-cancelable operating lease commitments extending for more than one year require future minimum payments totaling $315 million at December 31, 2006 as follows: 2007, $82 million; 2008, $59 million; 2009, $47 million; 2010, $34 million; 2011, $22 million and $71 million thereafter. The present value of these future lease payments under operating leases is approximately $263 million. Total lease and rental expenses under operating leases were $97 million in 2006, $96 million in 2005, and $88 million in 2004. Capital leases are not significant and are included in property, plant and equipment – net. Related obligations are included in debt.

 

49


Table of Contents

 

NOTE 5. SUPPLEMENTARY INCOME STATEMENT INFORMATION

 

(Millions of dollars)

                  

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

SELLING, GENERAL AND ADMINISTRATIVE

      

Selling

   $ 503     $ 475     $ 424  

General and administrative (a)

     583       512       445  
                        
   $ 1,086     $ 987     $ 869  
                        

DEPRECIATION AND AMORTIZATION

      

Depreciation

   $ 681     $ 649     $ 565  

Amortization of other intangibles

     15       16       13  
                        
   $ 696     $ 665     $ 578  
                        

OTHER INCOME (EXPENSES) – NET

      

Net income hedges (Note 13)

   $ —       $ (5 )   $ (2 )

Other currency

     (3 )     1       (1 )

Partnership income

     30       23       15  

Severance expense

     (15 )     (10 )     (10 )

Gain on divestitures (b)

     14       —         13  

Insurance recoveries

     15       —         —    

St. Louis distribution facility fire

     —         (8 )     —    

Customer obligation settlement

     —         20       —    

U.S. Gulf Coast hurricanes impact

     —         (16 )     —    

Other – net

     (9 )     5       5  
                        
   $ 32     $ 10     $ 20  
                        

INTEREST EXPENSE – NET

      

Interest incurred on debt

   $ 181     $ 179     $ 167  

Interest capitalized

     (21 )     (11 )     (7 )

Amortization of swap termination costs (Note 13)

     (5 )     (5 )     (5 )
                        
   $ 155     $ 163     $ 155  
                        

(a) 2006 includes stock option expense of $39 million. 2005 and 2004 do not include stock option expense.
(b) 2006 amount represents a gain of $14 million, $3 million after-tax, relating to the divestiture of the aviation services business and a Turkish joint venture. 2004 includes a gain from resolution of a prior divestiture matter.

NOTE 6. INCOME TAXES

Pre-tax income applicable to U.S. and foreign operations is as follows:

 

(Millions of dollars)

              

YEAR ENDED DECEMBER 31,

   2006    2005    2004

United States

   $ 424    $ 304    $ 281

Foreign

     940      826      667
                    

Total income before income taxes

   $ 1,364    $ 1,130    $ 948
                    

The following is an analysis of the provision for income taxes:

 

(Millions of dollars)

              

YEAR ENDED DECEMBER 31,

   2006    2005    2004

CURRENT TAX EXPENSE

        

U.S. Federal

   $ 77    $ 56    $ 41

State and local

     11      10      4

Foreign

     177      110      98
                    
     265      176      143
                    

DEFERRED TAX EXPENSE

        

U.S. Federal

     52      79      41

Foreign (a)

     38      121      48
                    
     90      200      89
                    

Total income taxes

   $ 355    $ 376    $ 232
                    

(a) 2005 includes $67 million related to valuation allowance adjustments, primarily in Brazil.

 

50


Table of Contents

An analysis of the difference between the provision for income taxes and the amount computed by applying the U.S. statutory income tax rate to pre-tax income follows:

 

(Dollar amounts in millions)

                                    

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

U.S. statutory income tax rate

   $ 477     35.0 %   $ 395     35.0 %   $ 332     35.0 %

State and local taxes – net of federal benefit

     7     0.5 %     4     0.4 %     6     0.6 %

U.S. tax credits and deductions (a)

     (10 )   -0.7 %     (8 )   -0.7 %     (13 )   -1.3 %

Foreign tax rate differentials (b)

     (114 )   -8.4 %     (103 )   -9.1 %     (87 )   -9.2 %

Repatriation and other foreign tax adjustments (c)

     —       —         92     8.1 %     —       —    

Tax audit settlements (d)

     (5 )   -0.4 %     (1 )   -0.1 %     (3 )   -0.3 %

Other – net

     —       —         (3 )   -0.3 %     (3 )   -0.3 %
                                          

Provision for income taxes

   $ 355     26.0 %   $ 376     33.3 %   $ 232     24.5 %
                                          

(a) U.S. tax credits and deductions relate to research and experimentation tax credits, export tax credits and manufacturing deductions.
(b) Foreign tax rate differentials include various tax incentives in Spain. The company also operates in various jurisdictions in Asia and South America that currently offer tax holidays. In 2005, a net $9-million income-tax benefit was recorded in Europe related principally to a tax legislation change.
(c) Tax charge in 2005 related to the repatriation of foreign earnings pursuant to the American Jobs Creation Act of 2004 ($67 million) and other foreign tax adjustments made to tax reserves and valuation allowances ($25 million).
(d) The tax audit settlements represent non-recurring benefits resulting from the settlement of various tax matters in the U.S.

During 2006, the taxing authority in Spain decreased its top marginal tax rate and during 2004, the taxing authority in Mexico decreased its top marginal rate. The effects of the tax-rate changes were immaterial.

Net deferred tax liabilities included in the consolidated balance sheet are comprised of the following:

 

(Millions of dollars)

            

DECEMBER 31,

   2006     2005  

DEFERRED TAX LIABILITIES

    

Fixed assets

   $ 867     $ 861  

State and local

     12       12  

Other

     94       62  
                
   $ 973     $ 935  
                

DEFERRED TAX ASSETS

    

Carryforwards

   $ 292     $ 280  

Benefit plans and related (a)

     210       194  

U.S. alternative minimum tax credits

     —         25  

Research and development

     36       44  

Inventory

     10       11  

Other

     148       125  
                
     696       679  

Less: Valuation allowances

     (234 )     (206 )
                
   $ 462     $ 473  
                

NET DEFERRED TAX LIABILITIES

   $ 511     $ 462  
                

Recorded as:

    

Current deferred tax assets (Note 8)

   $ 87     $ 112  

Long-term deferred tax liabilities (Note 8)

     598       574  
                
   $ 511     $ 462  
                

(a) Includes deferred taxes of $131 million in 2006 and $109 million in 2005 related to pension/OPEB funded status and minimum pension liability, respectively.

              Praxair evaluates deferred tax assets quarterly to ensure that estimated future taxable income will be sufficient in character (e.g., capital gain versus ordinary income treatment), amount and timing to result in their recovery. After considering the positive and negative evidence, a valuation allowance is established when management determines that it is more likely than not that a deferred tax asset will not be realized to reduce the assets to their realizable value. Considerable judgment is required in establishing deferred tax valuation allowances. At December 31, 2006, Praxair had $292 million of deferred tax assets relating to net operating losses (primarily foreign). Of this amount, $230 million relates primarily to NOLs in a Brazilian subsidiary, for which Praxair has a 100% valuation allowance. The valuation allowance increase in 2006 is primarily related to Brazilian NOLs along with related currency movements. The remaining $62 million of carryforwards expire principally through 2018 with no valuation allowances required. The U.S. alternative minimum credits were utilized in 2006.

A provision has not been made for additional U.S. Federal or foreign taxes at December 31, 2006 on $2.0 billion of undistributed earnings of foreign subsidiaries because Praxair intends to reinvest these funds indefinitely to support foreign growth opportunities. It is not practicable to estimate the unrecognized deferred tax liability on these undistributed earnings. These earnings could become subject to additional tax if they are remitted as dividends, loaned to Praxair, or upon sale of the subsidiary’s stock.

During 2006, the IRS completed its audit and issued its final assessment related to Praxair’s U.S. Federal income tax returns for the 2003 and 2004 tax years, resulting in an immaterial adjustment to the consolidated financial statements.

 

51


Table of Contents

 

NOTE 7. EARNINGS PER SHARE

Basic earnings per share is computed by dividing net income for the period by the weighted average number of Praxair common shares outstanding. Diluted earnings per share is computed by dividing net income for the period by the weighted average number of Praxair common shares outstanding and dilutive common stock equivalents, as follows:

 

     2006    2005     2004

NUMERATOR (MILLIONS OF DOLLARS)

       

Income before cumulative effect of change in accounting principle

   $ 988    $ 732     $ 697

Cumulative effect of change in accounting principle

     —        (6 )     —  
                     

Net income

   $ 988    $ 726     $ 697
                     

DENOMINATOR (THOUSANDS OF SHARES)

       

Weighted average shares outstanding

     322,444      322,658       324,706

Shares earned and issuable under compensation plans

     1,051      1,107       1,185
                     

Weighted average shares used in basic earnings per share

     323,495      323,765       325,891

Effect of dilutive securities

       

Convertible debt

     —        146       205

Employee stock options

     5,798      5,774       5,307
                     

Weighted average shares used in diluted earnings per share

     329,293      329,685       331,403
                     

BASIC EARNINGS PER COMMON SHARE

       

Income before cumulative effect of change in accounting principle

   $ 3.05    $ 2.26     $ 2.14

Net income

   $ 3.05    $ 2.24     $ 2.14

DILUTED EARNINGS PER COMMON SHARE

       

Income before cumulative effect of change in accounting principle

   $ 3.00    $ 2.22     $ 2.10

Net income

   $ 3.00    $ 2.20     $ 2.10

Stock options for 1,000, 74,200 and 40,000 shares were not included in the computation of diluted earnings per share for the years ended December 31, 2006, 2005 and 2004, respectively, because the exercise prices were greater than the average market price of the common stock.

NOTE 8. SUPPLEMENTARY BALANCE SHEET INFORMATION

 

(Millions of dollars)

            

DECEMBER 31,

   2006     2005  

ACCOUNTS RECEIVABLE

    

Trade

   $ 1,461     $ 1,357  

Other

     90       101  
                
     1,551       1,458  

Less: allowance for doubtful accounts (a)

     (95 )     (72 )
                
   $ 1,456     $ 1,386  
                

INVENTORIES (b)

    

Raw materials and supplies

   $ 104     $ 90  

Work in process

     50       67  

Finished goods

     227       216  
                
   $ 381     $ 373  
                

PREPAID AND OTHER CURRENT ASSETS

    

Deferred income taxes (Note 6)

   $ 87     $ 112  

Prepaid

     49       53  

Other

     50       36  
                
   $ 186     $ 201  
                

OTHER LONG-TERM ASSETS

    

Pension assets (Note 17)

   $ 102     $ 81  

Insurance contracts (c)

     77       72  

Long-term receivables

     97       90  

Deposits

     42       48  

Investments carried at cost

     12       13  

Deferred charges

     14       11  

Other

     103       91  
                
   $ 447     $ 406  
                

OTHER CURRENT LIABILITIES

    

Accrued expenses

   $ 190     $ 202  

Payrolls

     161       104  

Pension and postretirement (Note 17)

     42       127  

Interest payable

     32       33  

Employee benefit accrual

     28       28  

Severance

     12       12  

Insurance reserves

     15       10  

Other

     115       126  
                
   $ 595     $ 642  
                

OTHER LONG-TERM LIABILITIES

    

Pension and postretirement (Note 17)

   $ 515     $ 421  

Insurance reserves

     32       32  

Other

     384       380  
                
   $ 931     $ 833  
                

DEFERRED CREDITS

    

Deferred income taxes (Note 6)

   $ 598     $ 574  

Other

     58       53  
                
   $ 656     $ 627  
                

 

52


Table of Contents

(Millions of dollars)

            

DECEMBER 31,

   2006     2005  

ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

    

Cumulative translation adjustment

    

North America

   $ (120 )   $ (112 )

South America (d)

     (759 )     (852 )

Europe

     (12 )     (52 )

Asia

     (10 )     (40 )

Surface technologies

     26       6  
                
     (875 )     (1,050 )

Derivatives – net of taxes

     (1 )     (1 )

Pension/OPEB funded status obligation (net of $131 million and $109 million taxes in 2006 and 2005, respectively) (e)

     (251 )     (206 )
                
   $ (1,127 )   $ (1,257 )
                

(a) Provisions to the allowance for doubtful accounts were $52 million, $36 million, and $24 million in 2006, 2005, and 2004, respectively. The remaining allowance activity in each period related primarily to write-offs of uncollectible amounts, net of recoveries and currency movements.
(b) Approximately 15% and 16% of total inventories were valued using the LIFO method at December 31, 2006 and 2005, respectively. If inventories had been valued at current costs, they would have been approximately $19 million and $21 million higher than reported at December 31, 2006 and 2005, respectively.
(c) Consists primarily of insurance contracts and other investments to be utilized for non-qualified pension and OPEB obligations (see Note 17).
(d) Consists primarily of currency translation adjustments in Brazil and Argentina.
(e) Minimum pension liability in 2005.

NOTE 9. PROPERTY, PLANT AND EQUIPMENT – NET

Significant classes of property, plant and equipment are as follows:

 

(Millions of dollars)

            

DECEMBER 31,

   2006     2005  

Machinery and equipment

   $ 11,989     $ 11,133  

Buildings

     783       734  

Construction in progress and other

     858       550  

Land and land improvements

     267       244  
                
     13,897       12,661  

Less: accumulated depreciation

     (7,203 )     (6,553 )
                
   $ 6,694     $ 6,108  
                

Machinery and equipment includes production plants, tanks, cylinders, transportation equipment and other assets that have useful lives of 3 years to 30 years. Buildings have useful lives of 25 years to 40 years and land improvements have useful lives of up to 20 years.

NOTE 10. GOODWILL

Changes in the carrying amount of goodwill for the years ended December 31, 2006 and 2005 were as follows:

 

(Millions of dollars)

   NORTH
AMERICA
    SOUTH
AMERICA
   EUROPE     ASIA     SURFACE
TECHNOLOGIES
    TOTAL  

BALANCE, DECEMBER 31, 2004

   $ 974     $ 138    $ 331     $ 28     $ 80     $ 1,551  

Acquisitions

     18       1      2       —         —         21  

Purchase adjustments (a)

     (7 )     —        4       —         —         (3 )

Foreign currency translation

     6       22      (44 )     (1 )     (6 )     (23 )

Other

     —         —        —         (1 )     —         (1 )
                                               

BALANCE, DECEMBER 31, 2005

   $ 991     $ 161    $ 293     $ 26     $ 74     $ 1,545  

Acquisitions

     4       2      —         —         —         6  

Purchase adjustments

     3       —        —         —         —         3  

Foreign currency translation

     —         18      31       3       5       57  

Other

     —         —        2       —         —         2  
                                               

BALANCE, DECEMBER 31, 2006

   $ 998     $ 181    $ 326     $ 29     $ 79     $ 1,613  
                                               

(a) Purchase adjustments in North America pertain primarily to the resolution of prior-year tax matters. Purchase adjustments in Europe relate to the December 2004 German acquisition. The adjustments to goodwill had no impact on the income statement.

 

53


Table of Contents

 

The annual impairment tests required by SFAS No. 142, “Goodwill and Other Intangible Assets,” for 2004, 2005 and 2006 were performed during the second quarter of each year and no impairments were indicated.

NOTE 11. OTHER INTANGIBLE ASSETS

The following is a summary of Praxair’s other intangible assets at December 31, 2006 and 2005:

 

(Millions of dollars)

FOR THE YEAR ENDED

DECEMBER 31, 2006

   CUSTOMER &
LICENSE/USE
AGREEMENTS
    NON-COMPETE
AGREEMENTS
    PATENTS &
OTHER
    TOTAL  

Cost:

        

Balance, December 31, 2005

   $ 71     $ 38     $ 17     $ 126  

Additions

     5       2       —         7  

Foreign currency translation

     2       1       —         3  

Other

     (6 )     (2 )     (1 )     (9 )
                                

Balance, December 31, 2006

     72       39       16       127  
                                

Less: accumulated amortization:

        

Balance, December 31, 2005

     (22 )     (18 )     (5 )     (45 )

Amortization expense

     (6 )     (8 )     (1 )     (15 )

Foreign currency translation

     (1 )     —         —         (1 )

Other

     3       2       —         5  
                                

Balance, December 31, 2006

     (26 )     (24 )     (6 )     (56 )
                                

Net balance at December 31, 2006

   $ 46     $ 15     $ 10     $ 71  
                                

 

(Millions of dollars)

FOR THE YEAR ENDED

DECEMBER 31, 2005

   CUSTOMER &
LICENSE/USE
AGREEMENTS
    NON-COMPETE
AGREEMENTS
    PATENTS &
OTHER
    TOTAL  

Cost:

        

Balance, December 31, 2004

   $ 70     $ 36     $ 17     $ 123  

Additions

     7       5       —         12  

Foreign currency translation

     (3 )     (1 )     —         (4 )

Other

     (3 )     (2 )     —         (5 )
                                

Balance, December 31, 2005

     71       38       17       126  
                                

Less: accumulated amortization:

        

Balance, December 31, 2004

     (18 )     (13 )     (4 )     (35 )

Amortization expense

     (8 )     (7 )     (1 )     (16 )

Foreign currency translation

     1       —         —         1  

Other

     3       2       —         5  
                                

Balance, December 31, 2005

     (22 )     (18 )     (5 )     (45 )
                                

Net balance at December 31, 2005

   $ 49     $ 20     $ 12     $ 81  
                                

There are no expected residual values related to these intangible assets. Amortization expense for the years ended December 31, 2006, 2005, and 2004 was $15 million, $16 million, and $13 million, respectively. The remaining weighted-average amortization period for intangible assets is approximately 12 years. Total estimated annual amortization expense is as follows: 2007, $15 million; 2008, $10 million; 2009, $7 million; 2010, $6 million; 2011, $5 million and $28 million thereafter.

NOTE 12. DEBT

The following is a summary of Praxair’s outstanding debt at December 31, 2006 and 2005:

 

(Millions of dollars)

   2006     2005  

SHORT-TERM

    

U.S. bank borrowings

   $ 9     $ —    

Canadian borrowings

     —         91  

South American borrowings

     35       32  

Asian borrowings

     79       95  

Other international borrowings

     7       13  
                

Total short-term debt

     130       231  
                

LONG-TERM

    

U.S. Borrowings

    

6.90% Notes due 2006

     —         250  

4.75% Notes due 2007

     250       250  

6.625% Notes due 2007

     250       250  

6.50% Notes due 2008

     250       250  

2.75% Notes due 2008 (a)

     299       299  

6.375% Notes due 2012 (a, b)

     524       529  

3.95% Notes due 2013 (a)

     349       349  

5.375% Notes due 2016 (a)

     399       —    

Other borrowings

     8       9  

European borrowings

     590       786  

Canadian borrowings

     —         140  

South American borrowings

     83       54  

Asian borrowings

     21       34  

Other international borrowings

     4       4  

Obligations under capital lease

     10       12  
                
     3,037       3,216  

Less: current portion of long-term debt

     (56 )     (290 )
                

Total long-term debt

     2,981       2,926  
                

Total debt

   $ 3,167     $ 3,447  
                

(a) Amounts are net of unamortized discounts.
(b) December 31, 2006 and 2005 include a $25 million and $30 million fair value increase, respectively, related to SFAS 133 hedge accounting (see Note 13).

 

54


Table of Contents

On November 1, 2006, Praxair repaid $250 million of 6.90% notes that were due. The repayment was initially funded through the issuance of commercial paper. On November 2, 2006, Praxair issued $400 million of 5.375% notes due 2016. The proceeds were used to repay outstanding commercial paper and for general corporate purposes.

In 2005, the company entered into a five-year, $400-million revolving credit facility in Europe and a five-year, $200-million revolving credit facility in Canada with a syndicate of international banks. At December 31, 2006, there were no balances outstanding against either facility. At December 31, 2005, $253 million and $140 million were outstanding against the $400-million facility and $200-million facility at a weighted-average interest rate of 2.63% and 3.76%, respectively. The company has the ability to draw against each facility in one of four currencies in amounts not to exceed the then U.S. dollar equivalent of $400 million and $200 million, respectively.

In 2004, the company entered into a €450-million, five-year borrowing facility with a syndicate of international banks. As of December 31, 2006, the amount outstanding against this facility was €450 million, or $590 million (€450 million, or $533 million at December 31, 2005). The proceeds were used to acquire the German assets referenced in Note 3. Such borrowings are classified as long-term because of the company’s intent to refinance this debt on a long-term basis and the availability of such financing under the terms of this agreement. The weighted-average interest rate on this facility at December 31, 2006 was 3.6% (2.7% at December 31, 2005).

During November 2006, Praxair exercised its right to extend the maturity of its $1-billion senior unsecured credit facility with a syndicate of banks by one year, from 2010 to 2011, in accordance with the terms of the original agreement. The $1-billion senior unsecured credit facility was entered into by Praxair in December 2004. At December 31, 2006, $500 million of notes due in 2007 have been classified as long-term because of the company’s intent to refinance this debt on a long-term basis and the availability of such financing under the terms of its credit agreement. No borrowings were outstanding under the credit agreement at December 31, 2006 or 2005. Associated fees were not significant in each of the past three years.

Praxair’s major bank credit and long-term debt agreements contain various covenants which may, among other things, restrict the ability of Praxair to merge with another entity, incur or guarantee debt, sell or transfer certain assets, create liens against assets, enter into sale and leaseback agreements, or pay dividends and make other distributions beyond certain limits. These agreements also require Praxair to meet a leverage ratio as defined in the agreements. The company is in compliance with all financial debt covenants.

Scheduled maturities on long-term debt are as follows: 2007, $56 million; 2008, $572 million; 2009, $608 million; 2010, $13 million; 2011, $509 million and $1,279 million thereafter. At December 31, 2006, $176 million of Praxair’s assets (principally international fixed assets) were pledged as collateral for long-term debt, including the current portion of long-term debt.

At December 31, 2006, the estimated fair value of Praxair’s long-term debt portfolio was $3,027 million versus a carrying value of $3,037 million. At December 31, 2005, the estimated fair value of Praxair’s long-term debt portfolio was $3,176 million versus a carrying value of $3,216 million. These differences are attributable to interest-rate changes subsequent to when the debt was issued.

NOTE 13. FINANCIAL INSTRUMENTS

The following table is a summary of the notional amount of currency derivatives outstanding at December 31, 2006 and 2005 (all maturities within one year):

 

(Millions of dollars)

   2006    2005

Currency contracts

     

Balance sheet items

   $ 758    $ 749

Anticipated net income

     —        12

Forecasted transactions

     —        7
             
   $ 758    $ 768
             

At December 31, 2006, the fair value of all derivative contracts has been recorded in the consolidated balance sheet as $3 million in current assets and $3 million in current liabilities ($6 million in current liabilities at December 31, 2005).

CURRENCY CONTRACTS

Praxair enters into currency exchange forward contracts to manage its exposure to fluctuations in foreign-currency exchange rates. Hedges of balance-sheet items are related to recorded balance-sheet exposures, including intercompany transactions. Hedges of forecasted transactions are for the purchase of equipment related to in-progress construction projects and have been designated as hedges for accounting purposes. The impact of the hedges of forecasted transactions will not be significant. Additionally, at December 31, 2006, there were no notional value currency-exchange contracts that effectively offset each other ($104 million at December 31, 2005).

              There were no net-income hedges outstanding at December 31, 2006. The net-income hedges outstanding at December 31, 2005 were related to anticipated net income in South America which settled on January 2, 2006. There were no amounts recorded in Other income (expenses) – net as a result of net-income hedging contracts in 2006 and a loss of $5 million and $2 million in 2005 and 2004, respectively (see Note 5).

 

55


Table of Contents

 

Counterparties to currency-exchange forward contracts are primarily major banking institutions with credit ratings of investment grade or better and no collateral is required. There are no significant risk concentrations. Management believes the risk of incurring losses on derivative contracts related to credit risk is remote and any losses would be immaterial.

INTEREST RATE SWAPS

There were no interest rate swap agreements outstanding at December 31, 2006 and 2005, respectively.

During 2002, Praxair entered into and terminated $500 million notional amount of interest-rate swap agreements that effectively converted fixed-rate interest to variable-rate interest on the $500 million 6.375% notes that mature in April 2012. The termination resulted in a cash gain of $47 million, which Praxair recognized in earnings and was equally offset with a charge to earnings for the changes in the fair value of the underlying debt instrument. This debt increase of $47 million is being recognized in earnings as a reduction to interest expense over the remaining term of the underlying debt, or about ten years. For the year ended December 31, 2006, $5 million was recognized in earnings as a reduction to interest expense ($5 million during each of the years ended December 31, 2005 and 2004) and $25 million remains unrecognized at December 31, 2006 ($30 million at December 31, 2005) (see Note 12).

NOTE 14. SHAREHOLDERS’ EQUITY

At December 31, 2006, there were 800,000,000 shares of common stock authorized (par value $0.01 per share) of which 367,644,882 shares were issued and 320,860,846 were outstanding.

In 2004, the board of directors of Praxair declared a dividend of one purchase right (a Right) for each share of Praxair’s common stock held of record at the close of business on April 30, 2004; and that dividend was paid on May 3, 2004. On May 3, 2004, all prior Rights then outstanding expired. In addition, one Right is deemed to be delivered with and attached to each share of Praxair’s common stock issued after April 30, 2004 and before the redemption or expiration of the Rights. Each Right entitles its registered holder, when exercised under certain circumstances, to purchase for $150.00 (subject to adjustment and referred to as the “Exercise Price”) certain securities or assets of Praxair or a surviving entity. The Rights will expire on May 2, 2009, unless exchanged or redeemed prior to that date or unless extended by action of Praxair’s stockholders prior to that date. The redemption price is $0.001 per Right.

The Rights may not be exercised until at least 10 days (or a later date determined by the board of directors) after a person or group acquires 20 percent or more of Praxair’s common stock, or commences a tender offer that, if consummated, would result in 20 percent or more ownership of Praxair’s common stock. Separate Rights certificates will not be issued and the Rights will not be traded separately from the stock until such time. At no time will a Right confer any voting power to its holder.

Should an acquirer become the beneficial owner of 20 percent or more of Praxair’s common stock (other than as approved by Praxair’s board of directors) and under certain additional circumstances, Praxair Right-holders (other than the acquirer) would have the right to buy common stock in Praxair, or in the surviving entity if Praxair is acquired, having a value of two times the Exercise Price then in effect, for an amount in cash equal to the Exercise Price then in effect. Alternatively, Praxair’s board of directors may elect to exchange all of the Rights (other than the acquirer’s Rights which will have become void) at an exchange ratio of one share of Praxair common stock (and/or other securities, cash or other assets having equal value) per Right (subject to adjustment). Also, under certain circumstances, each Right may entitle the holder to purchase one one-hundredth share of preferred stock or such amount of preferred stock as may be substituted for each share of common stock issuable upon the exercise or exchange of a Right.

Praxair’s board of directors may redeem the Rights by a majority vote at any time prior to the 10th day following public announcement that a person or group has acquired 20 percent of Praxair’s common stock, or the date on which a person or group acquires such 20 percent. In addition, under circumstances of a “qualifying offer” as defined in the agreement by which the Rights were issued (the Stockholder Protection Rights Agreement as approved by Praxair’s shareholders at the April 27, 2004 Annual Meeting of Shareholders) the Rights may be redeemed upon the vote, at a special meeting, in favor of such redemption by shareholders representing a majority of the shares then outstanding.

NOTE 15. PREFERRED STOCK

At December 31, 2006 and 2005, there were 25,000,000 shares of preferred stock (par value $0.01 per share) authorized, of which no shares were issued and outstanding. Praxair’s board of directors may from time to time authorize the issuance of one or more series of preferred stock and, in connection with the creation of such series, determine the characteristics of each such series including, without limitation, the preference and relative, participating, optional or other special rights, and the qualifications, limitations or restrictions of the series.

 

56


Table of Contents

NOTE 16. STOCK-BASED COMPENSATION

The company adopted SFAS No. 123R effective January 1, 2006, resulting in the recognition of stock option expense of $42 million, $28 million after tax (or $0.09 for both basic and diluted earnings per share) for 2006. The expense was primarily recorded in selling, general and administrative expenses and no share-based compensation cost was capitalized.

SUMMARY OF PLANS

Effective in 2002, the board of directors and shareholders of the company adopted the 2002 Praxair, Inc. Long-Term Incentive Plan (the 2002 Plan), which replaced the 1992 Praxair Long-Term Incentive Plan. Under the 2002 Plan, the initial aggregate number of shares available for option and other equity grants was limited to a total of 15,800,000 shares. In April 2004, the shareholders approved an increase to the aggregate number of shares available for option and other equity grants under the 2002 plan to 31,600,000 shares. As of December 31, 2006, 13,640,872 shares remained available for equity grants under this plan. The 2002 Plan provides for the granting of nonqualified and incentive stock options, stock grants and performance awards and further provides that the aggregate number of shares granted as restricted stock or pursuant to performance awards may not exceed 20% of the total shares available under the Plan. The 2002 Plan also provides calendar year per-participant limits on grants of options, restricted stock and performance awards. Both officer and non-officer employees are eligible for awards under the 2002 Plan.

In 2005, the board of directors and shareholders of the company adopted the 2005 Equity Compensation Plan for Non-Employee Directors of Praxair, Inc. (the 2005 Plan) which replaced the 1995 Stock Option Plan for Non-Employee Directors. Under the 2005 Plan, the aggregate number of shares available for option and other equity grants is limited to a total of 500,000 shares. As of December 31, 2006, 425,220 shares remained available for equity grants under the 2005 Plan. All non-employee directors of the company are eligible for grants under the 2005 Plan.

Exercise prices for options granted under the 2002 and 2005 Plans may not be less than the closing market price of the company’s common stock on the date of grant and granted options may not be repriced or exchanged without shareholder approval. Options granted under the 2002 and 2005 Plans become exercisable after a minimum of one year after the date of grant and have a maximum duration of ten years. Options granted under predecessor plans had similar terms.

The company has the ability to repurchase shares on the open market to satisfy share option exercises and issues shares from treasury stock upon the exercise of certain stock options.

STOCK OPTION FAIR VALUE

The company utilizes the Black-Scholes Options-Pricing Model to determine the fair value of stock options under SFAS No. 123R consistent with that used for pro forma disclosures in prior years. Management is required to make certain assumptions with respect to selected model inputs, including anticipated changes in the underlying stock price (i.e., expected volatility) and option exercise activity (i.e., expected life). Expected volatility is based on the historical volatility of the company’s stock over the most recent period commensurate with the estimated expected life of the company’s stock options and other factors. The expected life of options granted, which represents the period of time that the options are expected to be outstanding, is based primarily on historical exercise experience. The expected dividend yield is based on the company’s most recent history and expectation of dividend payouts. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for a period commensurate with the estimated expected life. If factors change and result in different assumptions in the application of SFAS No. 123R in future periods, the stock option expense that the company records for future grants may differ significantly from what the company has recorded in the current period.

The weighted-average fair value of options granted during 2006 was $10.85 ($10.16 in 2005 and $10.67 in 2004) based on the Black-Scholes Options-Pricing model. The following weighted-average assumptions were used for grants in 2006, 2005 and 2004:

 

YEAR ENDED DECEMBER 31,

   2006     2005     2004  

Dividend yield

   1.9 %   1.6 %   1.4 %

Volatility

   17.6 %   22.7 %   32.5 %

Risk-free interest rate

   4.7 %   3.9 %   3.0 %

Expected term years

   5     5     5  

STOCK OPTION ACTIVITY

The following table summarizes option activity under the plans for 2006 (options are expressed in thousands; averages are calculated on a weighted basis; life in years; intrinsic value expressed in thousands):

 

ACTIVITY

   NUMBER OF
OPTIONS
    AVERAGE
EXERCISE
PRICE
   AVERAGE
REMAINING
LIFE
   AGGREGATE
INTRINSIC
VALUE

Outstanding at December 31, 2005

   21,644     $ 30.04      

Granted

   4,017       53.99      

Exercised

   (3,811 )     25.28      

Cancelled or expired

   (79 )     35.02      
              

Outstanding at December 31, 2006

   21,771       35.28    6.4    $ 523,684
                        

Exercisable at December 31, 2006

   14,066     $ 28.02    5.2    $ 433,384
                        

The aggregate intrinsic value represents the difference between the company’s closing stock price of $59.33 as of December 29, 2006 and the exercise price multiplied by the number of options outstanding as of that date. The total intrinsic value of stock options exercised during 2006 was $121 million ($93 million and $83 million for 2005 and 2004, respectively).

 

57


Table of Contents

Cash received from option exercises under all share-based payment arrangements for 2006 was $96 million. The cash tax benefit realized from stock option exercises totaled $38 million for 2006, of which $29 million in excess tax benefits was classified as financing cash flows.

As of December 31, 2006, $36 million of unrecognized compensation cost related to non-vested stock options is expected to be recognized over a weighted-average period of approximately 1.4 years.

PRO FORMA INFORMATION UNDER SFAS 123 FOR 2005 AND 2004

The following table illustrates the effect on net income and earnings per share as if the fair value recognition provisions had been applied to all outstanding and unvested awards in the prior year comparable periods:

 

 

(Dollar amounts in millions, except per share data)

            

YEAR ENDED DECEMBER 31,

   2005     2004  

NET INCOME

    

As reported

   $ 726     $ 697  

Less: total stock-based employee compensation expense determined under fair value based method for all awards (net of $14 million taxes in 2005 and 2004)

     (26 )     (28 )
                

Pro forma net income

   $ 700     $ 669  
                

BASIC EARNINGS PER SHARE

    

As reported

   $ 2.24     $ 2.14  

Pro forma

   $ 2.16     $ 2.05  

DILUTED EARNINGS PER SHARE

    

As reported

   $ 2.20     $ 2.10  

Pro forma

   $ 2.12     $ 2.02  

NOTE 17. RETIREMENT PROGRAMS

Pensions – Praxair has two main U.S. retirement programs which are non-contributory defined benefit plans: the Praxair Pension Plan and the CBI Pension Plan. The latter program benefits primarily former employees of CBI Industries, Inc. which Praxair acquired in 1996. Effective July 1, 2002, the Praxair Pension Plan was amended to give participating employees a one-time choice to remain covered by the old formula or to elect coverage under a new formula. The old formula is based predominantly on years of service, age and compensation levels prior to retirement, while the new formula provides for an annual contribution to an individual account which grows with interest each year at a predetermined rate. Also, this new formula applies to all new employees hired after April 30, 2002 into businesses adopting this plan. U.S. pension plan assets are comprised of a diversified mix of investments, including domestic and international corporate equities, government securities and corporate debt securities. In addition, Praxair has several plans that provide supplementary retirement benefits primarily to higher level employees that are unfunded and are nonqualified for federal tax purposes. Pension coverage for employees of certain of Praxair’s international subsidiaries generally is provided by those companies through separate plans. Obligations under such plans are primarily provided for through diversified investment portfolios, with some smaller plans provided for under insurance policies or by book reserves.

Praxair’s U.S. packaged gases business has a defined contribution plan. Company contributions to this plan are calculated as a percentage of salary based on age plus service. Praxair’s U.S. healthcare business sponsors a defined contribution plan which provides for a matching contribution as well as a company contribution that is not dependent on employee contributions. In both plans, U.S. employees may supplement the company contributions up to the maximum allowable by IRS regulations. Certain international subsidiaries of the company also sponsor defined contribution plans where contributions are determined under various formulas. The cost for these defined contribution plans was $13 million in 2006, $11 million in 2005, and $9 million in 2004 (the cost is not included in the tables that follow).

U.S. employees other than those in the packaged gases and healthcare businesses are eligible to participate in a defined contribution savings plan. Employees may contribute up to 40% of their compensation, subject to the maximum allowable by IRS regulations. Company contributions to this plan are calculated on a graduated scale based on employee contributions to the plan. The cost for this plan was $14 million in 2006, $13 million in 2005 and $12 million in 2004 (the cost is not included in the tables that follow).

Postretirement Benefits Other Than Pensions (OPEB) – Praxair provides health care and life insurance benefits to certain eligible retired employees. These benefits are provided through various insurance companies and healthcare providers. Praxair is also obligated to make payments for a portion of postretirement benefits related to retirees of Praxair’s former parent. Additionally, as part of the CBI acquisition in 1996, Praxair assumed responsibility for healthcare and life insurance benefit obligations for CBI’s retired employees. All postretirement healthcare programs have cost caps that limit the company’s exposure to future cost increases. In addition, as part of the retirement elections made for July 1, 2002, all current employees were given the choice of maintaining coverage in the current retiree medical design, or to move to a design whereby coverage would be provided, but with no Praxair subsidy whatsoever. Also, all new employees hired after April 30, 2002 into a business adopting these plans will not receive a company subsidy. Praxair does not currently fund its postretirement benefits obligations. Praxair retiree plans may be changed or terminated by Praxair at any time for any reason with no liability to current or future retirees.

 

58


Table of Contents

Medicare Modernization Act of 2003 – The Medicare Modernization Act of 2003 established a prescription drug benefit under Medicare, known as “Medicare Part D,” and a federal subsidy to sponsors of retiree health care benefit plans that provide prescription drug benefits that are at least actuarially equivalent to those available under Medicare Part D. In 2005, the Center for Medicare and Medicaid Services (CMS) released the regulations for implementing the act. Based on these regulations and subsequent guidance provided by CMS, the prescription drug benefits provided to participants are at least actuarially equivalent to those available under Medicare Part D and, accordingly, the company is entitled to a subsidy. As such, there was a $5 million and $2 million reduction to Praxair’s OPEB expense for 2006 and 2005, respectively, and a reduction of $29 million and $22 million to Praxair’s OPEB obligation at December 31, 2006 and 2005, respectively.

Praxair uses a measurement date of December 31 for its pension and other post-retirement benefit plans.

PENSION AND POSTRETIREMENT BENEFIT COSTS

The components of net pension and OPEB costs for 2006, 2005, and 2004 are shown below:

 

(Millions of dollars)    PENSIONS     OPEB  

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2006     2005     2004  

NET BENEFIT COST

            

Service cost

   $ 43     $ 35     $ 33     $ 7     $ 6     $ 6  

Interest cost

     98       91       85       15       16       16  

Expected return on assets

     (116 )     (102 )     (91 )     —         —         —    

Net amortization and deferral

     31       20       10       (1 )     (1 )     (3 )
                                                

Net periodic benefit cost

   $ 56     $ 44     $ 37     $ 21     $ 21     $ 19  
                                                

The changes in projected benefit obligation (PBO), accumulated benefit obligation (ABO) and plan assets as of December 31, 2006 and 2005 for Praxair’s pension and OPEB programs are shown below:

 

     PENSIONS        
(Millions of dollars)    2006     2005     OPEB  

YEAR ENDED DECEMBER 31,

   U.S.     INTL     U.S.     INTL     2006     2005  

CHANGE IN BENEFIT OBLIGATION (PBO)

            

Benefit obligation, January 1

   $ 1,242     $ 417     $ 1,118     $ 387     $ 265     $ 276  

Service cost

     28       15       24       11       7       6  

Interest cost

     70       28       66       25       15       16  

Participant contributions

     —         —         —         —         8       7  

Plan amendment

     —         —         —         —         (7 )     —    

Actuarial loss (gain)

     (12 )     47       91       21       3       (11 )

Benefits paid

     (58 )     (22 )     (57 )     (21 )     (26 )     (31 )

Curtailment / settlement (gain)

     —         (1 )     —         (1 )     —         —    

Acquisition / divestiture

     (6 )     —         —         4       (1 )     —    

Currency translation

     —         35       —         (9 )     3       2  
                                                

Benefit obligation, December 31

   $ 1,264     $ 519     $ 1,242     $ 417     $ 267     $ 265  
                                                

Accumulated benefit obligation (ABO)

   $ 1,200     $ 473     $ 1,167     $ 376       N/A       N/A  
                                    

CHANGE IN PLAN ASSETS

            

Fair value of plan assets, January 1

   $ 929     $ 401     $ 781     $ 366       —         —    

Actual return on plan assets

     125       65       62       44       —         —    

Company contributions

     109       17       129       11       —         —    

Benefits paid (funded plans only)

     (47 )     (22 )     (43 )     (21 )     —         —    

Currency translation

     —         18       —         1       —         —    
                                                

Fair value of plan assets, December 31

   $ 1,116     $ 479     $ 929     $ 401       —         —    
                                                

 

59


Table of Contents

The following tables summarize the funded status of the plans reconciled to amounts recorded in the consolidated balance sheet. Effective for 2006, this information is presented in accordance with the provisions of SFAS No. 158 (see Note 1) while 2005 is presented in accordance with SFAS No. 87.

 

     PENSIONS        
(Millions of dollars)    2006     2005     OPEB  

YEAR ENDED DECEMBER 31,

   U.S.     INTL     U.S.     INTL     2006     2005  

FUNDED STATUS, END OF YEAR

            

Funded status – fair value of plan assets in deficit of benefit obligation (PBO)

   $ (148 )   $ (40 )   $ (313 )   $ (16 )   $ (267 )   $ (265 )

Unrecognized (gains) losses – net

     N/A       N/A       374       41       N/A       25  

Unrecognized prior service cost

     N/A       N/A       (4 )     3       N/A       2  

Unrecognized transition amounts

     N/A       N/A       —         1       N/A       —    
                                                

Net amount recognized, December 31

   $ (148 )   $ (40 )   $ 57     $ 29     $ (267 )   $ (238 )
                                                

RECORDED IN THE BALANCE SHEET

            

Other long-term assets

   $ 1     $ 101     $ —       $ 81     $ —       $ —    

Other current liabilities

     (9 )     (11 )     (94 )     (11 )     (22 )     (22 )

Other long-term liabilities

     (140 )     (130 )     (144 )     (61 )     (245 )     (216 )

Accumulated other comprehensive income (loss), before tax

     N/A       N/A       295       20       N/A       —    
                                                

Net amount recognized, December 31

   $ (148 )   $ (40 )   $ 57     $ 29     $ (267 )   $ (238 )
                                                

AMOUNTS RECOGNIZED IN ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) CONSIST OF:

            

Minimum pension liability

     N/A       N/A     $ 295     $ 20       N/A       N/A  

Net actuarial loss (gain)

     288       71       N/A       N/A       28       N/A  

Prior service cost (credit)

     (4 )     2       N/A       N/A       (3 )     N/A  

Deferred tax benefit

     (99 )     (14 )     (104 )     (5 )     (18 )     N/A  
                                                

Amount recognized in accumulated other comprehensive income (loss) (Note 8)

   $ 185     $ 59     $ 191     $ 15     $ 7       N/A  
                                                

The amounts in accumulated other comprehensive income (loss) that are expected to be recognized as components of net periodic benefit cost during 2007 are as follows (in millions):

 

     PENSION    OPEB

Net actuarial loss

   $ 25    $ —  

Prior service cost (credit)

     2      1
             
   $ 27    $ 1
             

The following table provides information for pension plans where the accumulated benefit obligation exceeds the fair value of the plan assets:

 

     PENSIONS

(Millions of dollars)

   2006    2005

YEAR ENDED DECEMBER 31,

   U.S.*    INTL    U.S.    INTL

OBLIGATION IN EXCESS OF PLAN ASSETS

           

Projected benefit obligation

   $ 93    $ 343    $ 1,242    $ 269

Accumulated benefit obligation (ABO)

   $ 89    $ 313    $ 1,167    $ 229

Fair value of plan assets

     —      $ 202    $ 929    $ 157

* In 2006, plan assets related to the two main U.S. retirement programs exceed the ABO by a total of $5 million, while in 2005 the ABO exceeded plan assets.

The incremental effect of applying SFAS No. 158 on individual lines on the Consolidated Balance Sheet at December 31, 2006, was:

 

(Millions of dollars)

  

BEFORE
APPLICATION
OF SFAS.

NO 158

   

INCREMENTAL
EFFECT OF
APPLYING
SFAS.

NO 158

   

AFTER

APPLICATION
OF SFAS

NO. 158

 

Assets

      

Other long-term assets

   $ 608     $ (161 )   $ 447  
            

Liabilities & Equity

      

Deferred credits

   $ 767     $ (111 )   $ 656  

Other long-term liabilities

   $ 797     $ 134     $ 931  

Accumulated other comprehensive income (loss) (AOCI)*

   $ (943 )   $ (184 )   $ (1,127 )
            
     $ (161 )  
            

* In accordance with SFAS No. 158, the increase to AOCI of $184 million is made only after first considering the minimum pension liability required by SFAS No. 87, which resulted in a decrease of $139 million to AOCI. The net increase of $45 million reflects the recognition of previously unrecognized net losses, in accordance with SFAS No. 158.

 

60


Table of Contents

The assumptions used to determine the benefit obligations and the net benefit cost for the pension and OPEB plans are shown below:

 

     PENSIONS        
     U.S.     INTL     OPEB  
     2006     2005     2006     2005     2006     2005  

WEIGHTED AVERAGE ASSUMPTIONS USED TO DETERMINE BENEFIT OBLIGATIONS AT DECEMBER 31,

            

Discount rate

   5.88 %   5.62 %   6.00 %   5.45 %   5.88 %   5.62 %

Rate of increase in compensation levels

   3.50 %   3.25 %   3.00 %   3.00 %   N/A     N/A  

WEIGHTED AVERAGE ASSUMPTIONS USED TO DETERMINE NET PERIODIC BENEFIT COST FOR YEARS ENDED DECEMBER 31,

            

Discount rate

   5.62 %   5.85 %   6.00 %   5.35 %   5.62 %   5.85 %

Rate of increase in compensation levels

   3.25 %   3.00 %   3.00 %   3.00 %   N/A     N/A  

Expected long-term rate of return on plan assets (a)

   8.25 %   8.50 %   8.30 %   7.75 %   N/A     N/A  

(a) For 2007, the expected long-term rate of return on plan assets will be 8.25% for the U.S. plans. Expected weighted average returns for international plans will vary. These rates are determined annually by management based on a weighted average of current and historical market trends, historical and expected portfolio performance and the current and expected portfolio mix of investments.

 

     OPEB  

ASSUMED HEALTHCARE COST TREND RATES

   2007     2006  

Healthcare cost trend assumed

   9.00 %   10.00 %

Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)

   5.00 %   5.00 %

Year that the rate reaches the ultimate trend rate

   2010     2010  

These healthcare-cost trend rate assumptions have an impact on the amounts reported. However, cost caps limit the impact on the net OPEB benefit cost in the U.S. To illustrate the effect, a one-percentage point change in assumed healthcare cost trend rates would have the following effects:

 

     ONE-PERCENTAGE POINT  

(Millions of dollars)

   INCREASE    DECREASE  

Effect on the total of service and interest cost components of net OPEB benefit cost

   $ 1    $ (1 )

Effect on OPEB benefit obligation

   $ 7    $ (7 )

 

61


Table of Contents

PENSION PLAN ASSETS

Praxair’s U.S. and international pension plans’ weighted-average asset allocations at December 31, 2006 and 2005, and the target allocation for 2007, by asset category are as follows:

 

     U.S.     INTL  

ASSET CATEGORY

   TARGET    2006     2005     TARGET    2006     2005  

Equity securities (a)

   60%-80%    64 %   70 %   30%-55%    46 %   47 %

Debt securities

   20%-40%    35 %   30 %   45%–70%    53 %   51 %

Real estate

   0%    0 %   0 %   0%    1 %   1 %

Other (b)

   0%    1 %   0 %   0%    0 %   1 %

(a) Equity securities do not include any Praxair common stock
(b) Primarily consists of cash equivalents and short-term investments.

The investments of the U.S. pension plan are managed to meet the future expected benefit liabilities of the plan over the long term by investing in diversified portfolios consistent with prudent diversification and historical and expected capital market returns. When Praxair became an independent, publicly traded company in 1992, its former parent retained all liabilities for its term-vested and retired employees. Praxair’s plan received assets and retained pension liabilities for its own active employee base. Therefore, the liabilities under the Praxair U.S. pension plan mature at a later date compared to pension funds of other similar companies. Investment strategies are reviewed by the board of directors and investment performance is tracked against appropriate benchmarks.

The international pension plans are managed individually based on diversified investment portfolios, with different target asset allocations that vary for each plan.

CONTRIBUTIONS

Pension contributions were $126 million in 2006 and $140 million in 2005. Estimates of 2007 contributions are in the area of $25 to $50 million, of which $22 million is required by funding regulations or laws.

ESTIMATED FUTURE BENEFIT PAYMENTS

The following table presents estimated future benefit payments, net of participant contributions:

 

     PENSIONS    OPEB

(Millions of dollars)

 

YEAR ENDED DECEMBER 31,

   U.S.    INTL    TOTAL
PAYMENTS
   MEDICARE
SUBSIDY
    NET
PAYMENTS

2007

   $ 61    $ 30    $  22    $    (3)   $ 19

2008

   $ 63    $ 25    $ 23    $    (3)   $ 20

2009

   $ 68    $ 26    $ 22    $    (3)   $ 19

2010

   $ 72    $ 26    $ 22    $    (3)   $ 19

2011

   $ 76    $ 27    $ 22    $    (4)   $ 18

2012 – 2016

   $  457    $  158    $ 98    $   (21)   $  77

NOTE 18. COMMITMENTS AND CONTINGENCIES

In accordance with SFAS No. 5, “Accounting for Contingencies,” the company accrues liabilities for contingencies when management believes that a loss is probable and the amounts can be reasonably estimated, while contingent gains are recognized only when realized. In the event any losses are sustained in excess of these accruals, they will be charged to income at that time. Commitments represent obligations such as those for future purchases of goods or services that are not yet recorded on the company’s balance sheet as liabilities. The company records liabilities for commitments when incurred (i.e., when the goods or services are received).

Praxair is subject to various lawsuits and government investigations that arise from time to time in the ordinary course of business. These actions are based upon alleged environmental, tax, antitrust and personal injury claims, among others. Praxair has strong defenses in these cases and intends to defend itself vigorously. It is possible that the Company may incur losses in connection with some of these actions in excess of accrued liabilities. Management does not anticipate that in the aggregate such losses would have a material adverse effect on the company’s consolidated financial position or liquidity; however, it is possible that the final outcomes could have a significant impact on the company’s reported results of operations in any given period.

              Among such matters are claims brought by welders alleging that exposure to manganese contained in welding fumes caused neurological injury. Praxair has never manufactured welding consumables. Such products were manufactured prior to 1985 by a predecessor company of Praxair. As of December 31, 2006, Praxair was a co-defendant with many other companies in 1,531 lawsuits alleging personal injury caused by manganese contained in welding fumes. There were a total of 5,394 individual claimants in these cases. The cases were pending in several state and federal courts.

 

62


Table of Contents

The federal cases are being transferred to the U.S. District Court for the Northern District of Ohio for coordinated pretrial proceedings. The plaintiffs seek unspecified compensatory and, in most instances, punitive damages. In the past, Praxair has either been dismissed from the cases with no payment or has settled a few cases for nominal amounts. There also are eight proposed class actions seeking medical monitoring on behalf of welders. None of the class actions have been certified. No reserves have been recorded for these cases as management does not believe that a loss from them is probable or reasonably estimable.

The following table sets forth Praxair’s material commitments and contractual obligations as of December 31, 2006, excluding leases, debt, OPEB and long-term pension obligations which are summarized elsewhere in the financial statements (see Notes 4, 12, and 17):

 

(Millions of dollars)

   UNCONDITIONAL          
EXPIRING THROUGH    PURCHASE    CONSTRUCTION    GUARANTEES

DECEMBER 31,

   OBLIGATIONS    COMMITMENTS    AND OT HER

2007

   $ 220    $ 671    $ 77

2008

     175      296      —  

2009

     150      3      1

2010

     118      —        —  

2011

     115      —        —  

Thereafter

     413      —        11
                    
   $ 1,191    $ 970    $ 89
                    

Unconditional purchase obligations of $1,191 million represent contractual commitments under various long- and short-term, take-or-pay arrangements with suppliers and are not included on Praxair’s balance sheet. These obligations are primarily minimum purchase commitments for helium, electricity, natural gas and feedstock used to produce atmospheric gases, carbon dioxide and hydrogen. During 2006, payments under these contracts totaled $717 million, including $302 million for electricity and $278 million for natural gas. A significant portion of these risks is passed on to customers through similar take-or-pay contractual arrangements. Purchase obligations which are not passed along to customers do not represent a significant risk to Praxair.

Construction commitments of $970 million represent outstanding commitments to customers or suppliers to complete authorized construction projects as of December 31, 2006. A significant portion of Praxair’s capital spending is related to the construction of new production facilities to satisfy customer commitments which may take a year or more to complete.

Guarantees and other of $89 million include $22 million related to required minimum pension contributions and $67 million related to Praxair’s contingent obligations under guarantees of certain debt of unconsolidated affiliates. Unconsolidated equity investees had total debt of approximately $285 million at December 31, 2006, which was non-recourse to Praxair with the exception of the guaranteed portions described above. Praxair has no financing arrangements with closely-held related parties.

At December 31, 2006, Praxair had undrawn outstanding letters of credit, bank guarantees and surety bonds valued at approximately $595 million from financial institutions. These related primarily to customer contract performance guarantees (including plant construction in connection with certain on-site contracts), self-insurance claims and other commercial and governmental requirements.

NOTE 19. S EGMENT INFORMATION

The company’s operations are organized into five reportable segments, four of which have been determined on a geographic basis of segmentation: North America, Europe, South America and Asia. In addition, Praxair operates its worldwide surface technologies business through its wholly owned subsidiary, Praxair Surface Technologies, Inc., which represents the fifth reportable segment.

Praxair’s operations consist of two major product lines: industrial gases and surface technologies. The industrial gases product line centers on the manufacturing and distribution of atmospheric gases (oxygen, nitrogen, argon, rare gases) and process gases (carbon dioxide, helium, hydrogen, electronic gases, specialty gases, acetylene). Many of these products are co-products of the same manufacturing process. Praxair manufactures and distributes nearly all of its products and manages its customer relationships on a regional basis. Praxair’s industrial gases are distributed to various end markets within a regional segment through one of three basic distribution methods: on-site or tonnage; merchant liquid; and packaged or cylinder gases. The distribution methods are generally integrated in order to best meet the customer’s needs and very few of its products can be economically transported outside of a region. Therefore, the distribution economics are specific to the various geographies in which the company operates and are consistent with how management assesses performance.

Praxair evaluates the performance of its reportable segments based primarily on operating profit, excluding inter-company royalties and special charges. Sales are determined based on the country in which the legal subsidiary is domiciled. Corporate and globally managed expenses, and research and development costs relating to Praxair’s global industrial gases business, are allocated to operating segments based on sales. Long-lived assets include property, plant and equipment, other intangible assets and goodwill.

The table below presents information about reportable segments for the years ended December 31, 2006, 2005 and 2004. Effective in 2006, Praxair changed its presentation of segment sales to reflect external sales only. Segment operating profit was not impacted. Prior period information has been reclassified to conform to current period presentation.

 

63


Table of Contents

(Millions of dollars)

   2006    2005    2004

SALES (a)

        

North America

   $ 4,696    $ 4,429    $ 3,959

Europe

     1,163      1,088      836

South America

     1,348      1,123      866

Asia

     636      543      487

Surface technologies (b)

     481      473      446
                    
   $ 8,324    $ 7,656    $ 6,594
                    

OPERATING PROFIT

        

North America

   $ 822    $ 685    $ 623

Europe

     266      263      214

South America

     252      202      152

Asia

     111      95      80

Surface technologies (b)

     68      48      34
                    
   $ 1,519    $ 1,293    $ 1,103
                    

TOTAL ASSETS (c)

        

North America

   $ 5,549    $ 5,500    $ 5,210

Europe

     1,921      1,706      1,866

South America

     2,030      1,764      1,405

Asia

     1,124      977      847

Surface technologies

     478      544      550
                    
   $ 11,102    $ 10,491    $ 9,878
                    

DEPRECIATION AND AMORTIZATION

        

North America

   $ 380    $ 373    $ 344

Europe

     105      101      72

South America

     106      91      70

Asia

     72      63      55

Surface technologies

     33      37      37
                    
   $ 696    $ 665    $ 578
                    

CAPITAL EXPENDITURES AND ACQUISITIONS

        

North America (Note 3)

   $ 625    $ 517    $ 573

Europe (Note 3)

     119      107      756

South America

     189      154      96

Asia

     141      126      153

Surface technologies

     40      17      19
                    
   $ 1,114    $ 921    $ 1,597
                    

SALES BY MAJOR COUNTRY

        

United States

   $ 3,761    $ 3,610    $ 3,317

Brazil

     1,111      939      700

Other – foreign

     3,452      3,107      2,577
                    
   $ 8,324    $ 7,656    $ 6,594
                    

LONG-LIVED ASSETS BY MAJOR COUNTRY

        

United States

   $ 3,489    $ 3,457    $ 3,454

Brazil

     1,191      1,010      813

Other – foreign

     3,698      3,267      3,318
                    
   $ 8,378    $ 7,734    $ 7,585
                    

(a) Intersegment sales, primarily from North America to other segments, were not significant for the years ended December 31, 2006, 2005 and 2004.
(b) On July 3, 2006, Praxair completed the sale of its aviation services business, which contributed full year 2005 sales of approximately $80 million ($67 million of which was reflected in the Surface technologies segment).
(c) Includes equity investments as of December 31 as follows:

 

(Millions of dollars)

   2006    2005    2004

North America

   $ 56    $ 54    $ 52

Europe

     124      126      132

Asia

     38      38      26
                    
   $ 218    $ 218    $ 210
                    

 

64


Table of Contents

NOTE 20. QUARTERLY DATA (UNAUDITED)

 

(Dollar amounts in millions, except per share data)

                           

2006

   1Q    2Q    3Q    4Q     YEAR  

Sales

   $ 2,026    $ 2,076    $ 2,099    $ 2,123     $ 8,324  

Cost of sales, exclusive of depreciation and amortization

   $ 1,207    $ 1,238    $ 1,259    $ 1,264     $ 4,968  

Depreciation and amortization

   $ 171    $ 174    $ 173    $ 178     $ 696  

Operating profit

   $ 352    $ 382    $ 392    $ 393     $ 1,519  

Net income

   $ 225    $ 247    $ 247    $ 269     $ 988  

BASIC PER SHARE DATA

             

Net income

   $ 0.69    $ 0.76    $ 0.76    $ 0.83     $ 3.05  

Weighted average shares (000’s)

     323,804      323,519      323,582      323,077       323,495  

DILUTED PER SHARE DATA

             

Net income

   $ 0.68    $ 0.75    $ 0.75    $ 0.82     $ 3.00  

Weighted average shares (000’s)

     330,043      329,880      329,498      329,508       329,293  

2005

   1Q    2Q    3Q (a)    4Q     YEAR  

Sales

   $ 1,827    $ 1,919    $ 1,890    $ 2,020     $ 7,656  

Cost of sales, exclusive of depreciation and amortization

   $ 1,109    $ 1,167    $ 1,144    $ 1,221     $ 4,641  

Depreciation and amortization

   $ 162    $ 163    $ 165    $ 175     $ 665  

Operating profit

   $ 309    $ 322    $ 317    $ 345     $ 1,293  

Income before cumulative effect of change in accounting principle

   $ 195    $ 209    $ 108    $ 220     $ 732  

Cumulative effect of change in accounting principle (b)

     —        —        —        (6 )     (6 )
                                     

Net income

   $ 195    $ 209    $ 108    $ 214     $ 726  
                                     

BASIC PER SHARE DATA

             

Income before cumulative effect of change in accounting principle

   $ 0.60    $ 0.65    $ 0.33    $ 0.68     $ 2.26  

Cumulative effect of change in accounting principle (b)

     —        —        —        (0.02 )     (0.02 )
                                     

Net income

   $ 0.60    $ 0.65    $ 0.33    $ 0.66     $ 2.24  
                                     

Weighted average shares (000’s)

     323,818      323,898      324,137      323,207       323,765  

DILUTED PER SHARE DATA

             

Income before cumulative effect of change in accounting principle

   $ 0.59    $ 0.63    $ 0.33    $ 0.67     $ 2.22  

Cumulative effect of change in accounting principle (b)

     —        —        —        (0.02 )     (0.02 )
                                     

Net income

   $ 0.59    $ 0.63    $ 0.33    $ 0.65     $ 2.20  
                                     

Weighted average shares (000’s)

     329,669      329,818      329,993      329,113       329,685  

(a) The third quarter 2005 includes an income tax charge of $92 million, or $0.28 per diluted share, for the repatriation of foreign earnings pursuant to the American Jobs Creation Act of 2004 and other tax adjustments.
(b) Related to the adoption of FIN 47, “Accounting for Conditional Asset Retirement Obligations” (see Note 2).

 

65


Table of Contents

MANAGEMENT’S STATEMENT OF RESPONSIBILITY FOR FINANCIAL STATEMENTS

Praxair’s consolidated financial statements are prepared by management, which is responsible for their fairness, integrity and objectivity. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America applied on a consistent basis, except for accounting changes as disclosed, and include amounts that are estimates and judgments. All historical financial information in this annual report is consistent with the accompanying financial statements.

Praxair maintains accounting systems, including internal accounting controls, monitored by a staff of internal auditors, that are designed to provide reasonable assurance of the reliability of financial records and the protection of assets. The concept of reasonable assurance is based on recognition that the cost of a system should not exceed the related benefits. The effectiveness of those systems depends primarily upon the careful selection of financial and other managers, clear delegation of authority and assignment of accountability, inculcation of high business ethics and conflict- of-interest standards, policies and procedures for coordinating the management of corporate resources, and the leadership and commitment of top management. In compliance with Section 404 of the Sarbanes-Oxley Act of 2002, Praxair assessed its internal control over financial reporting and issued a report (see below).

PricewaterhouseCoopers LLP, an independent registered public accounting firm, has completed an integrated audit of Praxair’s 2006, 2005 and 2004 consolidated financial statements and of its internal control over financial reporting as of December 31, 2006 in accordance with the standards of the Public Company Accounting Oversight Board (United States) as stated in their report appearing on page 67.

The Audit Committee of the Board of Directors, which consists solely of non-employee directors, is responsible for overseeing the functioning of the accounting system and related controls and the preparation of annual financial statements. The Audit Committee periodically meets with management, internal auditors and the independent accountants to review and evaluate their accounting, auditing and financial reporting activities and responsibilities, including management’s assessment of internal control over financial reporting. The independent registered public accounting firm and internal auditors have full and free access to the Audit Committee and meet with the committee, with and without management present.

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Praxair’s management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rule 13a-15(f). Under the supervision and with the participation of management, including the company’s principal executive officer and principal financial officer, the company conducted an evaluation of the effectiveness of its internal control over financial reporting based on the framework in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (often referred to as COSO). Based on this evaluation, management concluded that the company’s internal control over financial reporting was effective as of December 31, 2006.

Management’s assessment of the effectiveness of the company’s internal control over financial reporting as of December 31, 2006 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report appearing on page 67.

 

LOGO

STEPHEN F. ANGEL

President and Chief Executive Officer

 

LOGO

JAMES S. SAWYER

Executive Vice President and Chief Financial Officer

 

LOGO

PATRICK M. CLARK

Vice President and Controller

Danbury, Connecticut

February 27, 2007

 

66


Table of Contents

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

TO THE BOARD OF DIRECTORS AND SHAREHOLDERS OF PRAXAIR, INC:

We have completed integrated audits of Praxair Inc.’s 2006, 2005 and 2004 consolidated financial statements and of its internal control over financial reporting as of December 31, 2006, in accordance with the standards of the Public Company Accounting Oversight Board (United States). Our opinions, based on our audits, are presented below.

CONSOLIDATED FINANCIAL STATEMENTS

In our opinion, the accompanying consolidated balance sheets and the related consolidated statements of income, shareholders’ equity and cash flows present fairly, in all material respects, the financial position of Praxair Inc. and its subsidiaries at December 31, 2006 and 2005, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2006 in conformity with accounting principles generally accepted in the United States of America. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audits. We conducted our audits of these statements in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit of financial statements includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, and evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

As discussed in Notes 1 and 2 to the consolidated financial statements, the Company has recognized conditional asset retirement obligations to conform with the provisions of FASB Interpretation No. 47, “Accounting for Conditional Asset Retirement Obligations” as of December 31, 2005; recognized compensation expense for all share-based payments in accordance with the provisions of FASB 123(R), “Share-Based Payments,” beginning as of January 1, 2006; and recognized the funded status of its benefit plans in accordance with the provisions of FASB Statement No. 158, “Employers’ Accounting for Defined Benefit Pension and Other Postretirement Plans – an amendment of FASB Statements No. 87, 88, 106, and 132(R),” as of December 31, 2006.

INTERNAL CONTROL OVER FINANCIAL REPORTING

Also, in our opinion, management’s assessment, included in Management’s Report on Internal Control Over Financial Reporting appearing on page 66 of the 2006 Annual Report to Shareholders, that the Company maintained effective internal control over financial reporting as of December 31, 2006 based on criteria established in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO), is fairly stated, in all material respects, based on those criteria.

Furthermore, in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2006, based on criteria established in Internal Control – Integrated Framework issued by the COSO. The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting. Our responsibility is to express opinions on management’s assessment and on the effectiveness of the Company’s internal control over financial reporting based on our audit. We conducted our audit of internal control over financial reporting in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. An audit of internal control over financial reporting includes obtaining an understanding of internal control over financial reporting, evaluating management’s assessment, testing and evaluating the design and operating effectiveness of internal control, and performing such other procedures as we consider necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinions.

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

LOGO

PRICEWATERHOUSECOOPERS

Stamford, Connecticut

February 27, 2007

 

67


Table of Contents

FIVE-YEAR FINANCIAL SUMMARY

 

(Dollar amounts in millions, except per share data)

                              

YEAR ENDED DECEMBER 31,

   2006     2005 (a)     2004     2003     2002  

FROM THE INCOME STATEMENT

          

Sales

   $ 8,324     $ 7,656     $ 6,594     $ 5,613     $ 5,128  

Cost of sales, exclusive of depreciation and amortization

     4,968       4,641       3,987       3,328       2,950  

Selling, general and administrative

     1,086       987       869       766       751  

Depreciation and amortization

     696       665       578       517       483  

Research and development

     87       80       77       75       69  

Other income (expenses) – net

     32       10       20       (5 )     48  
                                        

Operating profit

     1,519       1,293       1,103       922       923  

Interest expense – net

     155       163       155       151       206  
                                        

Income before taxes

     1,364       1,130       948       771       717  

Income taxes

     355       376       232       174       158  
                                        
     1,009       754       716       597       559  

Minority interests

     (31 )     (37 )     (30 )     (24 )     (20 )

Income from equity investments

     10       15       11       12       9  
                                        

Income before cumulative effect of change in accounting principle

     988       732       697       585       548  

Cumulative effect of change in accounting principle (b)

     —         (6 )     —         —         (139 )
                                        

Net income

   $ 988     $ 726     $ 697     $ 585     $ 409  
                                        

PER SHARE DATA (c)

          

Basic earnings per share:

          

Income before cumulative effect of change in accounting principle

   $ 3.05     $ 2.26     $ 2.14     $ 1.79     $ 1.68  

Net income

   $ 3.05     $ 2.24     $ 2.14     $ 1.79     $ 1.26  

Diluted earnings per share:

          

Income before cumulative effect of change in accounting principle

   $ 3.00     $ 2.22     $ 2.10     $ 1.77     $ 1.66  

Net income

   $ 3.00     $ 2.20     $ 2.10     $ 1.77     $ 1.24  

Cash dividends per share

   $ 1.00     $ 0.72     $ 0.60     $ 0.46     $ 0.38  

WEIGHTED AVERAGE SHARES OUTSTANDING (000’S) (c)

          

Basic shares outstanding

     323,495       323,765       325,891       326,388       325,536  

Diluted shares outstanding

     329,293       329,685       331,403       330,991       329,489  

OTHER INFORMATION AND RATIOS

          

Total debt

   $ 3,167     $ 3,447     $ 3,525     $ 2,816     $ 2,748  

Capital expenditures and acquisitions (d)

   $ 1,114     $ 921     $ 1,597     $ 1,056     $ 611  

Cash flow from operations

   $ 1,752     $ 1,475     $ 1,243     $ 1,137     $ 1,001  

Total assets at year end

   $ 11,102     $ 10,491     $ 9,878     $ 8,305     $ 7,401  

Return on equity (e)

     23.4 %     21.3 %     20.0 %     20.5 %     21.7 %

After-tax return on capital (e)

     14.6 %     12.8 %     12.1 %     12.3 %     12.9 %

Debt-to-capital ratio (e)

     39.9 %     45.6 %     47.9 %     46.2 %     52.3 %

Shares outstanding at year-end (000’s) (c)

     320,861       322,339       323,621       326,086       324,536  

Number of employees

     27,042       27,306       27,020       25,438       25,010  

(a) Amounts include a $92 million income tax charge, or $0.28 per diluted share, recorded in the 2005 third quarter related to the repatriation of foreign earnings pursuant to the American Jobs Creation Act of 2004 and other tax adjustments.
(b) 2005 and 2002 net income include the cumulative effect of accounting changes relating to the implementation of new accounting standards for asset retirement obligations, goodwill impairment and derivatives, respectively.
(c) Per share data, weighted average and total shares outstanding have been adjusted, where applicable, to reflect the December 15, 2003 two-for-one stock split which was effected as a stock dividend.
(d) Capital expenditures and acquisitions for 2004 include the acquisition of HCS in June for $245 million and the German acquisition in December for $667 million (see Note 3 to the consolidated financial statements). Capital expenditures and acquisitions for 2003 include the purchase of previously leased assets for $339 million.
(e) Non-GAAP measure. See the Non-GAAP Financial Measures on page 69 for definitions and reconciliation to reported amounts.

 

68


Table of Contents

NON-GAAP FINANCIAL MEASURES

The company presents the following non-GAAP financial measures on pages 38-39 and 68 of this annual report:

 

(Dollar amounts in millions, except per share data)

      

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2003     2002  

After-tax return on capital

   14.6 %   12.8 %   12.1 %   12.3 %   12.9 %

Return on equity

   23.4 %   21.3 %   20.0 %   20.5 %   21.7 %

Debt-to-capital

   39.9 %   45.6 %   47.9 %   46.2 %   52.3 %

AFTER-TAX RETURN ON CAPITAL

After-tax return on capital is defined as after-tax adjusted operating profit plus income from equity investments, divided by average capital, and excluding special items. Capital is comprised of total debt, minority interests, shareholders’ equity and preferred stock. Praxair’s definition of after-tax return on capital may not be comparable to similar definitions used by other companies. The company believes that its after-tax return on invested capital is an appropriate measure for judging performance as it reflects the approximate after-tax profit earned as a percentage of investments by all parties in the business (debt, minority interests, preferred stock, and shareholders’ equity).

 

(Dollar amounts in millions)

      

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2003     2002  

Reported operating profit

   $ 1,519     $ 1,293     $ 1,103     $ 922     $ 923  

Less: pro forma stock option expense

     —         (40 )     (42 )     (42 )     (38 )
                                        

Adjusted operating profit

     1,519       1,253       1,061       880       885  
                                        

Less: adjusted taxes

          

Reported income taxes

     355       376       232       174       158  

Less: tax benefit on pro forma stock option expense

     —         (14 )     (14 )     (14 )     (13 )

Less: Repatriation and other income tax charges

     —         (92 )     —         —         —    
                                        

Adjusted taxes

     (355 )     (270 )     (218 )     (160 )     (145 )
                                        

Less: tax benefit on interest expense (a)

     (41 )     (42 )     (39 )     (36 )     (46 )

Add: equity income

     10       15       11       12       9  
                                        

Net operating profit after tax (NOPAT)

   $ 1,133     $ 956     $ 815     $ 696     $ 703  
                                        

Beginning capital

   $ 7,551     $ 7,358     $ 6,099     $ 5,252     $ 5,627  

Ending capital (b)

   $ 7,943     $ 7,551     $ 7,358     $ 6,099     $ 5,252  

Average capital

   $ 7,747     $ 7,455     $ 6,729     $ 5,676     $ 5,440  

After-tax return on capital ( b,c )

     14.6 %     12.8 %     12.1 %     12.3 %     12.9 %

(a) Tax benefit on interest expense is computed using the effective rate adjusted for non-recurring income tax benefits and charges. The effective rates used were as follows: 2006, 26%; 2005, 26%; 2004, 25%; 2003, 24%; and 2002, 22%.
(b) 2003 ending capital includes the impact of the purchase of previously leased assets for $339 million. Consequently, after-tax return on capital was reduced by 0.4% in 2003.
(c) After-tax return on capital was reduced by 0.6% in 2004 due to the German acquisition in December (see Note 3 to the consolidated financial statements).

RETURN ON EQUITY

Return on equity is defined as income before changes in accounting principles, excluding special items and goodwill amortization, divided by average shareholders’ equity. Praxair’s definition of return on equity may not be comparable to similar definitions used by other companies. The company believes that its return on equity is an appropriate measure for judging performance for shareholders.

 

(Dollar amounts in millions)

      

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2003     2002  

Reported income before accounting change

   $ 988     $ 732     $ 697     $ 585     $ 548  

Less: pro forma stock option expense, net of taxes

     —         (26 )     (28 )     (28 )     (25 )

Add: Repatriation and other income tax charges

     —         92       —         —         —    
                                        

Adjusted income before accounting change

   $ 988     $ 798     $ 669     $ 557     $ 523  
                                        

Beginning shareholders’ equity

   $ 3,902     $ 3,608     $ 3,088     $ 2,340     $ 2,477  

Ending shareholders’ equity

   $ 4,554     $ 3,902     $ 3,608     $ 3,088     $ 2,340  

Average shareholders’ equity

   $ 4,228     $ 3,755     $ 3,348     $ 2,714     $ 2,409  

Return on equity

     23.4 %     21.3 %     20.0 %     20.5 %     21.7 %

DEBT-TO-CAPITAL RATIO

Debt-to-capital ratio is defined as debt divided by total capital. Total capital consists of debt, minority interests and shareholders’ equity. Praxair’s definition of debt-to-capital may not be comparable to similar definitions used by other companies. The company believes that debt-to-capital is appropriate for measuring its financial leverage.

 

(Dollar amounts in millions)

      

YEAR ENDED DECEMBER 31,

   2006     2005     2004     2003     2002  

Total capital

          

Debt

   $ 3,167     $ 3,447     $ 3,525     $ 2,816     $ 2,748  

Minority interests

     222       202       225       195       164  

Shareholders’ equity

     4,554       3,902       3,608       3,088       2,340  
                                        
   $ 7,943     $ 7,551     $ 7,358     $ 6,099     $ 5,252  
                                        

Debt-to-capital ratio

     39.9 %     45.6 %     47.9 %     46.2 %     52.3 %

 

69


Table of Contents

INVESTOR INFORMATION

Elizabeth T. Hirsch, Director, Investor Relations

Praxair, Inc.

39 Old Ridgebury Road

Danbury, Connecticut 06810-5113

e-mail: investor_relations@praxair.com

(203) 837-2210

INVESTOR INFORMATION AT WWW. PRAXAIR.COM/INVESTORS

 

— Annual reports    — Monthly business trends   
— Calendar    — Press releases   
— Disclosure practices    — Quarterly earnings   
— FAQs    — Stock information   
— Financial news & information    — Investor package   
— Five-year financials    — Presentations   
— Earnings guidance    — SEC filings   
   — Sustainability report   

COMMON STOCK LISTING (SYMBOL: PX)

New York Stock Exchange

OTHER STOCK EXCHANGES TRADING PRAXAIR STOCK

Cincinnati

Midwest

Pacific

NUMBER OF SHAREHOLDERS

There were 20,242 shareholders of record as of December 31, 2006.

DIVIDEND POLICY

Dividends on Praxair’s common stock are usually declared and paid quarterly. Praxair’s objective is to continue quarterly dividends and consider annual dividend increases in conjunction with continued growth in earnings per share.

STOCK TRANSFER AGENT AND STOCK RECORD KEEPING

Registrar and Transfer Company is Praxair’s stock transfer agent and registrar, and maintains shareholder records. For information about account records, stock certificates, change of address and dividend payments, contact:

1-800-368-5948 or info@rtco.com

website address: http://www.rtco.com

BY MAIL , ADDRESS SHARE HOLDER INQUIRIES TO:

Shareholder Relations Department

Registrar and Transfer Company

10 Commerce Drive

Cranford, NJ 07016

DIVIDEND REINVESTMENT PLAN

Praxair provides investors a convenient, low-cost program that allows dividends to be automatically reinvested into additional shares of Praxair common stock and allows purchases of additional shares of Praxair common stock without commissions. Contact Shareholder Relations at Registrar and Transfer Company for full details at the address above.

COMPLIANCE WITH NYSE CORPORATE GOVERNANCE LISTING STANDARDS

As required by New York Stock Exchange rules, on May 18, 2006, the company submitted to the NYSE an unqualified CEO annual certification of compliance with NYSE’s Corporate Governance Listing Standards. Praxair expects to do so again within 30 days after the annual meeting of shareholders.

Praxair has also filed with its annual report on Form 10-K for 2006 the CEO and CFO certifications (regarding the quality of the company’s financial statements and its disclosure controls and procedures) required by §302 of the Sarbanes-Oxley Act of 2002 (as implemented by Securities and Exchange Commission Rule 13a-14(a) of the Securities Exchange Act of 1934).

ANNUAL SHAREHOLDERS MEETING

The 2007 annual meeting of shareholders of Praxair, Inc. will be held at 9:30 a.m. on Tuesday, April 24, 2007 at the Sheraton Danbury, 18 Old Ridgebury Road, Danbury, Connecticut.

NYSE QUARTERLY STOCK PRICE AND DIVIDEND INFORMATION

 

MARKET PRICE

  

TRADING

HIGH

  

TRADING

LOW

  

CLOSE

  

DIVIDEND

PER SHARE

           

2006

           

First Quarter

   $ 57.44    $ 50.65    $ 55.15    $ 0.25

Second Quarter

   $ 57.60    $ 50.76    $ 54.00    $ 0.25

Third Quarter

   $ 60.08    $ 51.60    $ 59.16    $ 0.25

Fourth Quarter

   $ 63.70    $ 57.20    $ 59.33    $ 0.25

2005

           

First Quarter

   $ 48.50    $ 41.06    $ 47.86    $ 0.18

Second Quarter

   $ 49.42    $ 43.48    $ 46.60    $ 0.18

Third Quarter

   $ 51.74    $ 44.55    $ 47.93    $ 0.18

Fourth Quarter

   $ 54.31    $ 45.80    $ 52.96    $ 0.18

2004

           

First Quarter

   $ 38.76    $ 34.52    $ 37.12    $ 0.15

Second Quarter

   $ 40.14    $ 34.80    $ 39.91    $ 0.15

Third Quarter

   $ 43.03    $ 37.59    $ 42.74    $ 0.15

Fourth Quarter

   $ 46.25    $ 40.73    $ 44.15    $ 0.15

Praxair and the flowing airstream design, AOD, CoJet, Grab’n Go, I-SO, MixFlo, Medipure, StarSolver and ProStar are trademarks or registered trademarks of Praxair Technology, Inc. in the United States and/or other countries.

© 2007 Praxair Technology, Inc. All rights reserved.

Design: SVP Partners, Wilton, CT | Major Photography: Ted Kawalerski, NY

Board Photography: James Rudnick, NY | Illustration: Daniels and Daniels, CA

 

71

SUBSIDIARIES OF PRAXAIR, INC.

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

The following is a list of the Company’s subsidiaries, including unconsolidated affiliates, as of December 31, 2006.

 

    

Place of

Incorporation            

    

3R Associati S.p.A.

   Italy   

640733 British Columbia Ltd.

   British Columbia   

A. I. C. E. Reti S.c.a.r.l.

   Italy   

Accent Cay Holdings Inc.

   British Virgin Islands   

Agas Servizi S.r.l.

   Italy   

American Home Oxygen and Hospital Equipment, Inc.

   Florida   

AMKO Service Company

   Ohio   

Andaluza de Gases S.A.

   Spain   

Antwerpse Chemische Bedrijven (LCB) N. V.

   Belgium   

Argim Ltd.

   Israel   

Arroweld Italia S.p.A.

   Italy   

Asistencia Tecnologica Medioambiental, S.A.

   Spain   

Asistir Ltda.

   Colombia   

AST Services, LLC

   Delaware   

Augusta Company Limited

   Thailand   

Beijing Praxair Huashi Carbon Dioxide Co., Ltd.

   China   

Beijing Praxair, Inc.

   China   

Bieffe Saldatura S.r.l.

   Italy   

Calizas Elycar, S.L.

   Spain   

Carbitalia S.p.A.

   Italy   

Carbonorte S.L.

   Spain   

Carburo del Cinca, S.A.

   Spain   

Caring Medical Supply Corp.

   Pennsylvania   

Carolina Home Care, Inc.

   South Carolina   

Casa di cura Villa Erbosa S.p.A.

   Italy   

CBI Investments, Inc.

   Delaware   

Chanceller Servicos de Lavanderia Industrial Ltda.

   Brazil   

Cliffside Helium, L.L.C.

   Delaware   

Chemgas S.r.l.

   Italy   

Cliffside Refiners, L.P.

   Delaware   

Clifford F. Schultze & Co.

   Illinois   

Coatec Gesellschaft für Oberflächenveredelung mbH & Co. KG

   Germany   

Compressions Gas Tecnic S.r.l.

   Italy   

Coan Service S.r.l.

   Italy   

Consorcio Gemini

   Brazil   

Ltd.

   British Columbia   


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation            

Consorgas S.r.l.

   Italy

Consorzio Tuscia Energia

   Italy

Constructors Lix da Cuna S.A.

   Brazil

Consultora Rynuter S. A.

   Uruguay

Craig Home Care, Inc.

   Texas

Cryo Teruel S.A.

   Spain

Cylmaint N.V.

   Belgium

D’Angelo S.p.A.

   Italy

Dayvault’s Home Medical, Inc.

   North Carolina

Distribuidora Mexicana de Criogénicos, S.A. de C.V.

   Mexico

Doctors Choice Home Medical Equipment of Largo, Inc.

   Florida

Domolife S.r.l.

   Italy

Dryce Italia S.r.l.

   Italy

ESA S.r.l.

   Italy

Eubask, S. L.

   Spain

FAS S.r.l.

   Italy

Ferrygas, S.A.

   Spain

Flarco S.r.l.

   Italy

Fred E. McGilberry & Associates, Inc.

   Texas

Gas Lucchetta S.r.l.

   Italy

Gas Tecnici Foligno S.r.l.

   Italy

Gascarbo SAIC

   Argentina

Gases de Ensenada S.A.

   Argentina

Gases Tachira S.A.

   Venezuela

Gases Valles del Tuy S.A.

   Venezuela

General Gas S.r.l.

   Italy

Globos Properties S.a.r.l.

   Luxembourg

GNL Gemini Comercializacao e Logistica de Gas Ltda.

   Brazil

Grenslandgas G.m.b.H.

   Germany

Grupo Praxair, S. de R.L. de C.V.

   Mexico

HCS Holdings, Inc.

   Delaware

Helium Centre Pte. Ltd.

   Singapore

Hielo Seco Srl.

   Bolivia

Home Care Medical, Inc.

   Florida

Home Care Supply, Inc.

   Delaware

Home Care Supply, L.L.C.

   Texas

Home Hospital Services, Inc.

   Texas

Hobart Industrial Gases and Supplies, Inc.

   Indiana

I.T.A. S.r.l.

   Italy

Iberica del Carbonico S.A. (Ibercasa)

   Spain


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

IGAT - Industria Gas Tecnici S.p.A.

   Italy

Industria Paraguaya de Gases S.A.

   Paraguay

Industrias Reunidas de Plastico e Mineracao S. A.

   Brazil

Ingemedical Ltda.

   Colombia

Innovative Membrane Systems, Inc.

   Delaware

Integrar Comercio e Servicos Industriais Ltda.

   Brazil

International Compressor Technologies S.A.S.

   France

International Cryogenic Equipment Corporation

   Delaware

Istragas Gas Tecnici e Petroliferi D.o.o.

   Slovenia

Italargon S.r.l.

   Italy

Jalopy Shoppe, Inc.

   Texas

Jamaica Oxygen & Acetylene Limited

   Jamaica

Jindal Praxair Oxygen Company Private Limited

   India

Julio Pastafiglia & Cia. S.A.

   Argentina

Kelvin Finance Company Limited

   Ireland

Korea Liquid Carbonic Co., Ltd.

   Korea

Kosmoid Finance

   Ireland

Kosmoid Finance (UK) Limited

   United Kingdom

Kunshan Praxair Co., Ltd.

   China

L. Clausen & Cia. Srl

   Argentina

Lake County Medical Gas, Inc.

   Illinois

Lida S.A.S.

   France

Liquid Carbonic Corporation

   Delaware

Liquid Carbonic del Paraguay S.A.

   Paraguay

Liquid Carbonic LNG International, Inc.

   Delaware

Liquid Carbonic of Oklahoma, Inc.

   Oklahoma

Liquid Ltda.

   Brazil

Liquido Carbonico Colombiana S.A.

   Colombia

Lo-Cost Gas Ltd.

   British Columbia

M-R Medical, Inc.

   Texas

Magaldi Gas Tecnici S.r.l.

   Italy

Magaldi Life S.r.l.

   Italy

Malaysian Industrial Gas Company Sdn. Bhd.

   Malaysia

Mathews Chemical & Supply Co.

   California

Maxima Air Separation Center Limited

   Israel

Maxima Medical Ltd.

   Israel

McGaughey-Cresswell-Mann, Inc.

   Texas

Medi-Rents Business Trust

   Massachusetts

Medi-Rents of Maine, Inc.

   Massachusetts

Medi-Rents, Inc.

   Massachusetts

 


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Medical Center Pharmacy of Boston, Inc.

   Massachusetts

Medical Gases S. R. L

   Argentina

Medigas Italia S.r.l.

   Italy

MetFabCity Inc.

   Delaware

Neotex Solucoes Ambientais Ltda.

   Brazil

Newbridge Surgical Supplies, Inc.

   New York

Nitraco N.V.

   Belgium

Nitrogen Services, Inc.

   Delaware

Nitropet, S.A. de C.V.

   Mexico

Novigas - Consorzio con Attivita Esterna

   Italy

Nuova Illafor S.r.l.

   Italy

Nupharm, Inc.

   Texas

O2 Investments, Inc.

   Texas

O3 Investments, Inc.

   Virginia

Old Danford S.A.

   Uruguay

Oriol S.r.l.

   Italy

Orobie Energia S.c.r.l.

   Italy

Oxigeno del Norte S.A.

   Spain

Oxigenos Camatagua, C. A.

   Venezuela

Oxigenos de Colombia Ltda.

   Colombia

Oximesa S.L.

   Spain

Oxinorte Operaciones S.A.

   Spain

Oxirent Argentina S. A.

   Argentina

Oxygene Industriel Girardin, Inc.

   Canada

P.T. Maharani Praxair Cilegon (MPC)

   Indonesia

Panservice S.r.l.

   Italy

Pittsburg Production, LLC

   Delaware

Praxair & M. I. Services France S.a. r. l.

   France

Praxair & M.I. Services, S.r.l.

   Italy

Praxair (Beijing) Semiconductor Gases Co., Ltd.

   China

Praxair (China) Investment Co., Ltd.

   Peoples Republic of China

Praxair (Guangzhou) Industrial Gases Co., Ltd.

   China

Praxair (Huizhou) Industrial Gases Limited

   China

Praxair (Nanjing) Carbon Dioxide Co., Ltd.

   China

Praxair (Nanjing) Gases Co., Ltd.

   China

Praxair (Shanghai) Co., Ltd.

   China

Praxair (Shanghai) Semiconductor Gases Co., Ltd.

   China

Praxair (Shanghai) Trading Co., Ltd.

   China

Praxair (Thailand) Company Limited

   Thailand

Praxair (Wuhan), Inc.

   China


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Praxair (Yueyang) Co., Ltd.

   Peoples Republic of China

Praxair Alberta Ltd.

   Alberta

Praxair Alberta Partnership

   Alberta

Praxair Argentina S.R.L.

   Argentina

Praxair Asia, Inc.

   Delaware

Praxair Australia Pty Limited

   Australia

Praxair B.V.

   Netherlands

Praxair Bolivia Ltda.

   Bolivia

Praxair Canada Inc.

   Canada

Praxair Carbondioxide Private Limited

   India

Praxair Chemax Semiconductor Materials Co. Ltd.

   Taiwan

Praxair Chile Ltda.

   Chile

Praxair CMP Products, Inc.

   New Hampshire

Praxair Costa Rica, S.A.

   Costa Rica

Praxair Deer Park Cogen, Inc.

   Delaware

Praxair Deutschland GmbH & Co. KG

   Germany

Praxair Deutschland Holding GMBH & Co. KG

   Germany

Praxair Distribuciones, S.C.A.

   Venezuela

Praxair Distribution Southeast, LLC

   Delaware

Praxair Distribution, Inc.

   Delaware

Praxair do Brasil Ltda.

   Brazil

Praxair e Companhia - Comércio e Serviços

   Portugal

Praxair E-Services Private Limited

   India

Praxair Employees Association of Danbury, Inc.

   Connecticut

Praxair Energy Resources, Inc.

   Delaware

Praxair Energy Services, Inc.

   Delaware

Praxair España, S.L.

   Spain

Praxair Euroholding, S. L.

   Spain

Praxair Europe Finance-Consultadoria e Projectos Lda.

   Portugal

Praxair Fray Bentos S.C.A.

   Uruguay

Praxair Free Trade Zone Costa Rica, Ltd.

   Costa Rica

Praxair Gases Alberta Ltd.

   Alberta

Praxair GmbH

   Germany

Praxair Healthcare Services of Indiana, LLC

   Delaware

Praxair Healthcare Services, Inc.

   Delaware

Praxair Holding Company

   Nova Scotia

Praxair Holding Latinoamerica, S.L.

   Spain

Praxair Holding N.V.

   Belgium

Praxair Holdings International, Inc.

   Delaware

Praxair Hungary Kft

   Hungary

Praxair Hydrogen Supply, Inc.

   Delaware

Praxair Iberica, S.A.

   Spain

Praxair India Private Limited

   India


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Praxair Industrias S. de R.L. de C.V.

   Mexico

Praxair Industriegase GmbH & Co. KG

   Germany

Praxair Industriegase Verwaltungs GmbH

   Germany

Praxair International Finance

   Ireland

Praxair Investments B.V.

   Netherlands

Praxair K.K.

   Japan

Praxair Korea Company, Limited

   Korea

Praxair Latin America Holdings LLC

   Delaware

Praxair Luxembourg Finance S.a.r.l.

   Luxembourg

Praxair Management Services, Inc.

   Delaware

Praxair Maritime Company

   Nova Scotia

Praxair Mexico, S. de R.L. de C.V.

   Mexico

Praxair Mexico Holdings S. de R.L. de C.V.

   Mexico

Praxair MRC S.A.S.

   France

Praxair N.V.

   Belgium

Praxair Pacific Ltd.

   Mauritius

Praxair Paraguay S.R.L.

   Paraguay

Praxair Partnership

   Delaware

Praxair PC Partnership - Association Praxair PC

   Canada

Praxair Peru S.R.L.

   Peru

Praxair Philippines, Inc.

   Philippines

Praxair PHP S.A.S.

   France

Praxair Plainfield, Inc.

   Delaware

Praxair Polska Sp. z o.o.

   Poland

Praxair Portugal Gases S.A.

   Portugal

Praxair Produccion España, S.L.

   Spain

Praxair Puerto Rico B. V.

   Netherlands

Praxair Puerto Rico LLC

   Delaware

Praxair Qingdao Co., Ltd.

   Peoples Republic of China

Praxair S.A.S.

   France

Praxair S.r.l.

   Italy

Praxair S.T. Technology, Inc.

   Delaware

Praxair Sante SAS

   France

Praxair Services (UK) Limited

   United Kingdom

Praxair Services Canada Inc.

   Ontario

Praxair Services GmbH & Co. KG

   Germany

Praxair Services, Inc.

   Texas

Praxair Shanghai Meishan Inc.

   China

Praxair Shaogang (Guangdong) Co., Ltd.

   China

Praxair Shaogang Co., Ltd.

   China

Praxair Sixon (Anhui) Industrial Gases Co., Ltd.

   China

Praxair Soldadura S.L.

   Spain


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Praxair Sudamerica S.L.

   Spain

Praxair Surface Holdings SARL

   France

Praxair Surface Technologies (Europe) S.A.

   Switzerland

Praxair Surface Technologies Co., Ltd.

   Korea

Praxair Surface Technologies do Brasil Ltda.

   Brazil

Praxair Surface Technologies España, S.A.

   Spain

Praxair Surface Technologies G.m.b.H.

   Germany

Praxair Surface Technologies K.K.

   Japan

Praxair Surface Technologies Limited

   United Kingdom

Praxair Surface Technologies Mexico, S.A. de C.V.

   Mexico

Praxair Surface Technologies Pte. Ltd.

   Singapore

Praxair Surface Technologies S.A.S.

   France

Praxair Surface Technologies S.r.L.

   Italy

Praxair Surface Technologies, Inc.

   Delaware

Praxair Taiwan Co., Ltd.

   Taiwan

Praxair Technology Solutions, Inc.

   Delaware

Praxair Technology, Inc.

   Delaware

Praxair UK Limited

   United Kingdom

Praxair Uruguay Ltda.

   Uruguay

Praxair Venezuela Sociedade en Comandita por Acciones

   Venezuela

Praxair Verwaltungs GmbH

   Germany

Praxair-Ozone, Inc.

   Delaware

Praxair.com GmbH

   Switzerland

Premetal S.r.l.

   Italy

Prerreducidos Vizcaya AIE.

   Spain

Prerreducidos Bizkaia 1, S.A.

   Spain

Production Praxair Canada Inc.

   Canada

Productos Especiales Quimicos, S.A. de C.V.

   Mexico

Pyronics S.A.

   Belgio

Quality Health Systems, Inc.

   New York

Quimica Basica, S.A.

   Spain

R.S.L.S. con S.a.r.l. (name change from R.S.B. S.c.r.l.)

   Italy

Rapidox Gases Industriais Ltda.

   Brazil

Ravenna Servizi Industriali S.C.p.A.

   Italy

RBG Comercio de Metais Ltda.

   Brazil

Rettifiche F.C.F. S.r.l.

   Italy

Rhee (Beheer) B.V.

   Netherlands

Rivoira S.p.A.

   Italy

Rivoira Siad Servizi S. Con S.A.R.L.

   Italy

S. E. B. S.c.r.l.

   Italy

S.B.S. Bakeware Technologies S.L.

   Spain

Sauerstoff und Stickstoffrohrleitungs

   Germany


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Seoul Cold Air Products Co., Ltd.

   Korea

SGX Services Inc.

   Ontario

Shanghai Chemical Industry Park Industrial Gases Co., Ltd.

   China

Shanghai Praxair Baosteel, Inc.

   China

Shanghai Praxair-Yidian Inc.

   China

SIAD Austria GmbH

   Austria

SIAD Bulgaria ood

   Bulgaria

SIAD Czech spol. s r.o.

   Czech Republic

SIAD Healthcare S.p.A.

   Italy

SIAD Hungary KFT

   Hungary

SIAD Macchine Impianti S.p.A.

   Italy

SIAD Romania s.r.l.

   Rumania

SIAD Servizi S.r.l.

   Italy

SIAD Slovakia spol. s r.o.

   Slovakia

Sinopal Pte. Ltd.

   Singapore

Smeding B. V.

   Netherlands

Sociedade Portuguesa de Oxigenio Ltda.

   Portugal

Societa Azionaria Miniere Anidride Carbonica S.A.M.A.C.

   Italy

S.p.A.

  

Societa Italiana Acetilene e Derivati S.p.A.

   Italy

Soudobeam S. A.

   Belgium

Stabiagas ASA S.r.l.

   Italy

Summania S.r.l.

   Italy

Suncoast Medical Oxygen, Inc.

   Florida

Sure/Arc Welding Supply (1977) Ltd.

   Canada

TAFA Incorporated

   Delaware

Tecno Project Industriale S.r.l.

   Italy

Tecnoservizi Ambientali S.r.l.

   Italy

Thai Carbonic Company, Ltd.

   Thailand

The Infusion Network of Louisiana, Inc.

   Louisiana

Tianjin Praxair, Inc.

   China

Tongling Praxair Co., Ltd.

   China

Topaz Consultora S.A.

   Uruguay

Tradewinds Insurance Limited

   Bermuda

Praxair Precision Components, Inc.

   Arizona

Tri-Parish Rental, Inc.

   Louisiana

Vinyard Engine Systems, Inc.

   Nevada

Waldron and Kern, Inc.

   Texas

Welco-CGI Gas Technologies, LLC

   Delaware

Weld Consult S. A.

   Belgium

Wescott Enterprises, Inc.

   South Carolina

Westair Cryogenics Company

   Delaware


SUBSIDIARIES OF PRAXAIR, INC. (Continued)

Praxair, Inc. and Subsidiaries


EXHIBIT 21.01

 

    

Place of

Incorporation        

Westair Cryogenics Holding Company

   Delaware

Westair Gas and Equipment, L.P.

   Texas

White Martins de Camacari S.A.

   Bahia

White Martins e Companhia - Comércio e Serviços

   Portugal

White Martins e White Martins Comércio e Serviços

   Portugal

White Martins Gases Industriais do Nordeste S.A.

   Brazil

White Martins Gases Industriais do Norte S.A.

   Brazil

White Martins Gases Industriais Ltda.

   Brazil

White Martins Investimentos Ltda.

   Brazil

White Martins Steel Commercial Ltda.

   Brazil

Withrow Oxygen Service, Inc.

   California

WMTM Equipamentos de Gases Ltda.

   Brazil

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Praxair, Inc. and Subsidiaries


EXHIBIT 23.01

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 33-48480, 33-93444, 333-304, 333-18141, 333-40003, 333-57386, 333-102020 and 333-139328) and in the Registration Statements on Form S-8 (No. 33-48479, 33-48478, 33-87274, 33-92868, 33-18111, 333-18113, 333-33801, 333-64608, 333-81248, 333-97191, 333-115191, 333-115192 and 333-124618) of Praxair, Inc. of our report dated February 27, 2007 relating to the financial statements, management’s assessment of the effectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in the Annual Report to Shareholders, which is incorporated in this Annual Report on Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

Stamford, Connecticut

February 27, 2007

RULE 13a-14(a) CERTIFICATIONS

Praxair, Inc. and Subsidiaries


EXHIBIT 31.01

I, Stephen F. Angel, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Praxair, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: February 27, 2007

    By:  

/s/ Stephen F. Angel

      Stephen F. Angel
     

President and Chief Executive Officer

(principal executive officer)

RULE 13a-14(a) CERTIFICATIONS

Praxair, Inc. and Subsidiaries


EXHIBIT 31.02

I, James S. Sawyer, certify that:

 

1. I have reviewed this Annual Report on Form 10-K of Praxair, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

Date: February 27, 2007

    By:  

/s/ James S. Sawyer

      James S. Sawyer
     

Executive Vice President and Chief Financial Officer

(principal financial officer)

SECTION 1350 CERTIFICATION

Praxair, Inc. and Subsidiaries


EXHIBIT 32.01

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Praxair, Inc. (the “Company”), hereby certifies that the Company’s Annual Report on Form 10-K for the year ended December 31, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 27, 2007

    By:  

/s/ Stephen F. Angel

      Stephen F. Angel
     

President and Chief Executive Officer

(principal executive officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by 18 U.S.C. § 1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

SECTION 1350 CERTIFICATION

Praxair, Inc. and Subsidiaries


EXHIBIT 32.02

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Praxair, Inc. (the “Company”), hereby certifies that the Company’s Annual Report on Form 10-K for the year ended December 31, 2006 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: February 27, 2007

    By:  

/s/ James S. Sawyer

      James S. Sawyer
     

Executive Vice President and Chief Financial Officer

(principal financial officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by 18 U.S.C. § 1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.